‫ﺔ‬

‫ﻟ‬‫ﺩ‬
‫ﺎ‬‫ﻴ‬
‫ﻠﺼ‬‫ﻟ‬
‫ﺎﺕ‬‫ﻧ‬
‫ﺎ‬
‫ﺘﺤ‬‫ﻣ‬
‫ﺇ‬
‫ﺔ‬
‫ﻨ‬‫ﻬ‬‫ﻤ‬
‫ﻟ‬‫ﺍ‬‫ﺔ‬
‫ﺭﺳ‬‫ﺎ‬
‫ﻤ‬‫ﺎﻥﻣ‬
‫ﺘﺤ‬‫ﻣ‬
‫ﺇ‬‫ﺯ‬‫ﺎ‬
‫ﻴ‬
‫ﺘ‬‫ﺇﺟ‬
‫ﺓﻓﻲ‬
‫ﺪ‬‫ﺎﻋ‬
‫ﻤﺴ‬‫ﻠ‬
‫ﻟ‬
Fi
rst100

1-Whichofthefol
lowingisnotanindicat
ionforTr
anexa micAc id?
a-Tr
eat
me ntofheamorrhageass
ocia
tedwi t
he xc
ess
ivefibrinol
ysis
b-Ananti
doteforStr
eptokina
seoverdose
c-Pr
ophylaxi
sofheredi
taryangi
oedma
d-Pr
eventheammorhageduet oHeparinoverdos
e protamine sulfate for heparin
also dose 1mg for each 1mg enoxapring
& 100mg daltaparin & 100 mg heparin

2-Whic
hofthefol
lowi
ngdr
ugsdoe
snotc
aus
eins
omni
a?
a-MAOI’s
b-Ca
ffe
ine
c-Be
tablo
ckers
d-Ba
rbi
tura
tes

3-Whi chofthefol lowi ngi sal ipidl owe r i

ngdr ugs ?
a-Aprotini
n
b-Tranexamicaci d
c-Lansoprazol
e acipimox prevent release of fat from
d-AcipimoxAprotinin is a serine protease inhibitor used to reduce the tissue giving in combination with
lipid lowering drugs
the risk for perioperative blood loss and the need for
blood transfusion in high-risk patients during cardiopulmonary
bypass for coronary artery bypass graft surgery
4-Whichoft hef
oll
owi
ngH2r
ece
ptor
sant
agoni
stha
sthehi
ghe
sta
ffi
nit
y
forc
ytochromep450?
a-Nizat
idine
b-Ranit
idine
c-Cimetidine
d-Famotidine

5-Whichofthefol
lowi
ngs
idee
ffe
ctswi
llbec
aus
edbya
nta
cidsc
ont
aini
ng
NaHCO3?
a-Belc
hing
b-Consti
pat
ion
c-Diar
rhea
d-Blur
redvisi
on
6-Whi choft hef
oll
owi
ngi
sadopa
minea
nta
goni
st
?
a-Granise
tron
b-Dompe ridone
c-Cis
a pri
de
d-Lope r
ami de

7-Whichofthef oll
owingdr
ugsi
sas
yst
emi
camoe
bic
ide
?
a-Dil
oxanidefuroat
e
b-Pyri
methamine
c-Emeti
n
d-Sodi
umSt ibogluconat
e

8-Whi chofthefol
lowi
ngdrugsi
sthedr
ugma
yca
usedi
scol
our
ati
onofna
il
bedsandmuc usme
mbrane
s?
a-Tet
racycli
ne
b-Chloroquine
c-Doxyc ycl
ine
d-Rif
a mpici
n

9-Whi choff ollowingdrugsi

sthedr
ugofc
hoi
cef
ort
het
rea
tme
ntofa
ll
for
msofSc histosomias
is?
a-Pra
z iquan t
e l
b-Me be ndazol e
c-Niclos a
mi de
d-Thiabe ndaz ole

10-Whichoft hefol
lowi
ngdr
ugsc
anbeus
edf
ort
het
rea
tme
ntofi
nfl
uenz
a
Ainfec
tion?
a-Zi
dovudi ne(AZT)
b-Amant adine
c-Ri
bava ri
n
d-Vida
ra bine

11-Whi choft hefollowingdrugsi

susedinthet
rea
tmentofLei
shmani
asi
s?
a-Pyrimetha mine
b-Diloxami de
c-SodiumSt i
bogluconate
d-Eme ti
n
12-Whi choneoft hefol
lowingsta
tement
saboutt
etr
acycl
inei
snotc
orrec
t?
a-Iti
sus efulfort
het rea
tmentofresi
st
antst
rai
ns
b-I
tiscont
rai
ndi
cat
e dinpregna
ncy
c-I
tiss
a f
eininf
ect
ionscausedbyChla
mydi
a
d-I
tcanleadt
odisc
ol our
ati
onofte
ethi
fgi
vent
ochi
ldr
en

13-Whichofthef
oll
owi
ngdr
ugwi
lla
nta
goni
zeMethot re xate?
a-Thia
mine
b-Foli
cacid folinic acid = leucoverin
c-Biot
in methotrexate antidote
d-Cyanocobal
ami
n used 24 hrs after methotrexate

14-lodi
neisfoundi
nal
loft
hef
oll
owi
nge
xce
pt:
a-Codl i
veroi
l
b-Seafood
c-Ke l
p
d-Iodiz
edsalt

15-Ma
tchthest
ateme
nts(
1-4)t
othet
rac
eele
me nt
s(A-
D)l
is
ted
bel
ow.
eachans
we rmaybeus
edmoret
hanonce:

a
-Zi
ncb-Coppe
rc-Chr
omi
umd-Se
leni
um

1.Formationofr edandwhit
ebloodcell
s-b
2.Prote
ctsce l
lsagai
nstdamagedur
ingc e
llula
rme t
abol
is
m-d
3.Promoteswoundhe al
inga
ndnorma lgrowth-a
4.He l
psma intai
nnormalglu
c os
eme t
abolism-c

16-Ma t
chthedrugchar
act
eri
st
ics(
1-4)wit
hthedr
ugl
is
tedbe low( a-d).
eachanswerma ybeus
edmorethanonce
a-Auranofi
n
b-Pencil
la
mi ne penicillamine for wilson disease
c-Aspir
in copper accumulation in the body
d-Corti
cost
eroi
ds

1-Pl
at
el
etfunct
ioneff
ect
-c
2-Or
alfo
rmofgol d-
a
3-Gi
venona nemptyst
omach-
b
4-Maybegivenint
raar
ti
cul
arl
y-d
17-f
orea
chsideef
fec
t(1-4)l
is
tthemos
tli
kel
yca
use(
a-d)
.ea
cha
nswe
r
maybeusedmoret
hanonces

a-SodiumBic a
rbonate
b-AluminiumHydr oxide
c-Ami t
ri
ptyl
ine
d-Ma gnes
iumHydr oxide

i
1-Ma yc
ausediar
rhea-
d
i
2-Shoul
dnotbeus e
dbypa t
ie
ntofhe
artf
ail
ure
-a
i
3-Ma yc
ausedrymouth-c
i
4-Canbeincor
porat
edwithanant
aci
dsmixt
uretoc
ont
roldi
arhoe
a-b

18-Pyr idoxinerequi
reme
ntsma
yinc
rea
sedur
inga
dmi
nis
tra
tionofa
llt
he
fol
lowi nge xcept:
a-Isoniazid
b-Cyc loserine
c-Or alcontracept
ive
s
d-Le vodopa

19-Allofthefoll
owingprepa
rat
ionsc
ont
aina
lcohole
xce
pt:
a-Syrupsi
mple x
b-Aroma t
icammon iaspi
ri
tUSP
c-Terpi
nhydra t
eeli
xirUSP
d-Bella
donatinct
ureB.P

20-Whichoft hefoll
owi ngsoluti
onsisus
eda
sana
str
inge
nt?
a-St
rongiodinesoluti
onUSP
b-Alumini
uma ce
tatetopicalsol
utionUSP
c-Acet
icacidNF
d-Benzal
koniumc hloridesoluti
onNF

21-Ane xt
rapyramidaladver
seeff
ect
sisc
aus
edbyt
hebl
ocki
ngof
:
a-Ser
otoni
nr ece
ptorsinthebra
in
b-Acet
ylcholi
ner e
c e
ptorsi
nthebrai
n
c-Dopaminereceptorsinth
ebrai
n
d-Dopaminer e
ceptorsouts
idet
hebrai
n

22-Arar
esideef
fec
tofsomea
nti
convul
sant
sisSt
eve
ns-
Johns
on
syndr
ome.Thisi
saseve
re:
a-Ski
nreaction
b-Bonema rrowtoxi
ci
ty
c-Rena
lf a
ilure
d-CNSs uppress
ion

23-I
fawoma n,rec
eivi
ngcar
bama
zepi
nebec
omespr
egna
nt,i
tis
import
antthatsherece
ive
sdai
lys
uppl
ement
sof
:
a-VitA
b-VitB6
c-Foli
cacid
d-Ribofl
avin

24-
Whi c
hoft hef
oll
owinga
res
idee
ffe
ctsofphe
nyt
oint
rea
tme
nt?
a-Acne
b-Hirsuit
ism
c-Gingivalhyper
pla
sia
d-a,b,andc

25-Whichdr ugisc
ons
ide
reda
sAl
pha
-1-Adr
ene
rgi
cbl
ocke
r:
a-Hydral
a z
ine
b-Minoxidil
c-Pra
zosin
d-Guanethidine

26-Nit
roglycerin-
allthefol
lowingaretr
ueexcept:
a-Canbedi spensedinhos pit
alpackof500and1000t
abs
b-Containersmus tbema deofglassandbecovere
dwi
thati
ght
-f
it
ti
ng
c-Closetightl
ya f
teruse
d-Tablet
smus tbes t
oredatcontr
oll
edR.T
e-Tablet
snott ober efr
igera
ted

27-Themosti
mport
anta
dve
rsereac
tiontote
rbuta
linei
s:
a-Tachyc
ardi
a b-CNSs t
imulat
ion
c-Finemuscl
etr
emor d-Gastr
icir
ri
tat
ion
e-Alloft
heabove

28-
Whichofthefol
lowingistr
uea boutPe
nic
ill
inV?
a-I
tisi
nact
ivate
dbyg a
s t
ri
ca c
id
b-I
tisac
idstabl
e
c-I
tismoreacti
vet
hanBe nzylpe
nc i
ll
in
d-I
tisa
bsor
bedbe
tt
era
fte
rfoods

29-Whi chofthefol
lowi
ngi
saqui
nol
onea
nti
biot
ic?
a-Cl
inda mycin
b-Chlortet
rac
ycli
ne
c-Ci
pr ofl
oxaci
n
d-Cla
r it
hromycin

30-
Tubercul
osisi
sca
use
dbya
:
a-Mycopl
a sma
b-Mycobacter
ium
c-Mic
rococcus
d-Micr
oba c
ter

31-
pertuss
isisanot
herna
mef
or:
a-Cough
b-Diphther
ia
c-Whoopingc ough
d-Scarl
etfever

32-i
nthetr
eat
mentofpul
mona
ryt
ube
rcul
osi
s,a
nti
biot
ict
rea
tme
ntmus
tbe
cont
inue
dforatl
east
:
a-6months
b-4months
c-2months
d-1month

33-a
llofthefol
lowi
nga
repr
odr
ugse
xce
pt:
a-Suli
ndac
b-Diazepam
c-Enala
pril
d-Sulf
asala
zine

34-whichrouteofdr
uga
dmi
nis
tra
tioni
sli
kel
ytos
ubj
ectadr
ugt
ofi
rstpa
ss
eff
ect?
a-Int
ravenous
b-Inhal
a t
ion
c-Oral
d-Sublingual
35-whichoft hefol
lowingstat
eme ntsis
/ar
ecorre
ct?
a-Ketaminei susedinthetrea
tme ntofmigra
ine
b-Acutesyste micanaphyla
xisshouldbetrea
tedimmedi
at
el
ybyI
V
inj
ect
ionofa drena
line
c-Sulphonylureasareoralant
ic
oa gula
nts
d-Noneoft hea bove

36-ve
r a
pamilexert
sit
seffec
tst
hroughwhi choft
hef ol
lowingact
ions
?
a-Preventi
ngentr
yofc a
lci
umc hannel
sthroughsl
owc hannels
b-Increas
ingsodi
ume ntr
y
c-Antagonizi
ngtheopeni
ngofthef a
stsodiumchannel
d-Noneoft heabove

37-
cardi
acgl ycosi
dema ybeus
efuli
ntr
eat
inga
lloft
hef
oll
owi
nge
xce
pt
a-Atr
ialf
lut t
er
b-Congestiveheartf
ail
ure
c-Ventr
iculartac
hycardi
a
d-Atr
ialfibri
ll
ati
on

38-s
tre
ptokinaseisindi
c a
tedf
ort
het
rea
tme
ntof
:
a-Impair
e dfatabsorpt
ion
b-Pulmona ryemboli
c-Tuberculosi
s
d-Psori
asis

39-
tre
tinoi
nisus e
dthera peuti
cal
ly:
a-Asaur i
naryacidi
fie
r
b-Asana nti
fungalagent
c-I
nthet r
eat
me ntoftube r
c ul
osi
s
d-Int
het r
eatmentofac ne

40-ac
alci
umc ha
nne
lbl
ockert
hati
sus
edpar
ente
ral
lyf
orc
ardi
aca
rryt
hmi
as
is
:
a-Vera
pamilhcl b-Ne f
edi
pine c-Capt
opr
il
d-Minoxi
dil

41-
Whic hoft
hef
oll
owi
ngha
snotbe
enus
edf
ort
het
rea
tme
ntof
Par
kins
onism?
a-Cogenti
n
b-Art
ane
c-Tof
rani
l
d-Kemadri
n

42-Thedr ugthati
smos
tli
kel
ytoi
nduc
ebr
onc
hos
pas
mis
:
a-Pindolol
b-Pentoxyfylli
ne
c-Ome pr
a z
ole
d-Lisinopril

43-
Thea nti
-infla
mma toryeff
ectofas
pir
inisduet
o:
a-Ana nt
icoagulantef
fect
b-Inhi
bit
ionoft hesynthesi
sofpros
tagl
andi
ns
c-Ana nt
igen-anti
bodyr ea
cti
on
d-Allofthea bove

44-
Themos tusefuldrugint
het
rea
tme
ntofdi
abe
tesi
nsi
pidusi
s:
a-Gli
bencl
amide
b-Ins
uli
n
c-Metocl
opramide
d-Desmopres
sina cet
ate

45-Thetr
icyclicant
ide
pre
ssa
ntI
imi
pra
mine(
Tof
rani
l)ha
sbe
ena
ppr
ove
dby
FDAf orus ein:
a-Parki
nson'sdis
e a
se
b-Hypertensi
on
c-Eneure
sis
d-Pepti
cul ce
r

46-Regul arus eofsubli

ngualdose
sofNit
rogl
yce
rini
sli
kel
ytor
esul
tin
a-Hepa toto xici
ty
b-Ne phrot oxici
ty
c-Pepticul cer
d-Tole r
a nc e
47-Alloft hefoll
owingarebetabl
ocke
rsexce
pt:
a-Me topr olol(Lopres
sor)i
b-Na dolol( Corgard)i
c-Ena l
apr il(Renit
ec)i
d-Propra nol ol(
Indera
l)i
48-Bi
sacodylfr
equent
lyc
anc
aus
e:
a-Abdominalcramps
b-Const
ipati
on
c-Ski
nra s
hes
d-Dizz
iness

49-
Ane xampleofapur eopi
oidAnt
agoni
st
:
a-Naloxonehc l(Nar
can)i
b-Pentazoci
ne( Sos
egon)i
c-Nalbuphine(Nubain)i
d-Mor phin
e

50-Carbamazepi
ne(te
gret
ol)i
sus
edf
ort
rea
tme
ntof
:
a-Ene ure
sis
b-Trigeminalne
ural
gia
c-Attenti
onofdefi
ctdis
order
d-Psor i
asi
s

51-
Buspirone(Buspar
)isc
las
sif
iedpha
rma
col
ogi
cal
lya
s:
a-Ant
idepress
ant
b-Anxiol
yticagent
c-Nar
coticanalges
ic
d-Hypnotic

52-
Dili
tiaze
mi susedpr
imar
il
yfori
tsa
bil
it
ytopr
oduc
e:
a-Coughde pr
eaai
on
b-Analgesi
a
c-Cal
ciumc hanne
lbloc
kade
d-Emes i
s

53-Ca rbocyst
einei
sa na
gentus
edcli
nica
llyas:
a-La xati
ve b-Coughsuppr
e s
sant
c-Dia gnost
icagent d-Mucolyt
ic
54-Thef oll
owingdrugsmaybegive
nbys ubl
ingualr
out
eexc
ept
:
a-Digoxi n
b-Ni fedi
pine
c-Nitroglycer
in
d-Isopr e
nali
ne

55-
Mat
cht
hef
oll
owi
nga
nti
biot
icst
othebe
stde
scr
ipt
iongi
venbe
low(
a-d)
a-Beta
lacta
ma nti
biot
icact
iveagai
nstps
eudo
mona
s
b-Penci
ll
inasere
sist
antbet
alac
tam
c-Contr
aindic
ate
dinc hi
ldr
en
d-Inhi
bit
srenalmetabol
ism

1-Pi
per
aci
ll
in-
a
2-Te
tra
cycl
ine
- c
3-Fl
ucl
oxac
ill
in-b
4-Ci
las
ti
n-d

56-Disi
nfe
ctantsa r
eexpe
cte
dtode
str
oyori
nhi
bitt
hegr
owt
hofmi
crobe
s
whichar
ein:
a-Theveget
atives t
age
b-Thespori
ngs tage
c-Bothaandb
d-Noneofthea bove

57-
Whi choft hefol
lowingisnotas
tor
agea
reaf
ori
ron:
a-Reti
culoendothel
ials
yste
m
b-Kidney
c-Hepatocyte
s
d-Mus c
le

58-
Whi chofthefol
lowi
ngi
sas
ulphonyl
ure
aant
idi
abe
ticdr
ug?
a-Chlor
propamide
b-Bume t
anide
c-Aceta
zolamide
d-Fruse
mide

59-Onedr opha savolumeof :

a-0.5ml b-0.1ml c
-0.15ml
d-Va r
iable,dependingontheliquidandthedr oppe
r
60-Ke t
or ol
ac(NSAIDs)isus
edine yeprepara
tionsasa/
an:
a-Anti-i
nf l
amma tor
y
b-Antihistamine
c-Astri
nge nt
d-Corticoster
oid

61-
Whichofthef
oll
owi
ngdr
ugsi
sava
sodi
lat
or?
a-Met
hyldopa
b-Mexit
ill
ine
c-Pr
azocin
d-Pr
opranolol

62-
Whichoft hefol
lowi
ngdr
ugsi
snota
ssoc
iat
edwi
thha
emol
yti
cane
ami
a?
a-Mef
enamica ci
d
b-Met
hyldopa
c-Met
hadone
d-Met
hylte
stoste
rone

63-Whichofthefol
lowingVi
tami
nsi
ses
sent
iali
nthef
orma
tionof
Prot
hrombin?
a-Vit
aminA
b-Vit
a mi
nBc ompl
e x
c-Vit
aminE
d-Vit
a mi
nK

64-
Whi c hofthefol
lowi
ngi
snotus
eda
sana
nti
tus
sive
?
a-Nos c
a pine
b-Pethidine
c-Codei ne
d-Diphe nhydra
mine

65-Whichoft hef
oll
owi
ngLoc
alAna
est
het
icsi
sus
efulf
ort
opi
cal
adminis
tra
tiononly?
a-Lidocai
ne
b-Bupivacaine
c-Benzocai
ne
d-Procai
ne

66-Thei ronpr epa

rat
iongive
nbyt
hei
ntr
ave
nousr
out
eis
:
a-Fe r
rouss ulphat
e
b-Iron-de xt
ran
c-Fe r
rousgl uconat
e
d-Iron-sor b
itolci
tr
icaci
d

67-
Carot
enoi
dsa
repr
ecur
sor
sforwhi
chvi
tami
n?
a-Vit
amineE
b-Vit
amineD
c-Vit
amineA
d-Vi
ta
mineK

68-
Whi chofthef ol
lowi ngisr ec
omme ndedf ordys pepsiainpregnancy?
a-Gaviscon(al
ginicaci
d/a
luminumhydroxi
de/
magnesi
umt r
isi
li
cat
e)
b-Pyl
orid(Rani
tidine
)
c-De-nol(t
ri
pot
as s
iumdicit
rat
obis
mutha
te,whi
chisabismut
h-cont
aini
ngc
ompound.I
tis
us
edt
oai
dhe
a l
ingofulc
ersi
nthes
toma
cha
ndi
nte
sti
ne(
pept
icul
cer
s).
d-Zant
ac(Ranit
idi
ne)

69-Whichofthefol l
owingdr
ugint
era
cti
onsi
snotus
edt
her
ape
uti
cal
ly?
a-Epinephri
ne/Li docai
ne
b-Probenici
d/Pe nici
ll
in
c-Pseudoephedr
ine/Sa l
but
amol
d-Trimethopr
im/Sul phamet
hoxaz
ole

70-Thema xi
mumda
ilydos
eofGl
ibe
ncl
ami
dei
s
a-2.5mg/day
b-5mg/day
c-20mg/da y
d-30mg/da y

71-Whichofthefol
lowi
ngi
snotus
edt
otr
eatps
ychos
is?
a-Aluoxet
ine
b-Haloper
idol
c-Perphe
nazine
d-Resperi
done

72-As ympa thomime t

icoft
enpre
sentinOTCappe
tit
esuppr
ess
anti
s:
a-Ephe dr i
ne
b-Phenyl ephe dri
ne
c-Phenyl propa nola
mine(PPA)
d-Ca f
fe i
ne
73-Opioi dsha vethefoll
owinguse
se xce
pt:
a-Antit ussive
b-Anti-inflamma t
ory
c-Anal ge s
ics
d-Prea na estet
ics

74-
Levoca
bas
tinei
sa/
an:
a-Ant
ihi
st
amine
b-Ant
imi cr
obia
l
c-Ant
iinfl
amma t
ory
d-Cor
ti
c os
ter
oid

75-Whi chofthef
oll
owi
ngi
snotus
eda
sapr
ophyl
axi
sformi
gra
ine
?
a-Pizoti
fin
b-Me toprol
ol
c-Prazocin
d-Propranolol

76-
Themos tcommonsi
dee
ffe
ctofs
ubl
ingua
lgl
yce
rylt
ri
nit
rat
eis
:
a-Nausea
b-Throbbingheada
che
c-Hyperte
ns i
on
d-Ski
nr ash

77-
Al lofthefoll
owingarecommoniodi
nedef
ici
enc
ysympt
omse
xce
pt:
a-Goitre
b-Int
e l
le
ctualdis
abili
ty
c-Growthr et
ardat
ion
d-Dec r
easedearl
ya ndlat
epregna
ncymis
car
ri
age

78-
Whi choft hef oll
owingi
nsul
insha
sthes
hor
tes
tdur
ati
onofa
cti
on?
a-I
sopha neinsuli
n
b-Solubleinsulin
c-I
ns ul
inzincs uspensi
on
d-Protaminez i
nci nsul
in

79-Vas
opress
in(ADH)i susedthe
rapeuti
call
yfor
:
a-Tre
atmentofpolyur
iacausedbyhype r
calc
eamia
b-Trea
tmentofpitui
ta
rydiabet
esinsi
pidus
c-Decre
aseches
tpa i
ninrefra
ctor
yuns t
ableangi
na
d-Inc
reasi
nguter
inecontr
acti
vit
y

80-or
alsympat
homi
met
icde
conge
sta
ntss
houl
dbea
voi
dedi
npa
tie
ntswho
have:
a-Asthma
b-Cough
c-Hyperte
nsi
on
d-Thr
oati
nfe
cti
ons

81-Pe
rce
nta
geoft
ota
lbodyi
odi
nei
nthyr
oidgl
andsi
s:
a-50%
b-75%
c-90%
d-95%

82-Dai
lysal
ivas
ecr
eti
oni
s:
a-1lit
re
b-1.5li
tr
es
c-1.8l
itr
es
d-2lit
res

83-Norma
lse
rumbi
li
rubi
nis
:
a-0.5-1mg%
b-1-3mg%
c-3-4mg%
d-4-5.5mg%

84-Ovar
ys e
cret
es:
a-FSHa ndLHonly
b-Oestr
ogenandProgest
rogenonl
y
c-Oest
rogen,Pr
ogest
rogenandAndroge
n
d-Allofthe
se

85-Thea bsenceofant
i-
Aa ndant
i-
RHa ggl
uti
ninpla
smame
anst
hatt
he
subje
ctis:
a-A+veorAB+ve
b-A-veorAB- ve
c-B+veorAB+ve
d-TypeO
86-Themos timport
antbuf
feri
nextr
ace
llul
arf
luidsi
s:
a-Ac e
tate
b-Bicarbonate
c-Phosphate
d-Protei
n

87-Reti
cul
ocyt
osi
sindi
cate
:
a-Inc
reas
edRBCf or
mation
b-Decrea
sedWBCfor
mation
c-Decre
asedRBCf
ormat
ion
d-Inc
rease
dWBCformat
ion

88-
Ke t
oster
oidsinurineincl
ude:
a-Adrenalandtest
icula
rfunct
ion
b-Pi
tui
taryfuncti
on
c-Hypothalamicf
unc t
ion
d-Pancreat
icfunc
tion

89-
Whichbloodc
anbes
afe
lygi
vent
oapa
tie
ntofbl
oodgr
oupABpos
it
ive
?
a-ABnegat
ive
b-Aposi
ti
ve
c-Bpos
iti
ve
d-Oposi
ti
ve

90-Funct
ionofga l
lbladde
ris:
a-Inc
reas
ea l
kalini
tyofbil
e
b-Incr
eas
ec oncentr
ati
onofbil
e
c-Inc
reas
eintra
bi l
ia
ryprese
nce
d-Incr
eas
ephos phatel
evel

91-
Ins
uli
ncauses:
a-I
ncr
easegluc
os emetaboli
sm
b-I
ncre
asegluconeoge
ne si
s
c-I
ncr
easeli
polysis
d-I
ncre
aseglycogenol
ysis

92-Majorpat
hwayofexc
ret
ionofCa
lci
umi
s:
a-Ki
dne y
b-Gut
c-Ki
dne yandGut
d-Noneoftheabove

93-Thes ecr
eti
onofa
ldos
ter
onei
scont
rol
ledby:
a-Angiotens
in
b-ACTH
c-Epi
ne phri
ne
d-Ins
ulin
94-Firstr
ela
yst
ati
onofpa
ini
s:
a-spinalc
ord
b-Me dull
a
c-pons
d-thala
mus

95-Te s
tost
eronei
sse
cre
tedby:
a-sert
olice
lls
b-leydigcel
ls
c-germc el
ls
d-adrenalmedull
a

96-Whichneurot
rans
mit
terc
ont
rol
sse
cre
tionofpr
ola
cti
n?
a-Dopamine
b-Ser
otoni
n
c-Somatos
tat
in
d-GABA

97-Nucleusofat
omc ont
ains
:
a-El
e c
trons
b-OnlyPr o
tons
c-El
e c
tronsandProt
ons
d-Prot
onsa ndNeutr
ons

98-Whi chofthef oll

owingisthef
ast
estt
obea
bsor
bedf
romt
hes
toma
ch?
a-Carbonhydrat
e
b-Prote
ins
c-Fats
d-Wa te
r
99-Functionofc a
l c
itoni
nisto:
a-DecreaselevelofCa lc
ium
b-Incr
easelevelofCa l
ci
um
c-Incr
easelevelofMg
d-Incr
easelevelofPot ass
ium

100-Thefol l
owingaretr
ueofi
nsul
ine
xce
pt:
a-Glycopeptide
b-Secr
e t
edbybe t
acel
ls
c-Causeslipogenes
is
d-Promotesgl yc
ogenes
is
Se
cond100

1-Wichoft hf ol
lowi
ngi
snotama
jorpa
thwa
yort
ypeofbi
otr
ans
for
mat
ions
?
i
a-Oxidation
b-Deami nation
c-Reduction
d-Hydrolysis
e-Conjuga t
ion

i2-Whichofthef
oll
owi
ngi
snotana
tur
all
yoc
cur
ri
nge
mul
si
fi
er?
i
a-Acaci
a
b-Cholest
erol
c-Gela
tine
d-Veegum
e-Tra
gac a
nth

i3-Whichoft hefoll
owingsympt
omsi
snotpr
ese
nti
ndi
git
ali
s
int
oxi
cation?i
a-AVbl oc k
b-Ventr
ic ul
artachyca
rdia
c-Vomiting
d-Vagala rr
estofthehear
t
e-Vis
ualdi st
urbances

(@)4-Whi choft hef oll

owingstat
eme ntsaboutpr
opylt
hiour
acilisfal
se?i
a-I
tisusedf ortre a
tme ntofhypert
hyroidism
b-I
tinhi
bitst hes ynthesi
softhyroi
dhor mone s
c-I
tdimini
s he spe r
ipheraldei
odinat
ionofT4a ndT3
d-I
tinhi
bitsi odideoxi dat
ion
e-I
tint
erfe
re swi ththee ffe
cti
venessofe xogenous
lyadminis
ter
e dthyr
oid
hor
mones
i5-Allofthef oll
owi
nga
redi
ure
tic
sexc
ept:
i
a-Ami nophylline
b-Glybur i
de
c-Spironolact
one
d-Bume tamide
e-Chlorthal
idone

i6-Whichofthef
oll
owingi
snotas
idee
ffe
ctofc
ode
ine
?i
a-Miosi
s
b-Nausea
c-Diar
rhea
d-Respi
rator
ydepr
essi
on
e-Addict
ion

(@)7-Allofthefol
lowi
nga
rena
tur
ale
str
oge
nsorc
onge
ner
sexc
ept:
i
a-Es
tradi
ol
b-Di
ethyls
ti
lbest
rol
c-Es
trone
d-Et
hinylest
radi
ol
e-Es
tropi
pate

(@)8-Epi nephr ineisnotgivenora

llybecaus
e:i
a-I
tisinacti
va tedi nthegastr
icmucosa
b-Localvasoc ons t
rict
ioni
nhibit
sabsorpt
ion
c-I
tisrapidlyi nactivat
edincirc
ula
tion
d-Noneoft hea bove
e-Allofthea bove

i9-Wichofthefol
lowi
ngc
ardi
acgl
ycos
ide
sdoe
snotoc
curna
tur
all
y?i
a-Digoxin
b-Oubain
c-Digit
oxin
d-Amr i
none
e-Nitr
oglyce
rin
(@)10-Va ri
ousopi
ate
sma
ybeus
eda
sal
loft
hef
oll
owi
nge
xce
pt:
i
a-Analges
ics
b-Anti
-inf
lammator
ies
c-Anti
diar
real
s
d-Aidstoanest
hesi
a
e-Anti
tuss
ive

i11-Whichoft
hef
oll
owi
ngi
snotas
ti
mul
antl
axa
tive?
i
a-Cascar
aSagr
ada
b-Senna
c-Cast
eroil
d-Bisac
odyl
e-Docsat
e

i12-Whi chofthefollowingacti
onisnots
eenwi
ths
ympa
thomi
met
ics?
a-Pupilc onst
ri
ct
ion
b-Incr
e asedheartr
a t
e
c-Swea tglandsti
mul at
ion
d-Bronc hiol
edil
a t
ion
e-Syst
e mi cbl
oodve sselcons
tri
ct
ion

i13-Allofthefollowings t
ateme nt
saboutpropanolola
ret
ruee
xce
pt:
i
a-Theor alr
outeofa dministr
ationispre
ferr
e d
b-Propranololpenetr
atesintot heCNS
c-Propranol
olispr i
ma r
ilybiotransf
ormedintheliver
d-Propranololca
us esra
s hesands or
ethroat
e-Iti
snons e l
ect
ivea l
phaa ntagonis
t

i14-Whichoft hef
oll
owi
ngdr
ugsi
snotapr
otonpumpi
nhi
bit
or?
i
a-Pant
oprazole
b-Rabeprazole
c-Lansoprazole
d-Sulf
isoxazole
e-Ome praz
ol e

(
@)15-Al
loft
hef
oll
owi
nga
res
idee
ffe
ctsofpr
oge
sti
n’se
xce
pt:
i
a-Weightgain
b-Headache
c-Fat
igue
d-Consti
pati
on
e-Nauseaandvomi
ti
ng

i16-Bacit
arc
ini snotus
ual
lygi
venpa
rent
ral
lybe
caus
eofi
ts:
i
a-Insolubi
li
ty
b-La ckofstabili
ty
c-Pa i
na tt
hei nje
cti
onsi
te
d-La ckofpote ncy
e-Ne phrot
oxicity

i
17-Whi chofthef
oll
owi
ngdr
ugss
houl
dnotbea
dmi
nis
ter
edwi
thhi
ghf
at
me al
s? i
i
|.Indi
na zi
r
i
||
. Ril
uzole
i
||
|.Stavudine

a-|
only
b-|
|
|only
c-|
and||only
d-|
|an
d|||onl
y
e-|
,||
and|||
i

i18-Ea c
hoft hefol
lowi
nge
xer
tant
imi
crobi
ala
cti
onbyi
nhi
bit
ingc
ellwa
ll
synthesi
se xcept:
i
a-Ce phal
os pori
ns
b-Pe ni
cil
lin
c-Ba ci
tra
c in
d-Va ncomyc in
e-Novobi ocin

i19-Whichoft
hefol
lowi
ngant
ibiot
icsorgr
oupofa
nti
biot
icsdoe
snota
ct
byinhi
biti
ngofce
llmembra
nefunct
ion?i
a-Eryt
hromyci
n
b-Amphoter
ici
nB
c-Col
ist
in
d-Nyst
ati
n
e-Pol
ymyxins

i20-
Whi choft hef
oll
owingdi
ure
tic
sdonotc
aus
epot
ass
iuml
oss?
i
a-Furosemide
b-Chlorthal
idone
c-Tri
a mtere
ne
d-Hydr ochl
orothi
azi
de
e-Me t
ol a
zole

i21-Whi c
hi snote
sse
nti
ala
minoa
cid?
a-Threonine
b-Tryptophane
c-Glutamone
d-Me t
hionine

i22–Hypercalcemi adoesnotoccuri
nnor
mali
ndi
vidua
lsbe
caus
e:i
a-Cal
ci
umi srapidlye xc
ret
ed
b-Cal
ciumisrapidlybiotra
nsfor
me d
c-Cal
ci
umi sinsoluble
d-Exc
es sc
alc
iumi snotabsor
bed

i23-Allofthefoll
owinga retrueofha emolyti
cjaundi
cee
xce
pt:
i
a-Thereisincr
e as
edproduc t
ionofBi lir
ubin
b-Urobili
noginconcentra
tioni sincr
easedinurine
c-Product
ionofUr obil
inogini sincr
eased
d-Bili
rubinisfoundintheur i
neoft hepa t
ient
e-Noneoft heabovebec ausea llar
etrue

i24-Whi
chofthef
oll
owi
ngbe
ta-
adr
ene
rgi
cage
ntsi
snots
hor
tac
ting?
i
a-Pir
but
erol
b-Salme
trol
c-Terbut
ali
ne
d-Albute
rol
e-Noneoftheabove

i25-Pos si
blet
rea
tme
ntofHypogl
yce
miadoe
snoti
ncl
ude:
i
a-Insulin
b-Ca ndy
c-Gluc ose
d-Fruitjuce
e-Gluc agon

i26-Whi chofthefol
lowi
ngAnt
ihype
rte
nsi
vea
gent
sha
snoa
dve
rsee
ffe
ct
onGl ucosetol
erance
?i
i1-metoprol
ol
i2-at
enolol
i3-ca
ptopril

i
a.1onl
y
i
b.3only
i
c.1and2i
i
d.2and3i
i
e.1,2and3i

i27-Signsands
ympt
omsofac
uteOti
ti
sme
diadonoti
ncl
ude:
i
a-Feve r
b-Irr
it
a bil
it
y
c-Stuffneck
d-Le t
ha r
gy
e-Thec hil
dmaybea
sasympt
omati
c

i28-Alternat
iveAnt
ibi
oticsf
orOti
ti
smediaf
ort
hec
hil
dal
ler
gict
o
Penicil
li
ni nc
ludeal
lofthefoll
owi
ngexc
ept:
i
a-Clindamyc in
b-Erythromyc i
n
c-Erythromyc i
n–Sulf
isoxazol
e
d-Ciprofloxaci
n
e
-Tr
ime
thopr
in–Sul
fame
thoxa
zol
e

i29-I
ti simportanttha
tthepat
ientr
ecogni
zesa
llt
hef
oll
owi
ngs
ignsa
s
possi
bleLi t
hiums ideeff
ect
sexcept:
a-Handt remors
b-Hea daches
c-Mudc l
ewe akness
d-Cons ti
pati
on
e-Polyuria

i
30-Whichofthefoll
owingisnotus
efuli
nthet
rea
tme
ntofa
cut
eDi
goxi
n
t
oxi
cit
y?i
i
1-cal
ci
uma dminist
rat
ion
i
2-li
doca
ineadminist
rat
ion
i
3-fa
bfragmentanti
bodies

i
a.1onl
y
i
b.3onl
y
i
c.1and2onl
y
i
d.2and3onl
y
i
e.1,2and3

i31-Somec ommonpa ti
entcompl
aint
sassoc
iat
edwi
thAnt
ichol
ine
rgi
c
drugsincludea l
lofthef
ollowi
ngexcept
:
a-Urinaryre t
enti
on
b-Shortnessofbr e
ath
c-Blurredvi si
on
d-Cons t
ipation
e-Drymout h

i32-Whi chofthefol
lowi
ngi
ronpr
epa
rat
ionsi
snota
vai
labl
eor
aldos
age
form? i
a-Irondextran
b-Fe r
rousfuma r
ate
c-Fe r
rousgluconat
e
d-Fe r
roussulphat
e
e
-Pol
ysa
ccha
ride–I
ronc
ompl
ex

i
33-I
nwhi chofthefol
lowingcondi
ti
onsi
sir
onsuppl
eme
nta
tioni
ndi
cat
ed
?i
i
1Pri
ma r
yhe mochromatosi
s
i
2Pat
ientrece
ivi
ngmu lti
plebl
oodtr
ansf
usi
ons
i
3Pre
gna nc
y

a-1onl
y
b-3Only
c-1and2onl
y
d-1,2and3

i34-Somes ymptomsofi
ronde
fic
ienc
yinc
ludea
lloft
hef
oll
owi
nge
xce
pt:
i
a-Fati
gue
b-Cons t
antthi
rst
c-Dystrophyofnail
s
d-Dys phagi
a
e-Dispneaone xer
ti
on

i35-Whi c
hofthef
oll
owi
nga
gent
swoul
dnotbei
ndi
cat
edf
orapa
tie
ntwi
th
angina?i
a-Isosor
bide
b-Flecai
nide
c-Ni f
edi
pine
d-Inderal
e-Di l
ti
azem

i36-Allofthefollowingma ybes ymptomsofamyoca

rdi
ali
nfa
rct
ion
except:
b-Agi t
ate
dbe haviora ndahenpa l
lor
c-Na us
ea,swe a
tinga nddys pnea
d-He ar
tburn,f
aintinga ndskippedbeat
s
e-De nt
alandne ckpa in,noreli
effromNit
rog
lyc
eri
n
i37-Allofthefol
lowingaretr
uea
boutmor
phi
nee
xce
pt:
i
a-Ma yc a
usediar
hoe a
b-Ame t
abol
it
eofc odei
ne
c-Hass peci
fi
creceptor
sintheGI
T
d-Ma yc aus
evomi t
ing

i38-Whi c
honeoft hefol
lowi
ngdr
ugsi
snota
vai
labl
easa
nti
psyc
hot
ic
depotinj
ec t
ion?i
a-Flupent
hi xol
b-Fluphenaz i
ne
c-Chlorproma zi
neHCL
d-Ha l
operidolDecano
ate

i39-Whichoneofthefol
lowings
tat
ementsa
boutchl
oralhydr
atei
sfa
lse?
i
a-Ma ycausegast
ri
ti
s
b-Cancausetoler
ance
c-Iti
sare s
pir
ator
ysti
mulant
d-Toxic
it
yi smuchincre
asedbyadmini
st
rat
ionofEt
hanol

i40-Whichoneofthefoll
owings ta
tementsaboutna
rcot
ica
nal
ges
icsi
sfa
lse
?i
a-Codei
neisusefulf
oritsantit
ussiveproper
ti
es
b-Pent
azocinei
smor eaddict
ivethanmor phi
ne
c-Pent
azoci
nema ycausehall
uc i
nations
d-Morphinecancausediar
hoe a

41-Whi choft hef ol

lowingshoul
dnotbeus
edt
opr
eve
ntmi
gra
inei
nan
ast
hma t
icpa tient?i
a-Propr
a nolol( I
nderal
)i
b-Pizot
ifen( Sanomigran)i
c-Ami t
ryptyline(Trypti
z ol
)i
d-Clonidine( Dixari
t)i

i42-Whichofthef
oll
owi
ngi
snotabe
nzodi
aze
pine?
i
a-Alpra
zolam
b-Clobaze
m
c-Chl
ormet
hia
zol
e
d-Chl
ordi
aze
poxi
de

i43-Whichofthefol
lowingistrueaboutBe nzodi
azepi
nes?
i
a-Pat
ient
scande vel
opaps ychologi
caldependence
b-Pati
ent
scande vel
opawi thdrawalsyndrome
c-Pat
ient
scande vel
optole
rancet ot
hedr ug
d-Alloft
hea bove

i44-Dopaminet a
blet
scannotbeus edtotre
atParkins
on’
sdi
sea
sebe
caus
eit
:
i
a-Doe snotcr
ossbloodbrai
nba rri
er
b-Istootoxi
ca ft
erl
ongterma dministr
ati
on
c-Istrans
for
me dtoL-dopabyt heautonomicneurons
d-Isnotme tabol
izedbymonoa mineoxidase

i45-Whichofthef
oll
owi
ngdr
ugsc
aus
eins
omni
a?i
a-MAOI ’s
b-Caffe
ine
c-Betabloc
kers
d-Barbi
tura
tes
e-a,bandc

i46-Whichofthef
oll
owi
ngi
snote
ffe
cti
vef
orpa
rti
als
eiz
ure
s?i
a-Phenytoi
n
b-Ethosuxi
mide
c-Carbamazepi
ne
d-Lamot r
igi
ne

i47-Amitryptyl
inecaus
esa l
loft
hef
oll
owi
nge
xce
pt:
i
a-Hypotensionintheel
de r
ly
b-Rais
ingoft heseiz
urethres
hol
d
c-Seda
tion
d-Consti
pa t
ion
i48-Allofthefollowingar
ecl
ini
cala
ppl
ica
tionsofde
smopr
ess
ine
xce
pt:
i
a-DiabetesInsi
pidus
b-Noc t
urnaleneuresi
s
c-Urinar
yr ete
nti
on
d-Postope r
ati
vepol yure
a

i49-Allofthef ol
lowi
ngha
veve
ryl
imi
tedc
ros
singt
hroughi
nfl
ame
d
me ni
ngese xcept:i
a-Clavulanicacidsal
ts
b-Penicil
lin
c-Teicoplanin
d-Erythromyc i
n

i50-Allofthefol
lowi
nga
rema
inl
yBa
cte
rios
tat
icse
xce
pt:
i
a-Chloramphenic
ol
b-Sulphadi
a zi
ne
c-Ampi ci
ll
in
d-Tetrac
ycline

i51-Thefoll
owinga
nti
biot
icsa
reus
edf
ort
rea
tme
ntofa
cnei
nma
ny
pati
entsexce
pt:i
a-Erythr
omyc i
n
b-Ne omycin
c-Clindamyci
n
d-Tetrac
ycli
ne

i52-Thef ol
lowingcanbeus
eda
stopi
cala
nds
yst
emi
cAnt
iba
cte
ria
l
prepara
tionsexcept:
i
a-Fuc i
dicacid
b-Mupi roci
n
c-Tetracycl
inehcl
d-Ge nta
myc in

i
53-Whi
choneoft
hef
oll
owi
ngi
snota
nindi
cat
ionf
orpot
ent
,topi
cal
cor
ti
c os
teroids? i
a-ChronicDi scoidLupusEryt
hema
tos
us
b-Psori
asis
c-Li
c hensimple xchroni
cus
d-Hypertrophicliche
nplanus

i54-Al
lofthefoll
owingst
a t
ementsofAc
yclovi
rar
etr
ueexcept:
i
a-Iti
sanucleosi
deanti
vir
aldrug
b-Iti
sconvert
edtotr
iphosphat
eandsubs
equent
lyi
nhi
bit
ssynthe
sisofvi
ral
DNA
c-Iti
sanal
ogueofpurine---
-bol
it
es
d-Iti
savai
lablet
opical
lyandoral
ly

i55-Stabi
li
tyofpharmaceuti
calpr
oduct
sisa
ffe
cte
dbyt
hef
oll
owi
ngf
act
ors
except:i
a-Tempe rat
ureandhumidit
y
b-Compos iti
onofdrugproduct
c-Dos agefor
ma ndpackingma t
eri
al
d-Dos estr
engthandpacksize

i56-Aqueousfilmcoati
nghasthef
oll
owi
ngpr
ope
rti
ese
xce
pt:
i
a-Hygroscopicinnat
ure
b-Ga s
tri
cflui
dr es
ist
ant
c-Wa t
ersolublecoat
ing
d-Lesscostl
yt omanufact
ure

i57-Thet r
eat
me ntofc
hoi
cef
orKa
pos
i’ss
arc
omai
swhi
choneoft
he
foll
owing? i
a-Bleomyc i
n
b-Da ct
inomycin
c-Doxor ubi
cin
d-Mi t
omyc in

i
58-Al
loft
hef
oll
owi
ngdr
ugsa
reNe
urol
ept
icswi
tht
hee
xce
pti
onofone
whi
chi
s:i
a-Butyrophenones
b-Trif
luope r
azine
c-Diphenylbutylpi
per
idi
nes
d-Benzhe xol

i59-Thefoll
owingc ha
ract
eri
st
icsanduse
sa ppl
ytoi
nte
rfe
rona
lphae
xce
pt
forone:i
a-Iti
sapr ote
in
b-Itisobt
a i
nedfromlymphobla
stoi
dsource
c-Iti
sa ninj
ecta
bleprepa
rat
ion
d-Itisahormone

i60-MonoAmi neOxi
das
eInhi
bit
or’
sinc
ludet
hef
oll
owi
nge
xce
pt:
i
a-Tranylcypromi
ne
b-Phena la
zine
c-Thioridazi
ne
d-Moc lobemide

i61-Pros
tat
eca
nce
rist
rea
tedbyt
hef
oll
owi
nge
xce
ptf
orone:
i
a-cypr
oter
onea
cet
at
e
b-tamoxi
fen
c-fl
utami
de
d-tr
ipt
orel
in

i62-meta
boli
smofe thylAlcoholinvol
vesal
lthefoll
owi
ngpa
thwa
yse
xce
pt
:
i
a-Oxidat
ion
b-Conversi
ontoa c
etal
dehydea ndacet
ate
c-Excret
edunchangedthroughthelungsandkidneys
d-Sulphat
econjugat
ion

i63-Thef
ollowingst
atement
sapplyt
oAz a
thi
opri
neexceptf
orone:
i
a-Iti
simmunos uppr
essa
nt
b-Itismet
abolize
dinthebodytoact
ive6Merca
ptopur
ine
c-Iti
scla
ssi
f i
edasantimeta
bol
ite
d-I
tisus
edt
otr
eatbod
yre
jec
ti
ona
fte
ror
gans
urgi
calt
rans
pla
nt

i64-Whi c
hoft hefoll
owingi
snotc
ytot
oxt
ic?
a-Alkylat
ingdrugs
b-Cytotoxi
ca ntibi
oti
cs
c-Corti
coste
roids
d-Vincaa l
kal
oi ds

i65-Whichofthefol
lowi
ngi
snotus
eda
sAnt
ima
nicdr
ug?
i
a-MAOI ’s
b-Carbamazepi
ne
c-Benzodi
azepine
d-Lit
hiumcarbonate

i66-Whichoft
hef oll
owingsta
tement
saboutNal
oxonei
sfa
lse?
i
a-Iti
sapureant
a gonis
ttoMorphine
b-Itcaus
eEuphoria
c-Iti
susedint
het rea
tmentofOpiat
eoverdos
e
d-Itcaus
esawithdrawalsyn
dromewhe ngive
ntoanopi
at
edepe
nde
nt
subje
ct

67-Whichofthefol
lowi
ngdr
ugsi
snotaTr
icyc
licAnt
ide
pre
ssa
nt?
i
a-Tri
mipramine
b-Maproti
li
ne
c-Nortr
ypt
ili
ne
d-Imipr
amineHCL

i68-Ca ptopri
landEna l
apri
ldoa l
lthef ol
lowingexcept:
i
a-Incr
e aserenninconcent
rati
oninbl ood
b-Inhibitane nzyme
c-Compe ti
velyblocksAngiote
nsin||atit
’srecept
ors
d-Ra i
se sthebloodPotass
iumc oncentrat
ion
i69-Wichofthefol
lowi
ngdr
ugsi
snotus
edi
nthet
rea
tme
ntofPa
rki
nson’
s
disea
se? i
a-Be nz
hexol
b-Ama ntadi
ne
c-Chlorpromaz
ine
d-Ca r
bidopa

i70-Whi choft hefollowingdr

ugsisnotc
lass
ifi
edasAnti
psyc
hoti
cdrug?
i
a-Chlorproma zine
b-Pimoz i
de
c-Risperi
done
d-Bus pi
rone
71-Whi choft hefol l
owingsta
tement
sisfa
lseaboutAmphet
amine?i
a-De cre
aserestlessness
b-Induceshype rsensiti
vit
yinchi
ldr
en
c-De cre
aseappe ti
te
d-Itisac ont
rolleddr ug

i72-Whichofthefoll
owi ngsta
tementsi
sfa
lsea
boutDi
amor
phi
ne]
(He
roi
n)?
a-Causesnause
aandvomi ti
ng
b-Ar e
spir
ator
ydepressant
c-HaspotentAtr
opinelikepropert
ie
s
d-Convert
edinthebod yt oAtr
opine

i73-Apa c
ka gei
nsertl
is
tsadrugdos
eforaneonat
ea sbei
ng10-
mi c
rogr
am/kg/day.Theagera
ngeforaneona
teisconsi
dere
dtobe
a-Birt
hto1mont h
b-1mont hto6mont hs
c-Birt
hto1we e
k
d-1ye a
rthrough5ye a
rs

i74-Thechil
d’sdoseofadrugisr
eporte
das1.
2mg/
kg/bodywe
igh.Wha
t
istheappr
opri
atedoesforachi
ldweighi
ng60l
b?
a-6mg
b-9mg
c-32mg
d-72mg
e-126mg

i75-Thei nf
usi
onofThe ophyli
neest
abl
ishe
dforane onat
eis
i0.08mg/kg/
hr.howma nymlofdr ugar
eneededforonedail
ybott
leift
he
bodywe ighis16lb?i
a-0.58mg
b-14mg
c-30mg
d-150mg
e-8mg
i76-BloodPr e
ssur
eme asure
me nt
sweremadefor1we e
konfive
pati
ent
s
withthefoll
owingaverages

Pa
tie
nts1 2 3 4 5

B.
P 140/
70 160/
84 180/
88 190/
90 150/
70

Wha ti
stheme
dia
nsys
tol
epr
ess
ure?
i
a-80
b-83
c-84
d-160
e-164

i77-Thec once
ntr
ati
onofSodi
umFl uor
idei
nacommuni
ty’
sdr
inki
ngwa
ter
is0.6ppm.expr
esst
hisc
oncent
rat
ionasaper
cent
age
a-0.00006%
b-0.0006%
c-0.006%
d-0.06%
e-0.6%

i78-Lanoxi
npediat
ri
cel
ixi
rcont
ains0.05mgofDi
goxi
npe
rml
.howma
ny
mi c
rogra
msa r
ether
ein3mlofthee l
ixir?
i
a-0.15micr
ogra
ms
b-0.015micr
ograms
c-1.
5micr
ograms
d-Noneoftheabove

i79-Apha rma c
istadd1pi ntofAl c
oholUSPt o1Lofamout hwa s
hf or
mula.
Wha tisthenewpe r
centa
geofa lcoholpr e
senti
fori
gina
lmout hwashwa s
label
eda s12%V/ V? i
a-30%
b-38%
c-45%
d-57%
e-59%
i80-Apr escr
ipti
onc al
lsforthedispensingof4%Pi l
ocarsol
utionwit
hthe
dire
cti
onof“Gt tIOUTI D”.Howma nymgofPi l
ocar
pineHCLi sbe i
ng
usedpe rday?As sumethatthedroppe riscal
ibr
ate
dtode l
ive
ri 20‘
dropsto
theml
a-4mg
b-6mg
c-12mg
d-24mg
e-60mg

i81-Theadul
tint
rave
nous(
IV)dos
eofZidovudineis2mg/kgq4hr
ssi
x
timesaday.Howma nymgwilla180-
lbpat
ientrec
e i
veda
ily?
i
a-12mg
b-164mg
c-650mg
d-980mg
e-2160mg

i82-Apha r
ma ci
stdil
utes100mlofCloroxwit
h1quartofwate
r
Expresst
hec oncent
rat
ionofSodiumHypoc hl
ori
tei
nthefi
naldil
uti
onasa
W/ Vrati
o.Comme r
cia
lCl or
oxcont
ainsi5.
25%W/ VSodiumHypoc hl
ora
te
a-1/9
b-1/10
c-1/100
d-1/180
e-1/200
Que s
tions83a nd84r el
atet
othefol
lowi
nghos
pit
alf
ormul
a
foraT- A-Cs olut
ion
CocaineHCL4%
Tetrac
a i
neHCL2%
EpinephrineHCLs ol
uti
on1/2000
SodiumChl or
ideinje
cti
onqs4ml

i83-Howma
nymgofCoc
aineHCLi
sint
hef
ina
lsol
uti
on?
i
a-400mg
b-4mg
c-20mg
d-8mg
e-160mg

i84-Howma nymlofAdr
ena
lineChl
ori
des
olut
ion(
0.1%)ma
ybeus
edt
o
preparet
hesol
uti
on?
i
a-0.002ml
b-0.04ml
c-1ml
d-2ml
e-5ml

i85-Ana dmi ni
stra
tionsetdel
iver
s60dropstotheml.Howma nydr
opspe
r
mi nuteareneededtoobtain20unit
sofHe pa
rinperminut
eiftheIV
admi xtur
ec ont
ains15,000unit
sper250mlofNor malSal
ine
?i
a-20
b-40
c-60
d-80
e-120

i
86-Dopamine(I
not
ropin)200mgin500mlofNormalSal
inea
t5
mic
rogr
am/kg/mi
nisorderedfora155-
lbpa
tie
nt.Whati
sthef
ina
l
concent
rationofs ol
uti
oni
nmi
cro/
ml?
i
a-0.4mi
cr ograms
b-2.5mic
r ograms /
ml
c-40microgr a
ms /ml
d-400micr ograms/ml
e-25microgr a
m/ ml

i87-Theest
imat
edCreati
ninecl
ear
ancer
atef
ora120l
bpat
ienti
si40ml/
min.
wha tmai
nte
nancedos
es houl
dbeadmini
st
ere
dift
henorma
lma i
ntenanc
e
doseis2mg/l
bofthebodywe i
ght?i
a-60mg
b-100mg
c-120mg
d-160mg
e-240mg

i88-Aphar
mac
istrepa
ckages10l
bofanoi
ntme
nti
ntoj
arst
obel
abe
led2
oz(wi
th)
.Howma nyjar
scanbefi
ll
ed?
i
a-73
b-80
c-83
d-88
e-100

i89-Howma nymlofGl
yce
rinwoul
dbeneede
dtopr
epa
re1lbofa
n
ointmentconta
ini
ngi
5%W/ W Gl
ycer
in?(
Thedens
it
yofgl
ycer
ini
s
1.25g/ml)
i
a-1.2ml
b-18.2ml
c-22.7ml
d-24ml
e-28.4ml
i90-Ahos pi
talc
lini
creques
ts2lbof2%Hydroc
ort
isoneoint
ment
.How
ma nygramsof5%Hydr oc
orti
soneoi
ntme
ntc
ouldbedilut
edwit
hWhit
e
Petrol
atumtoprepar
ethisorde
r?i
a-18.2g
b-27.5g
c-45.4g
d-363g
e-545g

i91-Howma nygramsofGl
aci
alAce
ticAcid(99.
9%W/ V)mustbeadde
d
to1galPurif
iedWate
rtopr
epa
reanir
riga
tionsol
uti
onc
onta
ini
ng0.25%
W/ VAc e
ticAcid?
i
a-1.2g
b-9.5g
c-12g
d-20g
e-95g

i92-Wha tisthedec
ayconst
ant(K)oft
heRadio-
Isot
ope32Pifi
tshal
fli
fe
is14.3da ys
.As s
umethatRadi
ophar
maceut
ica
lfol
lowfir
stt
-orderki
net
ics
a-0.048/day
b-0.07/day
c-0.097/day
d-0.1/day
e-0.15/day

i93-Apr e
---
---
ionc
all
sfor25m.eq.ofPot
assi
umChl
ori
de
Howma nygramsofKCL( MW 74.
6)areneede
d?i
a-7.46g
b-0.746g
c-8.86g
d-1.86g
e-0.186g
i94-Howma nymi l
li
li
ter
sofa10%KCL( MW 74.
6)sol
uti
oncont
ain5.
0
mEqofK+? i
a-2.100ml
b-21.000ml
c-3.730ml
d-37.300ml
e-0.373ml
i95-Thedoseofadrugis0.
5mg/kg.Wha
tdos
eshoul
dbegive
ntoa6ye ar
s
oldchildwhoweigh44lb?i
a-0.003g
b-0.033g
c-0.010g
d-0.100g
e-0.050g

i96-Ifapre-
---
--i
onorde
rrequir
es30gofconcent
rat
edSulf
uri
cAcid
(densit
yis1.
8g/ml),Whatvolumeshoul
dthephar
ma c
istmeas
ure?
i
a-1.67ml
b-18.00ml
c-30.00ml
d-16.67ml
e-166.70ml

i97-Ca l
cul
atet
hewe i
ghtof25mlofHydr
ochl
ori
cAc
idwhos
ede
nsi
tyi
s
1.18g/ml
a-29.500g
b-2.950g
c-0.295g
d-295.00g
e-Noneoft heabove
(@)98-Conve
rt2pi
nts3f
lui
dounc
esi
ntoml
a-1500ml
b-1050ml
c-150ml
d-105ml
e-10.5ml

i99-Convert60gra
mst
ogr
ains
a-9240grains
b-924gr a
ins
c-9.24grai
ns
d-0.924grains
e-0.0924grains

i100-Thedoseofadr
ugis0.6mg
Howma nydose
sarecont
aine
din96mgoft
hedr
ug?
i
a-16
b-160
c-360
d-600
e-Noneoftheabove

Thi
rd100

1-Semi
nalvesi
clesarepr
ese
ntbe
twe
en
a-Pr
ost
at
ea ndanus
b-Pr
ost
ateandrectum
c-Bl
adderandrec
tum
d-Pr
ost
ateandbladder

i
2-Se
mina
lve
sic
less
ecr
ete
a-Prosta
gla
ndins
b-Inhibi
n
c-Ac i
dphosphat
ase
d-Alloftheabove

i3-Cl
it
orisdevel
opsf
rom
a-Genit
altuber
cle
b-Genit
alridge
c-Mulle
rianduct
d-Urogenit
alsi
nus

i4-Commone s
tana
tomi
cals
it
eofa
ppe
ndi
xis
a-Paracea
cal
b-Retrocea
cal
c-Il
leal
d-Pelvic

i5-Theshortestpa r
toft
hec
oloni
s
a-Ascendingc olon
b-Transverscolon
c-Descendingc olon
d-Sigmoidc ol
on

i6-Whichofthefol
lowingf
act
orsa
ffe
ctt
hedi
st
ri
but
ionofadr
ug?
a-Lipi
ds ol
ubil
it
y
b-Plas
mapr ote
inbindi
ng
c-Polar
it
y
d-Molecularsi
ze
e-Alloftheabove

7-Therateofzero-orderr
eacti
ons
a-Changesconstantl
y
b-Isi
ndependentoft empera
ture
c-i
sindependentofc once
ntrat
ion
d-Hol
dsonl
yforl
ightc
atalyz
edrea
cti
on
e-Hol
dsonl
yforr
adioact
ivecompounds

i8-Asourceofant
ica
rci
noge
nicdr
ugsi
s
a-Bell
adona
b-Nuxvomi ca
c-Vincarose
a
d-Cascar
a
e-Digi
tal
is

9-Ifacent
ralnervoussyst
em( c
ns)drugisext
ens
ive
lyi
oni
zeda
tthephof
bloodi
twill
a-Pene
trat
ethebl ood–brainbar
rie
rslowly
b-pene
trat
ethebl ood–brainbar
rie
rrapidl
y
c-Notpenet
ratetheblood–brainbarr
ier
d-Beelimi
na t
eds lowl
y
e-Nottobedistr
ibutedtoanyti
ssuesi
tes

i10-Mostdr
ugsa re:
a-Str
ongelect
rolyte
s
b-We akel
ectr
olytes
c-None l
ect
rol
yt es
d-Highlyi
onic
e-Noneofthea bove

i11-Thema j
orme
cha
nis
mofde
gra
dat
ionofdr
ugsi
ntheGI
Tis
:
a-Oxidat
ion
b-Hydrolys
is
c-Ac e
tyl
ati
on
d-Conjugat
ion
e-Reducti
on

i12-Thebuf
ferequat
ioni
sal
soknowna
s
a-Young’sequa
tion
b-Charl
esequat
ion
c-Hende
rson-ha
ssel
bal
che
qua
ti
on
d-St
rokes
’law
e-Noneoftheabove

i13-Radioa
c t
ivedecayfol
lowsa
a-Mixedorde r
b-Fract
ionalorderrat
e
c-Zeroorderra t
e
d-Firs
torderra t
e
e-Secondorde rrat
e

i14-Themos tcommondi
si
nte
rgr
atori
ncompr
ess
edt
abl
etsi
s
a-De xt
rose
b-Lac t
ose
c-Starch
d-Potassi
umbi t
art
rat
e
e-Powde re
ds ucr
ose

15-Ana nt
idot
ef orhepa
rinove
rdos
eis
a-Pr
otaminesulphate
b-BAL
c-Atr
opine
d-Cal
ciums al
ts
e-Dic
uma rol

i16-Sali
cylicac i
disuse
dpr
ima
ril
yasa
n(a
)i
a-Ana l
ges i
c
b-Antipyretic
c-Coughs uppr
e s
sant
d-Uricosuricagent
e-Ke r
atolyt
ica gent

17-Whic
hofthef
oll
owi
ngi
sfoundi
nvi
tami
nb12?
i
a-Magne
sium
b-Nicke
l
c-I
ron
d-Cobal
t
e-Mangane
se

18-free
zedyi ngisbas
edon
a-press
urefilt
rat
ion
b-subli
ma t
ion
c-polymeri
z at
ion
d-paste
uriz
a t
ion
e-densi
fic
ation

19-t
hemos tpr
eval
entcomme
rci
als
oli
ddos
agef
ormsa
re
a-Hardcapsul
es
b-Softgel
ati
ncapsul
es
c-Tablet
s
d-Bulkpowde r
s
e-Divide
dpowde r
s

20-Ointme nt
sa r
et ypi
cal
lyuse
das
i|
.Emolli
ent s
i|
|
. Pr
ote
ctiveba r
riers
i|
|
|.Vehi
c l
esf orapplyi
ngdrugs

a-|
.Only
b-|
||
.Onl
y
c-|a
nd||only
d-|
|and|
||onl
y
e-|
,|
|and||
|i

i21-Ahume ct
antre
tar
ds
a-Bact
eria
lgrowth
b-Degradat
ion
c-Surf
aceevapora
ti
on
d-Sprea
dabili
ty
e
-Al
loft
hea
bove

22-Starc
hi suse
dint
abl
ett
inga
sa
i|
.Binder
i|
|
. Gli
dant
i|
|
|.Disi
ntegra
nt

a-|
|
.Only
b-|
||
.Onl
y
c-|a
nd||only
d-|
|and|
||onl
y
e-|
,|
|and||
|i

i23-Gumsa reusedi
nta
ble
tti
ngpr
ima
ril
yas
a-Disinte
gr a
tors
b-Glidants
c-Lub ri
cants
d-Bindinga gent
s
e-Bothba ndc

i24-Va nis
hingcre
amsa r
ecl
ass
ifi
eda
s
a-Oleaginous
b-Abs orpti
onbases
c-Wa ter-s
olubl
ebases
d-O/wba ses
e-W/ oba se
s

i25-Syrupnfis
a-Selfpres
erving
b-As upers
aturat
edsolut
ion
c-Adi l
utesoluti
on
d-highunstable
e-fla
voredandpr es
erved
i26-Reacti
onrat
eisinc
rea
sedmos
tra
pidl
yby
a-Humi dit
y
b-Hight emper
atur
e
c-Free
z i
ng
d-Photolysi
s
e-Hydrolysi
s

i27-Gmpregul
ati
onsa
repr
omul
gat
eda
ndr
evi
sedby
a-Congre
ss
b-Stat
eboar
dsofphar
macy
c-Thedea
d-Thefda
e-Theepa

28-Fer
ri
ti
nisa(
an)
i
a-Vit
amin
b-Micel
le
c-Emuls
ion
d-Aminoaci
d

29-Vitaminb6isal
soknowna
s
a-Thiamine
b-Ribofl
avin
c-Niaci
n
d-Pyri
doxine
e-Cyanocobal
amine

i30-Sunscr
eenpr epar
ati
onsc onta
ini ngpami
nobe
nzoi
cac
ids
houl
dbe
a-Useds pa
ringly
b-Applied2hr sbeforeexposure
c-Packagedina i
r-re
sist
antcontai
ne rs
d-Packagedinl i
ght-r
esi
stantconta
i ners
e-Usedonlyona r
rearsothertha
nt hef a
ce

31-Whi
choft
hef
oll
owi
ngs
tat
eme
ntsi
s(a
re)t
ruef
orunde
cyl
eni
cac
id?
i
|
.Itisoft
enuseda
sz i
ncs
a l
t
i
|
|.I
tma ycaus
eirr
it
ati
onandse
nsi
tiz
ation
i
|
||
.Itismostf
ungi
sta
ti
cofthef
att
yacids

a-|
.Only
b-|
||
.Only
c-|
.And||
.Only
d-|
|.And|
||onl
y
e-|
,||a
nd||
|
i

32-Whi chofthefol
lowingisc
las
sif
ieda
sfa
tsol
ubl
e?i
a-Vitamind
b-Niacin
c-Ascorbicac
id
d-Thiaminehydrochlor
ide
e-Ribofl
avin

i33-Thea cti
vec ons t
it
uentsofsa
linel
axa
tive
sar
e
a-Abs orbableanions
b-Nona bsorbablea ni
on s
c-Tribasiccati
ons
d-Abs orbablecationsanda ni
ons
e-Nona bsorbablec at
ionsandanions

i34-Bi
smut hsubsal
icyl
atei
sus
edi
nant
idi
arr
hea
lsf
ori
ts
a-Hydrophobicacti
on
b-Hydrophili
cacti
on
c-Adsorbentact
ion
d-Absorbentacti
on
e-Anti
ba c
teri
alact
ion

i35-Cell
uloseacet
atephtha
lat
eisus
edi
npha
rma
cya
sa(
an)
i
a-Emul s
ifi
e r
b-Enteri
cc oat
ingma t
eri
al
c-Suspendingagent
d-Flavori
nga gent
s
e
-Exc
ipi
ent

i36-Cocabutter(t
heobromaoi
l)i
sus
eda
sas
uppos
it
oryba
sebe
caus
eofi
ts
a-Solubili
ty
b-Me lt
ingpoint
c-Mi s
cibil
it
y
d-Re ac
tivi
ty
e-Lipophili
cproper
tie
s

i37-Themos twidelyus
edmet
hodf
ors
ter
il
iza
tionofpha
rma
ceut
ica
lis
a-Mi cr
ofilt
rat
ion
b-Ra di
a t
ion
c-Ethyleneoxideexpos
ure
d-Moi stheat
e-Dryhe at

i
38-Ophthal
mics
olut
ionss
houl
dbef
ormul
ate
dtoi
ncl
udewhi
choft
he
f
oll
owing?i
i
|
.Ster
ili
ty
i
|
|.I
sot
onicit
y
i
|
||
.Buffer
ing

a-|
.Only
b-|
|.Only
c-|
.And||only
d-|
|.And||
|.Onl
y
e-|
,||a
nd||
|i

i39-Sodal imeisuseda sa(an)i

a-Alka l
ini
z er
b-The ra
pe uti
cagentintopic
a lprepa
rati
ons
c-Stabil
izerinemuls i
ons
d-Re agentforabsorpt
ionofc arbondioxi
de
e-Preservati
veina r
oma ti
cwa ters
i40-Thelimuluste
sti
sre
lat
ive
lyne
wme
thodoft
est
ingf
or
a-Pyrogens
b-Mi cr
obialgrowt
h
c-Ac i
dit
y
d-Creaming
e-Lackofos molar
it
y

i41-Whichoft hefoll
owi
ngi
sas
soc
iat
edwi
the
xce
ssi
vei
nfus
ionofof
hypot
onicfluids?
a-Hemolys i
s
b-Hyperglycemi a
c-Dehydrati
on
d-Glycosuri
a
e-Noneoft hea bove

i42-Whichoft hefoll
owi
ngi
sas
soc
iat
edwi
the
xce
ssi
vei
nfus
ionof
hyper
tonicdextrose?
i
a-Lossofe l
ect
r ol
ytes
b-Hyperglycemi a
c-Dehydrati
on
d-Glycosuri
a
e-Alloftheabove

i43-Normalr
ectaltemperat
urei
susua
lly
a-Me a
sure
dint hemor ni
ng
b-Me as
uredi
nt hee veni
ng
c-Aboutsamea sthenormalora
lte
mperatur
e
d-About1clowe rthanoral
e-About1chigherthanoral

i44-Thelat
inoc
ulout
roi
str
ans
lat
edt
ome
an
a-Righteye
b-Eache ye
c-Lefteye
d-Eache ar
e
-Rightear
i
45-Advantagesofta
blet
soverl
iqui
ddos
efor
msi
ncl
udet
hef
oll
owi
ng
i
|
.Enhanceds t
abi
li
ty
i
|
|.Eas
eofa dminis
tra
ti
on
i
|
||
.Great
erac c
uracyofdosi
ng

a-|
|
.Only
b-|
||
.Onl
y
c-|
.And||
.Only
d-|
|and|
||
only
e-|
,|
|and|
||
i

i46-Thelat
inpostcibosca
nbet
rans
lat
edt
ome
an
a-Aftermeals
b-Be f
oremeals
c-Wi t
hme al
s
d-Wi t
houtme a
ls
e-Ont heemptystoma c
h

i47-Prednisoneisconve
rte
dtowhi
choft
hef
oll
owi
ngbyt
hel
ive
r?i
a-Cor t
isone
b-Hydr ocorti
sone
c-Prednisol
one
d-Me thylpr
e dni
sol
one
e-De xame t
ha s
one

i48-Thepr i
ncipa
lus
eofma
gne
siums
tea
rat
einpha
rma
ceut
icsi
sasa
(an)
:
a-Lubricant
b-Anta c
id
c-Sourceofmgi on
d-Disinte
grator
e-Binder

i
49-Ac
tiva
tedc
har
coa
lisus
edi
nsomea
nti
dot
esbe
caus
eofwhi
chofi
ts
prope
rti
es?i
a-Neutr
a l
izi
ng
b-Eme t
ic
c-Absorpti
ve
d-Adsorpti
ve
e-Sta
bil
izing

i50-Thema j
oruseofti
tani
umdi
oxi
dei
npha
rma
cyi
sin
a-Sunscr
e ens
b-Antaci
dt able
ts
c-Capsulesasadiluent
d-Effer
vesc e
ntsalt
s
e-Emulsions

i51-Whichofthefoll
owi
ngi
sus
eda
sahe
mos
tat
ica
gent
?i
a-He par
in
b-Oxyc el
c-Couma dins
d-Indanedi
ones
e-Noneoft heabove

i52-Anothe
rna
meofe xt
ende
dins
uli
nzi
ncs
uspe
nsi
oni
s
a-Nph
b-Lente
c-Ultr
ale
nte
d-Regular
e-Noneoftheabove

i53-Thelati
noc
uluss
ini
st
erme
ans
a-Righteye
b-Lefteye
c-Bothea r
s
d-Bothe yes
e
-Ri
ghte
ar

i54-Therecomme ndedmethodofmixingi
nsuli
n’si
sto
a-Shakevigorousl
y
b-Mi xgent
lybyr ol
li
ngbetweenpalmsofhands
c-Adds i
mul t
aneousl
ytocontai
ner
d-Addl e
nteinsuli
nfir
stt
henregul
arinsul
in
e-Noneoft heabove

i55-Theformulat
ionofdi
ff
erentac
tivei
ngr
edi
ent
stha
tha
vebe
enj
udge
dto
producesimil
aref
fect
sarecal
led
i|
.Ge ne
ric*****al
ence
i|
|.Ther
apeuti
c*****al
ence
i|
||
.Pharmaceut
ica
l*****al
ence

A-
|.Only
B-
||
.Only
C-
|.And||onl
y
D-
|,|
|and||
|i

i56-Whichoft hef oll

owi ngisat r
ues tat
e mentr egardingtr
ansder
ma l
deli
verysystems ?
a-Productsfromdi ffe
rentma nufacturesrequireide nti
c a
lamountsofthe
acti
veingredienttoyield*****a lentresponse s
b-Skinthicknessisnotaf act
orindr uga bsorpti
on
c-Thetransde r
ma lunitshoulda l
wa ysbepl ac eda tthesames i
te
d-Thet r
ansde r
ma lunitcont a
insmor edr ugtha nisne ededfordel
iver
yinto
thebodyove rthepr es
cribe dtheperiodofus e
e-Thetransde r
ma lunitma yremaina tt
achedt othes kinaft
erthelabe
led
deli
verype r
iodbe causedr uga bs
orptionc ase
s

57-
dosageofanti
convuls
antsi
sadjus
ted:
A-whensei
zuresoccurfr
equent
ly
B-eve
ry2we eks
C-eve
ry2ye a
rs
D-onlywhens i
deeffec
tsarese
en
E-
sea
sona
ll
y

i58-
whichoft hef ol
lowi
nga
gent
sisa
ssoc
iat
edwi
tht
inni
tusa
sar
esul
tof
toxi
cit
y?i
a-Sali
cylate
b-Phenytoin
c-Propranolol
d-Ac et
ami nophen
e-Cyclobenz apr
ine

i
59-
par
kinsonisprobablyduet o
A-t
ooli
ttl
edopa mineint hebrain
B-t
ool
itt
lelevodopai nthebr a
in
C-t
ool
itt
leacetyl
cholinei nthebrai
n
D-t
oomuc hlevodopai nthebrain
E-t
oomuchdopa mi neint hebrai
n

i
60-t
hegr eatestthre
atfromthemor
phi
nepoi
soni
ngi
s
A-renalshutdown
B-paral
ys i
sofs pinalcord
C-respi
ratoryde pre
ssion
D-cardiovascularcoll
apse
E-noneoft hea bove

61-aspecif
icnarcot
ica
nta
goni
sti
s
A-meperidine
B-pol
ybrene
C-nal
orphine
D-uni
versalant
idote
E-meprobama t
e

62-wi
chofthef
oll
owi
ngi
sus
edt
ocur
tai
lchr
oni
cur
ica
cids
tone
for
mat
ion?
i
A-all
opurinol
B-t
rimethoprim
C-mehtenamine
D-e
thacr
yni caci
d
E-f
urosemi de

63-
whi c
hoft hefol
lowi
ngi
sus
edt
olowe
rbl
oodl
ipi
dle
vel
s?
A-tri
me t
hadione
B-coles
evelam
C-f
lucyt
osine
D-coumari
n
E-propra
nolol

64-ca
pe c
itabi
neisusedtotr
eat
A-hypert
ens i
on
B-mus c
ularinjur
ies
C-ulc
e r
s
D-breas
tca ncer
E-congest
ivehe a
rtfa
il
ure

65-ma gnes
iumi onisneces
sar
yin
A-sti
mul at
ingenz ymesyst
ems
B-mus cul
arcontracti
ons
C-nerveconduction
D-alloftheabove
E-noneofthea bove

i
66-ac la
ssofpl a
nta lka
loi
dswi
del
yus
edt
otr
eatmi
gra
inei
s
A-vinicalkal
oids
B-di
gital
is
C-st
ramoni uma l
kaloids
D-ergotalkal
oids
E-bell
adonnaalkaloids

i
67-cycl
ospor
inei
sus
edf
or
A-al
ler
gies
B-angina
C-preventi
onoftra
nspla
ntr
eje
cti
on
D-s
teroidsdef
ici
ency
E-t
reatingle
adpoisoni
ng

i
68-pant
opr a
z ol
eisusedpr
ima
ril
ytot
rea
t
A-gastr
ichype ra
cidi
ty
B-hypertens
ion
C-c
a r
diacinsuffi
ci
ency
D-gout
E-migrainehe a
dache

i
69-citalopramisa(an)
i
A-diuretic
B-cardiotonic
C-antidepress
ant
D-a
nti-infla
mma tor
y
E-anthelminti
c

i
70-da unorubi
cinanddoxor
ubi
cinha
vebe
enc
ommonl
yas
soc
iat
edwi
th
A-ulcers
B-cardiactoxi
cit
y
C-colit
is
D-gout
E-
He patotoxi
ci
ty

i
71-inwhi chofthefol
lowi
ngdos
agei
sni
cot
inea
vai
labl
ewhe
nus
eda
s
smokingde t
erge
nt?
A-tra
nsderma l
B-nasaldrops
C-gum
D-aa ndc
E-a,ba ndc

i72-f
olica
cidadmini
st
rat
ionhasbeenrecommende
dduri
ngpr
egna
ncyt
o
preventwhic
hofthefol
lowingcongeni
talpr
obl
ems?i
A-spi
nabifi
da
B-cyst
icf
ibr
osis
C-pat
entduct
usart
eri
osus
D-li
mbde f
ormati
ons
E-cl
eftpa
lat
e

i
73-ana dvantageofa moxici
ll
inove
rampi
cil
li
nist
hati
t
A-ismor eacids table
B-isnotde s
troye dbype nci
ll
inas
e
C-hasabr oads pec t
rum
D-doesnotc aus ea l
ler
gies
E-hasalonge r----fofli
fe

i74-Arsenictr
ioxi
dewasa
ppr
ove
dbyt
hef
dai
n2000t
otr
eatwhi
choft
he
foll
owingdi s
ease?
i
a-Leukemi a
b-Mus cl
es pasms
c-Parki
ns on'
sdise
ase
d-Ne ur
algias
e-Colonc ancer

i75-Pri
mi done,usedi
nthet
rea
tme
ntofge
ner
ali
zedt
oni
c-c
loni
cse
izur
es,i
s
me t
aboli
ze dto:
a-Phenytoin
b-Phenoba rbit
al
c-Me t
formi n
d-Ca r
bama z e
pine
e-Noneoft heabove

i
76-vincr
isti
nehasbeenc
ommonl
yas
soc
iat
edwi
thwhi
choft
hef
oll
owi
ng
adver
seeve nts
?i
A-neurotoxici
ty
B-gout
C-duodena lul
cers
D-bloodc l
otti
ng
E-noneoft heabove
i77-
dol
a set
ron,a5-ht
3anta
goni
sti
san(
a)i
a-B-adrenergicbl
ocker
b-Anti
e metic
c-Glucocort
icoid
d-Localanesthet
ic
e-Sunscree
n

i78-
cholest
yraminer es
inha
sthepr
eva
lents
idee
ffe
ctof
a-Blockingabsorpt
ionofsomevit
ami
ns
b-Raisi
ngc holest
erolle
vel
s
c-Causingintoxic
ation
d-Incr
ea si
ngs e
nsit
ivit
ytouvli
ght
e-Alloftheabove

79-Lorazepampr oduceswhi
choft
hef
oll
owi
nga
cti
on(
s)?
A-sedati
on
B-lossofme mory
C-reduct
ionofa nxiet
y
D-alloftheabove
E-noneoft heabove

i80-Timolidecombinestheac
tionofnons
ele
cti
vebe
tabl
ocki
nga
genta
nd
a(an)
i
a-Diureti
c
b-Ca r
diotoni
c
c-Select
ivebetablocke
r
d-Anti-i
nflamma t
oryagent
e-Va s
ocons t
ri
ctor

i
81-Whichoft
hef
oll
owi
ngdr
ugsha
sbe
ena
ssoc
iat
edwi
thr
eye
'ss
yndr
ome
i
nchi
ldr
en?
a
-Aspir
in
b-Ac etami
nophen
c-Ibuprofe
n
d-Na proxen
e-Phe noba
rbit
al

i82-Ult
ra-
shortact
ingbar
bit
ura
tesa
reus
edpr
ima
ril
yas
a-Sedat
ives
b-Hypnoti
c s
c-Anti
spasmodicagent
s
d-Anti-
parki
nsonia
na ge
nts
e-Prea
nest
he t
icagent
s

i83-Noret
hindroneisadr
ugc
ommonl
yus
edi
n
a-Mixede s
trogens
b-Oralcontr
a c
eptive
s
c-Treat
ingcarcinomas
d-Diagnost
ictesti
ng
e-Aborti
faci
ents

i84-Somea nt
i-
convulsa
nt(e.
g.,c
arba
mazepi
ne,phenyt
oin,gaba
penti
n)are
fdaapprovedt
ot r
eatsei
zur
esbuthaveal
sobeeneff
ecti
veinthetre
atmentof
a-Parki
nsonis
m
b-Ne ur
algi
asorneuropat
hie
s
c-Colit
is
d-Na us
e a
e-Alloftheabove

i85-Efavir
enziscl
assi
fi
eda
sa(
an)
a-Mus clerel
axant
b-Sedativehypnot
ic
c-Tranquili
zer
d-Ana l
ge s
ic
e-Antivira
l

i
86-Le
pir
udi
nisus
edma
inl
ytot
rea
t
a-Gast
ri
tis
b-Minoranxi
etyst
at
es
c-Hepar
in-i
nduce
dthr
omboc
ytope
nia
d-Se
ve r
epain
e-Nause
a

i87-His
tamineisfoundinthehumanbodyi
n
a-Thegranule
sofma s
tcel
lsinthebl
ood
b-Themuc osall
ayeroftheGItract
c-Thehypothala
mus
d-Aa ndb
e-A,ba ndc

i88-Orl
ist
atisusedasa(
an)
i
a-Narcoti
ca nt
agoni
st
b-Na r
coti
ca nal
gesi
c
c-We i
ghtlossagent
d-Antiepi
lepti
c
e-Anesthet
ic

i89-Antipsychoti
csusua
llya
ctont
he
a-Cerebrum
b-Cerebe l
lum
c-Lowe rbrai
na reas
d-Braina ndspinalc
ord
e-Nervee ndi
ngs

i90-Lidoc aineisuseda
saloca
lane
sthe
ticora
sa(
an)
i
a-Ge ne r
ala nest
heti
c
b-Ant iprurit
ic
c-Preane stheti
c
d-Ant iarrhythmic
e-Ana lges i
c
d-Ant i-i
nf l
amma tor
yagent
e-Va socons tri
ct
or
91-Cocaineha sal ongdura
tionofloc
alane
sthe
tica
cti
onbe
caus
eiti
s
a-Mores t
abletha nmostlocalane
sthet
ic
s
b-Readi
lya bsorbed
c-Notbiotrans
forme d
d-Ava s
oc onst
rictor
e-Noneoft hea bove

i92-Tenec
tepla
seisusedpri
mari
lyt
ore
ducemor
tal
it
yas
soc
iat
edwi
th
whichofthefoll
owingcli
nic
alpr
obl
ems?i
a-Diabet
es
b-Myoc a
rdiali
nfarc
ti
on
c-He mor
rhage
d-Prost
at
ec ancer
e-Noneofthea bove

i93-Al
bit
eroli
sus
ual
lya
dmi
nis
ter
edbywhi
chr
out
e?i
a-Iv
b-Im
c-Nasal
d-Rect
al
e-Oral

i94-Nategli
nideisus
edmos
tcommonl
ytot
rea
t
a-Aids
b-Ge ni
talherpes
c-Diabetes
d-Cmvr e t
ini
tis
e-Inf
luenza

i95-Barbit
urate
s,ingener
al,ar
epar
ti
cula
rlynot
edf
or
a-Lackofha bit
uati
on
b-Producingmi cr
osomalenzymesi
nlive
r
c-Inst
abil
ity
d-Slowa bsorpt
ion
e-Poororalabsorpti
on
i96-Meloxi
came xert
sit
sact
ionbec
aus
eiti
sa(
an)
i
a-Nos t
eroi
dalanti
-i
nfla
mma t
ory
b-Ma oinhi
bit
or
c-Alkal
ine
d-Calci
umc hannelbl
ocker
e-Acid

i97-Oxcar
bazepi
neisus
edt
otr
eat
a-Part
ials
eiz
ures
b-Hdogkin'
sdise
ase
c-Anginapect
ori
s
d-Breastc
ancer
e-Depress
ion

i98-Whi c hofthef
oll
owi
ngi
scl
ass
ifi
eda
sac
hol
ine
rgi
cant
agoni
st
?i
a-Ace tylcholi
ne
b-Neos tigmine
c-Atropine
d-Betha ne c
ol
e-Me thac hol
ine

i99-Ni t
roglycer
inhasarel
ati
vel
yshor
t-
hal
fli
feduet
o
a-Itsvolati
lit
y
b-Itschemi cali
nst
abil
it
y
c-Itspoora bsor
pti
on
d-First-
pa s
s----
boli
sm
e-Al loftheabove

i100-Trihexylphe
nidyli
sus
edt
otr
eat
a-Parkinsonis
m
b-Angi na
c-Xe r
os t
omia
d-Gl a
uc oma
e-Muscles pas
ms
Four
th100

1-Whi chofthefol
lowi
ngNSAI
Dsi
sava
ila
blei
napa
rent
era
lfor
m?
A.Ibuprofe
n
B.Ke t
orola
c
C.Tolme t
in
D.Piroxic
am
E.Noneoft heabove

2-Muscl
er el
axantarese
ldomusedformor
e
Than
A.2to3we eksbe ca
useOftoxi
ci
ty
B.Ofinst
abil
it
y
C.Ofshortdura
tionofneed
D.Oftol
erancebe i
ngdevel
oped
E.Theyareusedlongercommonly

3-Li
nezoli
disusedagains
tinf
ect
ionsc
aus
edbya
nti
biot
icr
esi
st
ant
A.Gram-posit
ivecocci
B.Gram-negat
ivebacil
li
C.HIVvirus
D.Gram-posi
ti
veba c
il
li
E.Noneoftheabove

4-
Na t
eglini
des t
imul
ate
sther
ele
aseof
A.Ins
ulin
B.Epinephrine
C.Glucose
D.Glucagon
E.Norepinephri
ne

5-Mi
fepros
tonei
sar
ece
ptora
nta
goni
stofwhi
chhor
mone
?
A.Es
trogen
B.Thyroid
C.Insul
in
D.Cor t
is
ol
E.Progest
erone

6-Rivasti
gmi nehasthepr
ima
rya
cti
onofi
nhi
bit
ing
A.Ac et
ylc holi
nest
eras
e
B.Epinephr i
ne
C.Ga s
tricacid
D.Ca l
ciumi nfl
ux
E.Hist
ami ner e
lea
se

7-Whichofthef
oll
owi
nga
rel
owmol
ecul
ar-we
ighthe
par
in?
A.Tinza
pari
n
B.Enoxapa
rin
C.Dalt
epar
in
D.BandC
E.A.BandC

(@)8-Oc ularti
mol
oli
sus
edpr
ima
ryi
n
A.Glauc oma
B.Pinke ye
C.conjunctivit
is
D.Eyei nfecti
ons
E.Eyec leaners

9-Sucr
alf
atei
susedfors
hor
tte
rmt
her
apyof
A.Ulcer
s
B.Hypert
ensi
on
C.Carc
inomas
D.Calc
iumde pl
et
ion
E.Dent
alcari
es

10-Lor
aze
pamisc
las
sif
ieda
s
A.Loopdi
ure
ti
c
B.MAOi nhibit
or
C.Thia
z i
dedi ure
tic
D.Dibenzazepine
E.Pol
ycyc l
ica mine

i
11-pr
oba nthel
ineiscont
rai
ndi
cat
edi
npa
tie
ntswi
th
A.Gla
ucoma
B.Myastheniagravi
s
C.Obst
ruc t
ivedis
e a
seofGltra
ct
D.Ulc
erativecoli
tis
E.Al
loft heabove

12-Anti
epil
ept
icsasagr
oupa
renot
edf
orde
vel
opi
ngorc
aus
ing
A.Rashes
B.Atr
ialtac
hyca
r di
as
C.Tol
e r
ance
D.Spasms
E.Headache

13-Se
leniums ul
fi
deisuse
d
A.Oral
ly
B.Tol
erance
C.Byinject
ion
D.Bynoneoft heabove
E.Byalloftheabove

14-
Zonis
a mideisc
ons
ide
redabr
oads
pec
trum
A.Anti
bioti
c
B.Ant
iconvulsa
nt
C.Ant
iviral
D.NSAID
E.Ant
ihist
amine

15-Bac
lof
enisus
edpri
mar
il
yasa
(an)
A.Sympat
homimet
ic
B.Ant
ianxi
etyagent
C.Muscler
elaxa
nt
D.Anti
spas
modic
E.Tr
anquil
iz
er

16-Bet
ainter
fer
onisusedt
otr
eat
A.Adult
-o ns
etdia
bet
es
B.Hypert
ensi
on
C.car
diacins
uff
ici
ency
D.Multi
plescl
eros
is
E.Ulce
rs

17-
.Apr eval
entsi
deeffe
ctofpr
opyl
thi
our
aci
l(PTU)i
s:
A.Hea r
ingloss
B.Visualimpair
me nt
C.Acidosis
D.LeuKope ni
a
E.Mus cula
rspasm

18-c
a ndesart
anisus
eda
sa(
an)
A.Diuretic
B.Antihypert
ensi
ve
C.Hypnot i
c
D.Seda t
ive
E.Antidepres
sant

19-thephar
macologi
ca ct
ionsofs
uli
nda
cinc
lude
1.Anti
-i
nfl
amma t
orypropert
ies
11.Anal
gesi
cpropert
ie
s
111.Anti
pyr
eti
cpropert
ies

F.1only
G.11onl
y
H.1and11only
I
.11a nd111onl
y
J.1,
11a nd111

20-Mirt
azapineisusedt
otr
eats
ympt
omsof
A.Depres
s i
on
B.Par
kinsonism
C.Gout
D.Pet
itma lepi
lepsy
E.Noneoft heabove

21-Of
loxaci
nisc l
assi
fi
eda sa(a
n)
A.Anti
fungal
B.Ant
ivir
al
C.Bro
ad-spec
truma nt
ibi
otic
D.Narr
ows pect
ruma nti
biot
ic
E.Ant
iri
cket
tsi
al

22-Zidovudinema ycommonlyc
aus
ewhi
chof
Thefollowinga sasi
deeff
ect
?
A.Vas oconstr
icti
on
B.Dryne ssofthemouth
C.Hype ract
ivi
ty
D.Ane mia
E.Anur i
a

23-Mupicori
noi nt
menti
susedt
opi
cal
lyt
otr
eat
A.Conjunct
ivit
is
B.Allt
ypesofe yeinf
ect
ions
C.Impeti
go
D.Carc
inoma softheski
n
E.Hemorrhoids

24-Pe
ntoxi
fyl
li
neact
sprimar
il
yby
A.Dis
solvi
ngchol
est
erol
B.Decr
easi
ngvisc
osi
tyofth
eblood
C.Inc
reas
ingbiotr
ans
for
mat
ion
D.Oxidat
iveme c
hani
sms
E.Pre
venti
ngformati
onofc
hol
est
erol

25-Whi chofthefoll
owingi
smos
tus
efuli
ntr
eat
inghype
rte
nsi
vec
ris
is?
A.Sodiumni torpr
uss
ide
B.Ser
pa si
l
C.Chlorothi
azide
D.Spironolac
tone
E.Tri
amt ere
ne

26-Al l
opurinoldif
fersfr
ommos tot
herage
ntsus
edt
otr
eatgout
ycondi
ti
ons
because
A.Doe snotde creaseuri
cac i
dlevel
s
B.Preventsforma t
ionofuricacid
C.Increaseeliminati
onofur i
cacid
D.Ca usesrapidbiotra
nsformati
onofuri
cacid
E.Ha sanalgesicproper
ti
e s

27-Estrogent e
ndtoi nc
rea
set
her
iskof
A.Endome tri
alcar
cinoma
B.Hirsuitis
m
C.Hearingl oss
D.Visua lproble
ms
E.pre
gna ncy

28-Whi chofthefoll
owingdrugsi
scont
rai
ndi
cat
edwhe
nus
edwi
th
si
ldenafil
?
A.Fluroquinol
ones
B.Or gani
cnitra
tes
C.Pe ni
cil
lin’
s
D.Ca lc
iumc hannelbl
ocker
s
E.noneoft heabove
29-Ge nt
amici
ne xhibit
s
A.Signif
ica
nthepa t
otoxici
ty
B.Signif
ica
ntcardiotoxic
it
y
C.Signif
ica
ntderma ltoxic
it
y
D.Signif
ica
ntnephr otoxi
cit
y
E.Alloftheabove

30-Ri
s e
ndr onateiscla
ssi
fi
eda
sa(
an)
A.Cardiosuppr es
sant
B.Bis
phos phona t
e
C.Diuret
ic
D.Immunos uppre
ssant
E.Sympa t
homi me ti
c

i
31-Ca r
bama ze
pi neisuse
dasa
nant
iconvul
santa
swe
lla
stot
rea
tpa
inf
rom
A.Kidneyinfec
tions
B.Burns
C.Mus c
leinjur
ies
D.Si
nushe adache
E.Tr
igeminalne ural
gia

32-Methylphenidat
eisusedt otr
eat
A.Fat
igue
B.Hyperkinesi
sdisorder
s
C.Anxiet
y
D.Depression
E.Obesi
ty
33-Doxorubicinisusedtotreat
A.Awi deva ri
etyofinfe
c t
ions
B.Gram-pos it
iveinf
ecti
ons
C.Gram-ne gati
veinfect
ions
D.Vir
alinfe c
ti
ons
E.Car
cinoma s

34-Adr
ugi
sus
efuli
ntr
eat
ingpot
ent
ial
lyf
ata
lfunga
linf
ect
ionsi
s
A.Nyst
atin
B.Pr
opionicaci
d
C.Amphot e
ric
in
D.Nyst
atin
E.Gr
ise
of ul
vin

35-Theuseofthyr oi
dhormonesinthetre
atmentofobe
sit
yis
A.Widelyaccepted
B.Unjust
if
ied
C.Accept
ableinc ombinat
ionwit
hot he
rdrugs
D.Onlyaccept
a bleifot
hertr
eat
me ntsf
ail
E.Accept
ablei
ft hepati
entiscl
oselymonit
ore
d

36-Ana dvant
a geofdext
romethor
pha
noverc
ode
inea
sana
nti
tus
sivei
stha
t
it
A.Istwiceasa ff
ecti
ve
B.Ismores t
able
C.Hasnos idee f
fect
s
D.Producesveryl i
tt
lede
pres
sionoft
heCNS
E.Hasbe t
teranalges
icpr
opert
ies

37-Nonse l
ect
ive2-adre
norec
ept
ora
nta
goni
st
sar
eus
edpr
ima
ril
yin
A.Peri
phe r
alvascula
rdis
orde
r
B.Tachycardi
a
C.Migraineheadache
D.Atheroscl
erosi
s
E.Renalinsuf
fici
ency

38-Antimusc
a ri
nicdrugsar
ec ont
rai
ndi
cat
edi
n
A.Narrowangl eglaucoma
B.Par
a l
yti
cil
e ns
C.Pyl
or i
corintest
inalobs
truc
tion
D.Aa ndB
E.A,Ba ndC

39-Za
nami
vira
ndos
tel
ami
vira
rebot
hFDAa
ppr
ove
dfor
A.Tre
a t
mentofi
nfl
uenzaAinf
ecti
on
B.Tre
a t
mentofi
nfl
uenzaBinf
ect
ion
C.Pr
ophylaxi
sofi
nfl
uenzai
nfec
ti
ons
D.Aa ndB
E.A,Ba ndC

40-Whichoft hefol
lowi
ngdr
ugsi
snotapr
otonpumpi
nhi
bit
or?
A.Pant
opr a
z ol
e
B.Rabeprazole
C.Lansoprazole
D.Sulf
isoxazole
E.Omepr az
ol e

41-Ada ngerofprol
onge
dus
eofpi
loc
arpi
nes
alt
sasami
oti
cis
A.Tearning
B.Glaucoma
C.Conjuncti
vit
is
D.Detachedret
ina
E.Lensopacit
y

(@)42-As e
rioussidee f
fectoffur
ose
midei
ntr
eat
inghe
artpa
tie
ntsi
stha
t
i
t
A.Int
era
c twithdigital
isglycos
ides
B.Causesarte
rialblockade
C.Mayc ausea nur
ia
D.Causeshype rt
ension
E.Maylos eit
se ff
ects

43-Whi c
hoft hef
oll
owi
ngdrugsr
equi
ree
lec
troc
ardi
ogr
aphi
cmoni
tor
ing
pri
ortoinducti
onoft
her
apy?
A.Ziprasi
done
B.Arsenictr
ioxi
de
C.Cisapri
de
D.Aa ndB
E-A,Ba ndC
44-Lumivudineisusua
llyc
las
sif
ieda
sa(
an)
A.H2a nta
gonist
B.Ulcerprote
cta
nt
C.Antivi
ral
D.Oralantidi
abet
ic
E.Anthel
mi nt
ic

(@)45-Prolongedusa
gesofsubl
ingua
lni
tr
ate
sisl
ike
lyt
oca
use
A.Ulcer
s
B.Anuri
a
C.Rashes
D.Developmentoftol
era
nce
E.Per
sis
tentheadac
he

(@)46-Stre
ptokinaseisusedt
o
A.Diss
olvebloodc l
ots
B.Trea
tdigest
ivedisorder
s
C.Pr
omot ecarbohydra
tedegra
dat
ion
D.Trea
tmus cl
ei nj
urie
s
E.Repl
acepeps i
n

47-Goldcompoundshavebe
enus
edt
ote
at
A.Wor minfes
tat
ions
B.Ulcer
s
C.Kidnyfai
lure
D.Rheuma t
oidart
hri
ti
s
E.Psor
ias
is

(@)48-Ta moxifeni
scl
ass
ifi
eda
sa(
an)
A.Estr
ogen
B.Anti
e s
trogen
C.Androsterone
D.Test
osterone
E.Thyroi
dhor mone

(
@)49-
Ber
ibe
rii
sas
soc
iat
edwhi
thade
fic
ienc
yof
A.VitaminD
B.Thiamine(B1)
C.VitaminC
D.Niacin(B3)
E.Ribofla
vin(
B2)

50-Adr ugi susedtotr

eatde
lir
iumt
reme
nsi
s
A.Chlordiazepoxide
B.Halope r
idol
C.Dis
ulf i
ram
D.Metha done
E.Noneoft hea bove

51-Cr omol ynsodiuma c

tsby
A.De s
troyinghis t
amine
B.Releasinghistamine
C.Biotransfor
mi nghis
tamine
D.Preventingther e
lea
seofhist
ami
ne
E.Noneoft heabove

52-Thea nti
-inf
lammatoryact
ionofas
pir
ini
sduet
o
A.Ana lgesi
a
B.Inhibit
ionofclot
ti
ng
C.Ant i
pyreti
ceffec
t
D.De gradat
ionofprost
agla
ndins
E.Inhibit
ionofprost
agla
ndinssynt
hes
is

(@)53-Ca storoili
scl
ass
ifi
eda
swhi
cht
ypeofl
axa
tive
?
A.Lubric
a t
ing
B.Anthraquinone
C.Ir
rit
ant
D.Stoolsoft
e ni
ng
E.Bulkproduc i
ng

54-Pe
ncil
lami
nei
smos
tcommonl
yus
edt
otr
eat
A.Par
kins
onis
m
B.Wilson'
sdi
seas
e
C.Neoplas
ms
D.Raynaud'
sdis
ease
E.Gr
a m-posi
ti
veinf
ect
ions

55-Whic hofthefol
lowingdr
ugsarewit
hdr
awnfr
omt heUSma rke
t
In2001duet oincr
easedri
skofmyopat
hyandr
habdomyolys
is?
A.Cerevastati
n
B.Cisa
pr i
de
C.Dexfenflurami
ne
D.Terf
e nadine
E.Aste
mi zole

56-Doxycycl
ineor
alge
lisus
edt
otr
eat
A.Per
iodonti
ti
s
B.Aphthousulc
ers
C.Acne
D.Lymedi s
ease
E.Art
hrit
is

57-Whichofthefol
lowingdr
ugsr
equi
resados
agea
djus
tme
nti
npa
tie
nts
wit
hrenalimpai
rment?
A.Famotidi
ne
B.Capeci
tabi
ne
C.Gentamici
n
D.Aa ndC
E.A,Ba ndC

58-Apre valentsi
dee ff
ectofnor
ethi
ndr
onei
s:
A.Diarrhe a
ِ
B.Breakthroughbl eedi
ng
C.Blooddys cra
siency
D.Cardia cinsuff
icie
ncy
E.Abortion

(
@)59-t
hepr
efer
redwa
ytoof
fse
thypoka
lemi
aist
o
A.Ea
tci
tr
usf
rui
t
B.Eats
eafoodorf i
sh
C.Admini
ste
rpotassi
ums al
t
D.Admini
sterIVe l
ect
rol
yte
s
E.Di
mnishurinat
ion

60-Personsrec
eivi
ngMAOi nhi
bit
orss
houl
dcont
rolt
hei
rint
akeof
A.Somef e
rmentedandbe
ver
ages
B.Carbohydrat
es
C.Fatsandlipi
ds
D.Wa ter
E.sal
icylat
eanalges
ics

61-Whi chofthefol
lowi
ngdr
ug'
sma
yinhi
bitt
heme
tabol
is
mofz
ipr
asi
done
?
I.Erythromycin
II.Ke t
oconazole
III.Phenobar
bital

A.Ionly
B.IIonl
y
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII

62-Fl uma z
enali
sas
pec
ifi
cant
agoni
stf
orwhi
choft
hef
oll
owi
ngdr
ugs
?
I.Me peri
dine
II.Propoxyphene
III.Diazepam

A.Ionly
B.II
Ionly
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII
63-Whichoft hef ol
lowi
nga
nti
depr
ess
anta
lsoha
dani
ndi
cat
ionf
or
smoki
ngc es sa
tion?
A.Haloperidol
B.Bupropion
C.Cit
alopram
D.Mirtaza
pi ne
E.Par
oxe t
ine

64-Doc osanolisa(an)
A.Diuretic
B.Nonna rcoti
ca na
lges
ic
C.Anti-inflamma t
ory
D.Antiviral
E.Anthe l
mi nt
ic

65-Whi chofthefol
lowingstat
ement
sistr
ueregar
dingthe
Admi nis
trat
ionofal
endronat
e?
I.Ta k
emor ethan30minutesbef
oref
irs
tfoodorbever
ageoftheday
II.Takewith6t o8ouncesofpla
inwater
III.Remainfull
yupri
ght(si
tt
ingorst
andi
ng)forabout30minute
s

A.Ionl y
B.I IIonl y
C.Ia ndI Ionly
D.I Ia ndI I
Ionly
E.I ,IIa ndIII
66-Te stost
eroneisava
ila
blea
swhi
choft
hef
oll
owi
ngdos
agef
orm?
I.Oi ntme nts
II.Injec t
ion
III.Tra nsder
ma lpat
ch

A.Ionly
B.II
Ionly
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII
67-Whichofthef
oll
owi
ngi
sanor
alhypogl
yce
mica
gent
?
A.Ketor
olac
B.Pi
oglit
azone
C.Doconasol
D.Ril
uzole
E.Ter
binaf
ine

68-Thec oncur r
enta
dmini
str
ati
on(wit
hin1t
o2hoursofdosi
ng)of
nislopidines houldbeavoi
dedwithwhi
choft
hef
ollowing?
I.Hi gh_f atme al
II.Gr a
pe fruitjuic
e
III.Coc oa

A.Ionly
B.II
Ionly
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII

69-Whi chofthef
oll
owi
ngdr
ugsma
ybea
dmi
nis
ter
edwi
thoutr
ega
rdt
o
me als
?
I.Va l
aci
clovi
r
II.Ceti
ri
zine
III.Acar
bose

A.Ionly
B.IIonl
y
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII

70-Dexfenfl
uramine,anagentappr
ove
dfort
het
rea
tme
ntofobe
sit
y,wa
s
removedfromt heU.Sma rke
tdueto
A.Ca r
diacvalvula
rdysfunct
ion
B.Ga s
tri
culcerat
ions
C.Renaltoxici
ty
D.Ototoxici
ty
E.He
pat
ici
mpa
irme
nt

71-Theter
mina
lha
lf_l
if
eofa
lendr
ona
tei
s:
A.10days
B.10months
C.10year
s
D.10hours
E.10minut
es

72-Se r
ot oni
ns yndr
omeisc
har
act
eri
zedbywhi
choft
hef
oll
owi
ng
syndrome ?
I.Me ntalsta
teschange
s
II.Tremor
III.Diaphoresi
s

A.Ionly
B.II
Ionly
C.IandIIonl
y
D.IIandII
Ionly
E.I
,IIandIII

73-theFDAha sr ecomme ndedt

heremova
lofwhic
hingre
die
ntfoundi
n
cough/coldproduc tsduetoa nas
soc
iati
onwit
hhemorr
hagi
cstr
oke?
A.De xtrome t
hor phan
B.Psedoe phedrine
C.Gua nfenisen
D.Phe nylpropanolami ne
E.Ephe drine

(@)74-Whi chofthefoll
owi
nga
nta
cidss
houl
dnotbeus
edi
ndi
alys
is
pa t
ients
?
l.Alumi numhydroxi
de
ll.Ma gnnes
iumhydroxide
lll.
Calciumcar
bonate

A.lonl
y
B.llonly
C.landlllonly
D.llandlllonl
y
E.l
,llandlll

75-Me la
toninr
egul
ate
swhi
choft
hef
oll
owi
ngf
unc
tions
?
l.Sleep
ll.cir
cadian
lll.Respi
rat
ion

A.lonly
B.llonl
y
C.landl lonl
y
D.llandl l
lonl
y
E.l,llandlll

76-Tacr
oli
musoint
menti
sus
edpr
ima
ril
ytot
rea
t
A.Pain
B.Atopi
cdermat
iti
s
C.Sunbur
ns
D.Skingra
fts
E.Poi
sonivy

77-In2001,Whi chanalge
sice
xpe
rie
ncedsi
gni
fi
cantmis
usesanddi
ver
sion,
requi
ri
ngr e
vis
ionsinthewarni
ngs
ecti
onoft
heproduc
tlabe
ling?
A.Oxyc ont
in
B.De merol
C.Tylenol#3
D.Toradol
E.roxanol

(
@)78-Whi choft hefoll
owingdrugcombinat
ionha
s(ha
ve)be
ene
ffe
cti
ve
t
hera
pyforthetrea
tme ntofHeli
cobac
terpylor
i?
l
.Clar
it
hromycin/ranit
idi
nebis
mut hci
tr
ate
l
l.Omepraz
ole/cla
r i
thr
omycin
l
ll
.Ci
prof
loxa
cin/e
ryt
hromy
cin

A.lonly
B.llonl
y
C.landllonl
y
D.llandll
lonl
y
E.l,l
landll
l

79-Ziprasiodne,ana gentusedtotr
eats
chi
zophr
eni
a,e
xer
tsi
ts
phar
ma cologicaleff
ectsby:
A.Inhibi
tinghistaminereuptake
B.Sti
mul atingser
otoninsynthesi
s
C.Blockingdopa mine
D.Stimulatingdopami nerel
ease
E.Noneoft heabove

80-Oculart
imololi
sus
edpr
ima
ril
ytot
rea
t
A.Mydr i
asi
s
B.Glaucoma
C.Cat
a r
acts
D.Conjunct
ivi
ti
s
E.Noneoftheabove

81i
-Ceti
ri
z i
neisa
A.Nonspeci
fichist
ami neant
agoni
st
B.His
tamine1a ntagonist
C.His
tamine2a ntagonist
D.Hist
amine1a gonist
E.His
tamine2a gonist

82-Bi
vali
rudinisa(
an)
A.Ant
icoagulant
B.Ant
i-infe
ctive
C.NSAID
D.Ant
ivi
ral
E.
Anti
his
tamine

83-Cevimeli
neisuse
dtot
rea
t
A.De r
ma t
it
is
B.Xerost
omi a
C.Aller
gicrhi
nit
is
D.Tineaversi
col
or
E.Eczema

84-Crota
lideisusedtot
rea
tthebi
tesof
A.Fle
a s
B.NorthAme r
ica
nviper
s
C.Tic
ks
D.Rabidani mal
s
E.Bla
c kwi dowspide
rs

85-Whi choft hefollowi

ngs t
ate
mentsrega
rdingf
osphenyt
oinar
etrue?
l.Fosphenytoini scompletel
yconve
rtedtophenyt
ionaf
teri
ntra
venousor
Intra
mus culara dminist
rat
ion
ll.Theadmi nistrat
ionof1mmolofphe nyti
on
111.Moni torings erumphe n
yti
onle
ve l
sisnotnec
e s
sar
y

A.lonly
B.llonl
y
C.landl lonl
y
D.llandl l
lonl
y
E.l,llandlll
86-Theprinci
pala
dve
rsee
ffe
ctofa
car
bos
eis
A.Hema t
ologic
B.Gastr
ointe
sti
nal
C.Renal
D.Hepati
c
E.Dermal

87-UnoprostoneisFDAa ppr
ove
dtot
rea
t
A.Ova ri
anca ncer
B.Hodgkin'sdiseas
e
C.Ope nangleglaucoma
D.Conjuncti
vi t
is
E.Tinnit
us

88-Or a
lparentera
lKe t
orolacthe
rapyisl
imi
tedt
o5da
ysoft
her
apyduet
o
anincreas
edriskof
A.Re nali
mpa ir
me nt
B.Ga st
rointe
s t
inalbl
eeding/per
fora
ti
on
C.Liverfail
ure
D.CNSdi s
turbances
E.Aa ndB

89-Whi chofthefol
lowingHMG- CoAr
educ
tas
einhi
bit
orsc
aus
est
he
gre
atestper
centagei
ncreas
einHDL?
A.Simva st
at
in
B.Pravast
ati
n
C.Lova s
tat
in
D.Fluvasta
ti
n
E.Allproduce*****ale
ntreduc
ti
ons
90-Si but
rami
neshouldnotbeusedi
npa t
ient
s
l.Wi t
habodyma ssindexgre
ate
rthan30kg/m2
ll.TakingMAOi nhi
bitor
s
lll.Withpoor
lyc
ontroll
edhyper
tens
ion

A.lonly
B.ll
lonly
C.landl lonl
y
D.llandl l
lonl
y
E.l,llandlll

i
91-Diur e
ticste
ndt oenha
ncelit
hiumsa
ltt
oxi
cit
yduet
o
A.Sodiumde pl
eti
on
B.Pot
as si
umde plet
ion
C.Dir
ec tdruginte
racti
on
D.Inc
rea s
eda bsor
ption
E.I
ncreaseds ol
ubil
ityoft
heli
thiumsa
lt
s

92-Lefl
unamideisusedtotr
eat
A.Crohn'
sdisease
B.Rheumatoi
da rthr
it
is
C.Psor
iasi
s
D.Photoal
le
rgicreact
ions
E.Noneofthea bove

93-Suma t
ri
ptanuseiscont
rai
ndic
ate
dinpa
tie
nts
’:
l.withahi
storyofis
chemichear
tdis
eas
e
ll.Taki
ngphenelz
ine
lll.Wit
huncontr
oll
edhypert
ensi
on
A.lonly
B.ll
lonly
C.landllonl
y
D.llandll
lonl
y
E.l,l
landll
l

94-Eptif
ibat
idei scla
ssi
fi
edasa(
an)
A.Fluoroquinolone
B.Glycoproteinllb/l
ll
arec
ept
ori
nhi
bit
or
C.Diureti
c
D.Antihypertensive
E.Noneoft hea bove

95-Fina
ster
ide'
sa c
tionint hetr
eat
mentofbe
nignpr
ost
ati
chype
rtr
ophyi
sa
(an)
A.HMG-CoAr eductasei nhibi
tor
B.Alpha-5r
eductaseinhibitor
C.Serot
oninreuptakeinhi bit
or
D.P450he pat
icenzymei nhibit
or
E.Noneofthea bove

96-Aus efulagenti
nthet
rea
tme
ntofbl
adde
rinc
ont
ine
ncei
s
A.Na l
me fene
B..ol
terodine
C.Tolcapone
D.Va l
rubicin
E.Noneoft heabove
97-Whi chofthefol
lowi
nga
gent
sar
eappr
ove
dfort
rea
tme
ntofna
rcol
eps
y?
l.Mod afi
nil
ll.Methylphe
nida
te
lll.De
xtroamphet
amine

A.lonly
B.ll
lonly
C.landllonly
D.llandlllonl
y
E.l,llandlll

98-Mi s
opr ost
olisusedto
A.Treatga st
ri
cul c
ers
B.PreventNSAI D- i
nducedga
str
icul
cer
s
C.Preventos t
eoporos
is
D.Preventr e
naltoxic
ity
E.Tr
eatPa get'
sdiseas
e

99-Acarbose,ahypogl yce micagent

,e xer
tswhi
choft
hef
oll
owi
ng
mechanismsofa ct
ion?
A.Inc
reasedinsulinsecret
ion
B.Inc
reasedins
ul inrec
e ptorsensi
ti
vit
y
C.De creas
esci
r cula
ti
ngi ns ul
inanti
bioti
cs
D.Delaysdiges
tionofc a r
bohydrates
E.Noneoft heabove

100-Whichoft
hef
oll
owi
ngdr
ugsi
nte
rfe
reswi
tht
heme
tabol
is
mof
Indi
navi
r?
A.Ke t
oconazol
e
B.Ciprof
loxaci
n
C.Digoxin
D.Lorazepam
E.Noneoft heabove

Fi
ft
h100

1-Ana dvers
ee f
fec
tofc ommonl
yas
soc
iat
edwi
tht
heus
eof
theophyl l
ineHYHpr oduct
sis
A)Cr ys t
aluri
a
B)Ski nRa s
h
C)Sync ope
D)Pt os i
s
E)I nsomni a

i
2-Whi chofthefoll
owi ngst
ate
me nti
s(a
re)t
rueofe
pine
phr
ine
?
l
.Ma ybea dmini
ster
edbyi nhal
ati
on
l
l.Reducesart
eri
albloodpress
ure
l
ll.Pe
ripher
alvasodi
lator

A)1only
B)111onl
y
C)1and11onl
y
D)11and111onl
y
E)1,11and111

i
3-Dipivefr
in(pr oppi
ne)canbe
stbede
scr
ibe
dasa
(an)
i
A)Sholines
teras
ei nhi
bit
or
B)Osmot i
cdi ur
etic
C)Beta-adrener
gicblocki
ngagent
D)Prodrug
E)Chelati
nga gent
i4-Whichofthefol
lowingst
atementa
re(
is)t
rueoft
icl
opi
dineHCI
(Ti
cli
d)?
1.Onlyadminis
tere
dp a
rente
rall
y
11.Diss
olvesbl
oodc l
ots
111.I
nhibit
splat
ele
taggrega
tion

A)1onl y
B)111onl y
C)1a nd11onl y
D)11a nd111only
E)1,11a nd111

i
5-Thea ntiar
rhyt
hmica
cti
onoftocai
nide
(Tonoca
rd)a
nd
mexi
leti
ne (Mexit
il
)mos
tclos
elyre
semblest
hatof
A)Ac
ebut olol
B)Verapami l
C)Quinidine
D)Li
doc aine
E)Di
sopyr amide

i
6-Wghi choneoft hefoll
owingagent
sma
ybea
dde
dtol
oca
linj
ect
ionof
Xyl
oca i
nei nor dertopr ol
ongitsef
fec
t
A)Succinylchol i
nec hlori
de
B)Sodiumc arbxyme thylce
ll
ulose
C)Polyethylenegl ycol
D)Epinephrine

i
7-Colesti
polHCIi smos tc
ommonl
yempl
oye
dasa(
an)
i
A)Anti
dotef oratr
opineover
dos
age
B)Hypoglyc emicagent
C)Bi
lea ci
ds equest
rant
D)Fatsubstitut
e
E)Br
onc hodilat
or

i
8-Whi
choneoft
hef
oll
owi
ngdr
ugsdos
eNOTl
owe
rpl
asmal
ipopr
ote
in
Conc
e nt
rat
ions?
i
A)Si
mva st
a t
in
B)Clofi
bra
te
C)Pr
obuc o
l
D)Cholest
yramine
E)Nicot
inamide

i9-Adr ugthatha sbe enshownt ohaveast

ronga
nta
goni
smf
orbot
h
hist
aminea nds erotoninis
A)Chl orphenirami ne(Chlor-Tir
met
on)i
B)Tr i
polidine(Ac tidil
)i
C)Cy proheptadine( Peri
actin
) i
D)Lor ati
dine( Clariti
n)i
E)Prome thazine( Phenergan)i

i
10-I
doxur idine(Herpl
ex)i
sane
ffe
cti
vet
rea
tme
ntf
orde
ntr
icke
rat
it
is,
whi
chi scausedby
A)Escherichiacol
i
B)Ps
e udomona sa e
rugi
nosa
C)St
a phylococcusaure
us
D)Clostr
idiumdi ff
icl
e
E)Herpess i
mpl ex

11-I
sotre
tinoi
nisus edther
apeuti
cal
ly
A)Asaur inar
ya nalges
ic
B)Inthetr
e at
mentofc yst
icacne
C)Asa nantif
ungala ge
nt
D)Inthetreat
me ntofresi
st
anttuber
cul
osi
s
E)Asa nosmoticdiuret
ic

i12-Ana gentt
hatwoul
dbemos
tli
kel
ytoc
aus
edr
ugs
-induc
ed
bronchospa smis
A)ne docromi l
B)Ena lapril
C)I s
oprot e
renol
D)Pi ndolol
E)The
ophyl
li
ne

13i
-Albut
e r
ol(Provent
il,Ventol
in)isa
(an)
i
A)Alphareceptoranta
gonist
B)Alphareceptoragonis
t
C)Betare
ceptora nt
agonis
t
D)Betare
c e
ptora goni
st
E)AlphaandBe t
arecept
oragonist

i14-Whichofthef
oll
owi
ngdr
ugsi
s(a
re)hi
st
ami
nea
nta
goni
st
s?i
i1.Bromphenir
ami
ne
11i.pyr
ila
mine
i111.Ranti
dine

A)1onl y
B)111onl y
C)1and11onl y
D)11a nd111onl y
E)1,11a nd111
i
15-Oft hef ollowinggl ucocort
icoi
ds,whi
chonehasthegr
eat
esta
nti
-
i
nfl
amma torypot e
nc ywhe nadminis
ter
edsys
temi
call
y?i
A)Hydr oco rt
isone( Cortef
)i
B)Dexa me thasone( Dec a
dron)i
C)Tri
a mc inolone( Aris
tocort)
i
D)Predni s
one( Meticor
ten)i
E)Cortisone( Cortone)i

i
16-Benzoylpe
roxideiscommonl
yempl
oye
dint
het
rea
tme
ntof
A)Psori
asi
s
B)Pi
nwor ms
C)Acne
D)Tric
homonalinf
e c
tions
E)Se
bor r
hei
cderma t
it
is

i
17-Whi
choneoft
hef
oll
owi
nghor
mone
sisr
ele
ase
dfr
omt
hepos
ter
ior
pi
tui
tar
ygland?i
A)Oxytoci
n
B)Adrenocor
ti
cot
ropi
chor mone(ACTH)i
C)Thyroi
d–s t
imulat
inghormone(TSH)
i
D)Foll
icl
e–s t
imul
ati
n ghormone
(FSH)i
E)Growthhormone

i18-Duringovul at
ion,peakpla
smac onc
ent
rat
ion(
s)ofWhi
choft
he
foll
owingHor mone (s)wil
lbereac
hed?i
1i.Proge
s t
erone
i11.Foll
icl
e–s t
imulati
nghormone(FSH)i
i111.Lutei
nizinghormone( LH)i

A)1only
B)111only
C)1and11only
D)11and111only
E)1,
11a nd111

i19-Liot
ri
xi sathyroidpre
par
ati
ont
hatc
ont
ains
i1.Liot
hyroninesodium
i11.Levot
hyroxinesodium
111i.Desi
c c
atedthyroid

A)1only
B)111only
C)1and11only
D)11and111onl
y
E)1,11and111

20i-Aphe not
hiazi
neder
iva
tivec
ommonl
yus
edf
ori
tsa
nti
his
tami
nice
ffe
ct
is
?i
A)Prome thaz
ine
B)Proma zine
C)Ch l
orproma z
ine
D)Prochlorpr
oma zi
ne
E)Thi
ori
daz
ine

i21-Carbama z
epine(Tegr
etol
)isi
ndi
cat
edf
ort
het
rea
tme
ntof
1.Insomnia
11.Epileps
y
111.Trigeminalneur
algi
a

A)1only
B)111onl
y
C)1and11onl
y
D)11and111onl
y
E)
1,11and111

i22-Oft hefoll
owinga nxiolyti
ca gents
,theonethatposse
sse
sthel
eas
t
sedat
inga cti
onis
A)Di azepam( Val
ium)
B)Oxa ze pam(Serax)
C)Me pr obamate(
Mi l
town, Equanil)
D)Chl ordiaze
ppoxide( Libri
um)
E)Bus pirone(Buspar)
i23-Whi chofthefollowingi s(are)NOTt rueoftheophyl
li
ne?
1.Che mi ca
ll
yrela
tedt oca ff
eine
11.Increasest
hecont ract
ileforceoftheheart
111.Ca usesCNSde press
ion

A)1only
B)111only
C)1and11only
D)11and111onl
y
E)1,11and111

(@)24-Pe ni c
ill
insa r
ebe l
ievedtoexer
tthei
rant
iba
cte
ria
lef
fec
tbywhi
ch
oneofthef oll
owi ngme chanisms?
A)De t
e r
gente ff
e ctontheba c
teri
alcel
lmembrane
B)I
nhibiti
onofpr otei
nsynthesis
C)De s
tructionoft hebacter
ialcel
lnucle
us
D)Inhibit
ionofba ct
eri
alcellwallsynt
hesi
s
E)St
eri
chi
ndr
anc
eofme
mbr
anea
cids

i
25-Thea nti
bact
eria
lme cha
nismoft
hepe
nic
ill
insi
smos
tsi
mil
art
otha
tof
A)Lincomyc i
n(Lincoci
n)
B)Tetrac
ycli
neHCL( Achromyci
n)
C)Ciprofl
oxaci
n( Ci
pro)
D)Granis
ter
on(Kyt r
il
l)
E)
Probenecid(Benemid)

i
26-Fivehundre
dmil
li
gra
msofphenoxymet
hylpeni
cil
li
nisequi
val
entt
o
appr
oximatel
yhowmanyuni
tsofpe
nici
ll
ina
cti
vit
y?
A)125,000
B)200,000
C)1600
D)250,000
E)800,
000

i
27-Chlorhexidineglucona
tei
smos
tsi
mil
ari
nac
tiont
o
A)Qui
ndinegl uconate
B)Chl
orphe nira
mi ne
C)Cal
ciumgl uconat
e
D)Hexachlorophe ne
E)Chl
oroqui nephosphate

i
28-Sul fanomidesexer
tabac
ter
ios
tat
ice
ffe
ctbyc
ompe
tit
ive
l;yi
nhi
bit
ing
t
hea c
tionof
A)monoa mineoxidas
e
B)Xant hi
neoxi das
e
C)Pyr
imi dine
D)Para-ami nobenz
oicaci
d
E)Urica cid

i
29-Sulf
onessuc
hasdaps
onea
ree
mpl
oye
dcommonl
yint
het
rea
tme
ntof
A)Uri
narytr
acti
nfe
cti
on
B)Psor
ias
is
C)Bri
gh’sdis
ease
D)Hansen’
sdiseas
e
E)Cushi
ng’sdis
ease

i
30-whi choneoft hef ol
lowingte
tra
cyc
lineha
sthel
onge
stdur
ati
onof
ac
tion?
A)Doxyc li
ne(Vi bramy ci
n)
B)Te t
rac
yc l
ine(Ac hromyc i
n)
C)Mi nocycl
ine(Mi noc i
n)
D)Oxyt e
tracycl
ine( Terra
myc i
n)
E)De meclocycl
ine( Dc l
omycin)

i
31-Tricycli
ca nt
idepres
santsarebe li
evedt
oe xe
rtthei
ra nt
ide
pres
sant
ac
tionby
A)Potentia
tingGABAa ct
ivi
ty
B)Incr
eas i
ngthee f
fectofneurotransmit
ter
sonpostsynapti
crece
ptors
it
es
C)Blockinga l
phaadrenergicreceptors
D)Incr
e asi
ngtheme t
abolicbreakdownofbi oge
nicamine s
E)Blockingbe t
aadrenergi
cr e
ceptor

i
32-Me thylxanthine ssuchasc a
ffe
inea
ndthe
ophyl
li
nee
xer
tal
loft
he
fol
lowingpha rma cologiceffe
ctsEXCEPT
A)Ca rdiacs t
imul ation
B)Per i
phe r
a lvasoc onstr
ict
ion
C)Re laxati
onofs moot hmus cle
D)Di uresis
E)CNSs t
imul at
ion

i33-Whichoft hefol
lowingagent
sha
s(ha
ve)be
enf
oundus
efuli
nthe
trea
tmentofrheuma t
oidart
hri
ti
s?
1.Ergot
ami netar
tr
a t
e(Ergos
tat
)
11.Loperamide(Imodium)
111.Aurona f
in(Ridaur
a)

A)1onl
y
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i
34-Asa na nti
arr
hythmi
cdr
ug,proc
aina
midei
smos
tsi
mil
ari
nac
tiont
o
whi
choneoft hefol
lowi
nga
gent
s?
A)Ami oda r
one(K)
B)Pr
opr anolol
C)Digoxin
D)Verapa mil
E)Quinidine

i35-Whi
choft hefol
lowi
ngst
ate
ment
sar
e(i
s)t
rueofa
cet
ycys
tei
ne?
1.Mastcel
lst
abili
zer
11.Acet
aminophenanti
dot
e
111.Mucol
ytic

A)1onl y
B)111onl y
C)1a nd11only
D)11a nd111only
E)1,11a nd111

i36-Whichofthefoll
owingis(ar
e)t
rueofpr
ava
sta
tin?
1.Anti
hypert
ensiveagent
11.Pre
gnancyc a
tegoryX
111.HMG- CoAr educta
seinhi
bit
or

A)1onl y
B)
111onl y
C)
1a nd11only
D)11a nd111only
E)
1, 11a nd111

i37-Whic
hofthef
oll
owi
ngi
s(a
re)e
mpl
oye
dasa
nti
funga
lage
nts
?
1.Nata
myc i
n
11.Clor
imazol
e
111.Mafeni
de

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i38-Whichoft hefol
lowingis(
are
)dopa
mine
rgi
cant
ipki
nsona
gent
s?
1.Bromocri
ptine( Pa
rlode
l)
11.Per
goli
de (
Pe rmax)
111.Sel
egil
ine( Elde
pryl)

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i39-Age nt
sthatar
eempl
oye
dasga
str
ics
ti
mul
ant
sinc
lude
1.Ome prazol
e
11.Cis
a pri
de
111.Me tocl
opramide

A)1onl y
B)1110nl y
C)1a nd11only
D)11a nd111only
E)
1, 11a nd111

i
40-Me t
himazol
e(ta
poz
le)i
sus
edf
ort
hes
amet
her
ape
uti
cindi
cat
iona
s
A)Methaxsal
en
B)Da
nazole
C)Pr
opylthi
oura
cil
D)omeprazol
e
E)Azat
hiopri
ne
41-Pencil
lamineisadrugus
edt
her
ape
upt
ica
llyf
ort
het
rea
tme
nt0f
1.Wilson'
sdiseas
e
11.Rheuma t
oidarthr
it
is
111.Cyste
inuria

A)1only
B)111only
C)1and11only
D)11and111only
E)1,11and111

i
42-PolymyxinBispharmacol
ogi
cal
lya
ndmi
crobi
logi
cal
lys
imi
lart
o
A)Ampi ci
ll
in(Pol
yci
ll
in)
B)Col
is
tin(Coly-MycinS)
C)Gentamici
n(Garamyci
n)
D)Peni
c i
ll
inG
E)Tet
racycl
ine(Achr
omycin
)

i
43-Potenti
all
yf a
tala plast
icane
miaist
oxi
cef
fec
tas
soc
iat
edwi
th
A)Ciprofl
oxacin(cipro)
B)Cefadroxi
l(Dur a
c ef)
C)Disopyramide(Nor p
a ce
)
D)Clindamycin(Cle ocin)
E)Chloramphenicol( Chloromyc
eti
n)

i44-Agent
sindi
catedforthet
rea
tme
ntofde
pre
ssi
oni
ncl
ude(
is)
1.Bup r
opi
on(We ll
but
rin)
11.Fluoxe
ti
ne(Prozac
)
111.Phenel
zi
ne(Na r
dil)

A)1only
B)111only
C)1and11only
D)11and111only
E)
1,11a nd111
i45-Enhancedclot
ti
nga
bil
it
yoft
hebl
oodi
sas
soc
iat
edwi
tht
he
adminis
trat
ionof
1.Tocopherol
11.Ticl
opidine
111.Phytonadi
one

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i
46-Ca r
bidopacanbestbecl
a s
sifi
edasadrugtha
t
A)ReversesaymptomsofParkinson'
sdi
sea
s e
B)Exert
sa nant
ichol
iner
gicacti
on
C)Isadopa–de c
arboxyla
seinhibi
tor
D)Isaneuromuscularbl
ocki
nga gent
E)I
sas kelet
almusclere
laxa
nt

i
47-Isotret
inoin(Ac cutane
)isadr
ugempl
oyedi
nthet
rea
tme
ntofs
evere
re
cal
citrantcysti
ca cne.Whichoneoft
hef
oll
owi
ngisNOTanadve
rse
ef
fec
ta ssocia
tedwi thitsuse?
A)Hype rglyce
mi a
B)Hype rtr
igl
yc e
ridemia
C)Pseudotumorc e r
ebri
D)Conj uct
ivit
is
E)Fat
a labnorma l
iti
e s

i
48-Whic hofthefol
lowingi str
ueofisotre
tinoin(Ac
cutane)
A)Commonl yc a
usescheil
iti
s
B)Aderivat
iveofvitaminD
C)Isa
ppliedtopic
all
yt osevereacnel
es i
ons
D)Contr
a i
ndicat
edinpa t
ie
ntswi t
hdiabetes
E)Maybeus edsafel
yi npregnantpat
ientsaftert
hefi
rstt
rimest
er
i
49-Endorphinsare
A)Endogenousopioidpe pti
des
B)Ane wc l
assoftopicalanti
-inf
lammat
oryagent
s
C)Neuromusc ul
arbl
oc kingagent
s
D)Biogeni
ca minesbelievedtocaus
esc
hizophr
eni
a
E)Endogenouschelat
inga gent
s

i
50-Lovas t
ati
n( Me
vacor
)iscont
rai
ndi
cat
edf
orus
einpa
tie
ntswhoa
re
A)Hype r
sensi
tivet
oaspi
ri
n
B)Pr
egna nt
C)Chronicasthmat
ics
D)Mor ethan25%ove ri
dealbodywei
ght
E)Dia
be t
ics

51-Whi choft hefoll

owingdr
ugsisaavai
labl
einatr
ansder
maldos
agefor
m
forus
ei nthepr event
ionofna
useaandvomiti
ngas
soci
atedwit
hmotion
sic
knessina dult
s
A)Me t
oc lopramide
B)Onda nsetron
C)Scopola mine
D)Clonidine
E)Granisetron

i52-Whichoneoft hef ol
lowingdr
ugsi
sindi
cat
edf
ort
het
rea
tme
ntof
prima
rynoc turnalenure s
is?
A)Ritodine(Yut opar)
B)Amoxa pi
ne( As endin)
C)Metolazone( Zaroxolyn)
D)De smopre s
sina ceta
te(DDAVP)
E)Me the
na minehi ppurate(Ure
x)

i
53-Ane xampleofabenz
odi
aze
pinet
hati
snotme
tabol
ize
dtoa
cti
vem
et
abol
ite
si nthebodyis
A)Tri
a z
ol a
m
B)Chlordiaze
poxide
C)zol
pidem
D)Diaz
a pam
E)Hal
az epa
m

i
54-Whi c
hoft hefoll
owi
ng,ant
imi
crobi
alage
nswoul
dbeMOSTuse
fuli
n
t
hetrea
tmentofa ninf
ect
ionc
aus
edbynbetale
cta
mase
-pr
oduc
ing
st
aphyl
ococci
?
A)Amoxi c
ill
in
B)Cephapir
in
C)Cephale
xin
D)Dicl
oxacil
li
n
E)Bacampici
ll
in

i
55-Ga str
icintri
nsi
cfa c
torisagl
ycopr
ote
int
hati
sre
qui
redf
ort
he
Gast
rointe
s t
inalabs
orptionof
A)Me diumc hai
ntri
glyceri
des
B)Foli
ca cid
C)Ir
on
D)Tocophe rols
E)Cyanoc oba l
amin

i
56-Gi ngivalhyper
plasi
a,hi
rsut
iam,a
nda
taxi
aar
eadve
rsee
ffe
cts
as
sociatedwi t
htheuseof
A)Mi noxidil
B)Ch l
orpr omazi
ne
C)Gi
ns engr oot
D)Phe nytoin(Dil
ant
in)
E)Ciprofloxaci
n(Cipro)

i
57-Levobunolol(
Be t
agan)i
sadr uguse
dinthet
r e
atmentofgl
aucoma.
Whichoneofthefoll
owingbestdescr
ibest
heact
ionite
xe r
tsontheeye
?
A)Mioti
c
B)Decre
asestheproduct
ionofaqueoushumor
C)Int
erf
ereswitht
hee nz
ymec arboni
canhydr
ase
D)Act
sasanos
mot
icd
iur
eti
c
E)Mydr
iat
ic

i58-Cardiosel
ec t
ivit
yisapropert
yofwhi
choft
hef
oll
owi
ngbe
taa
dre
ner
gic
blocki
nga gents?
1.Cart
eolol(ocupress)
11.Me t
ipranololHCI( Opti
pranol
ol)
111.Betaxolol
( Betopt
ic)

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i59-Whichofthefoll
owingis(ar
e)apropert
yoranac
tionofpi
loc
arpi
ne?
1.Direc
tacti
ngmiotic
11.Ingr
edi
entinOc use
rtocul
arther
apeuti
csyst
em
111.Simil
arphar
ma col
ogicact
iontodorozol
amide
(Tr
usopt
)

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,
11and111

i60-Whi c
honeofthefoll
owi ngisNOTa
nef
fec
tofa
tropi
neont
hehuma
n
body?\
A)Ca rdi
acsti
mulat
ion
B)Dimi ni
shedsweati
ng
C)Mydr ias
is
D)Re ducti
onofgas
troint
est
inalt
one
E)Sti
mul at
ionofgast
ri
cs e
creti
on

i
61-Whic
honeofthefol
lowi
ngs
tat
eme
ntbe
stde
scr
ibe
stheme
cha
nis
mof
a
cti
onofant
ihi
st
amini
cdrugs
?
A)Theyinte
rferewi t
hthesynthesi
sofhist
amineint
hebody
B)Theyformi nac
tivecomp l
exeswithhist
amine
C)Theysti
mul at
etheme t
abolis
mofe ndogenoushi
st
amine
D)Theyblokther e
c ept
orsi
tesonwhi chhi
staminea
cts
E)The
ya realpha-adrener
gicblocker
s

i62-Ha l
oper
idol(Halol)dif
fersfr
omc hlor
proma
zine(
Thor
azi
ne)i
ntha
t
haloperi
dol
A)I snotananti
psycho t
icagent
B)Dos enotproducee xtr
apyramidalef
fect
s
C)I snotaphenot
hiazine
D)Dos enotcauseseda t
ion
E)Ca nnotbeadministeredpar
e nt
eral
ly

(@)63-Tomoxi fe
n(Nolva
dex)i
sana
gentt
hatc
anbe
stbede
scr
ibe
dasa
(a
n)
A)Gonadotropi
n-rel
eas
inghor
moneana
log
B)Antie
str
oge n
C)Enstr
ogen
D)Progest
in
E)Androgen

i64-Whichofthefoll
owingia(are
)tr
ueofaur
anof
in(
Rida
ura
)?
1.Mayc aus
ethromboc yt
openia
11.Oral
lyadminis
teredfor
mofgol dt
her
apy
111.I
tsusemayr esul
tinrenali
mpair
ment

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)1,11and111

i
65-Advant
agesofac
etami
nophe
nove
ras
pir
ini
ncl
udea
lloft
hef
oll
owi
ng
EXCEPT?
A)Noalt
era
tionofbl
eedi
ngti
me
B)Le
ssgast
ricirri
ta
tion
C)Nooccul
tbloodloss
D)Noappre
c i
ableeff
e c
tonuri
caci
dexc
ret
ion
E)Gr
eat
eranti-inf
lamma t
orya
cti
on

i66-
Theus eofc l
ozapine(
Cloz
ari
l)ha
sbe
ena
ssoc
iat
edwi
tht
he
devel
opme ntof
A)Thromboc ytopenia
B)Hype rcalcemia
C)Ar a
nul ocytosi
s(decinWBCSFROM MARROW)
D)Me ningi t
is
E)Hype ruricemia

i67-Al
thoughc las
sif
iedasant
ibi
oti
cs,da
cti
nomyc
in(Cos
megen)a
nd
plic
amyc i
n(Mi thra
cin)ar
eusedincance
rchemot
her
apybec
auset
heyha
ve
a(an)
A)I mmunos uppres
anteff
ect
B)Antivir
ale ff
ect
C)Abilit
yto" ster
il
ize"bl
ood
D)Ana boli
ce ff
e c
t
E)Cytotoxiceffect

i68-Thea nti
-i
nflamma t
oryeff
ectofaspir
ini
sduet
o
1.Resett
ingoft hehypotha
lamic"se
tpoint
"
11.Adrena lst
imulat
ion
111.Inhi
bi t
ionofprost
aglandi
nsynthesi
s

A)1only
B)111only
C)1and11only
D)11and111only
E)1,11and111

i
69-Thefi
rstdos
eeffe
ctischa
rac
ter
izedbymar
ke dhypot
ens
ionand
s
yncopeontaki
ngthefi
rstf
ewdosesofmedi
cat
ion.Thise
ffe
ctisse
enwi
th
t
heuseof.
1.Bepr
idi
l(Va
scor)
11.Ter
azos
in(
Hyt r
in)
111.Pr
azos
in(
Mi ni
press
)

A)1onl y
B)111onl y
C)1a nd11only
D)11a nd111only
E)1,11a nd111

i
70-Ca rbonmonoxideexertsi
tstoxicprimar
il
yby
A)Re a
c ti
ngwithbloodenzyme stoproduceaci
dicsubst
ances
B)Decreasi
ngtheoxygen-carryi
ngc apaci
tyoftheblood
C)Reac ti
ngwithaminoacidsinthebodyt ofor
ma mmoni a
D)Inhibit
ingt
hega gref
lex
E)Paralyzi
ngt
hemus cl
esofthediaphragm

71-Themos tseriouspotenti
alconsequenceofindes
ti
onofaliqui
d
hydr
ocarbonsuc ha skeros
eneorga soli
neis
A)Thea spi
rat
ionoft hepos i
ti
onintor e
spira
tor
yt r
act
B)Thec orr
osivea cti
onofthepos i
ti
onont hestomachli
ning
C)Thepa ra
lysisofpe ri
sta
lt
icmot i
onoft heGItract
D)Dissolut
ionoft hemuc oidcoatofthee s
ophagus
E)Thede st
ructi
onofbodye nzymesbyt hepo i
son

i
72-Deferoxami neme syla
teisc
ons
ide
redt
obeas
pec
ifi
cant
idot
efort
he
t
rea
tmentofpoi soningc a
usedby
A)Anti
chol i
nergicage nt
s
B)Opia
tena rcotic
s
C)Benzodiazepines
D)Loopdi ur
etics
E)I
roncont a
iningpr oduct
s

i
73-Whichoneofthefol
lowi
nga
gent
sisc
las
sif
iedpha
rma
col
ogi
cal
lya
sa
ca
rboni
canhydr
aseinhi
bit
or
A)Inda
pamide(
Loz ol
)
B)Ace
tazolamide(i
amox)
C)Chl
ort
ha li
done(Hygrot
on)
D)Tor
semi de(Demadex)
E)Amil
oride(Midamor)

i
74-Thet hia
zidedi
ure
tic
sde
cea
set
hee
xcr
eti
onof
A)Ur i
ca ci
d
B)Urea
C)Sodi
um
D)Bicarbonat
e
E)Creat
inine

i75-Ther enalexcre
tionofamphet
aminesc
anbedi
mini
she
dby
alkal
inizat
ionoftheur i
ne.Whichoft
hefol
lowi
ngwoul
dtendt
odi
mini
sh
theexc r
eti
onr a
teofa mphet
aminesul
fat
e?
1.me thena
mi nema ndela
te
11.Sodiumbi carbonate
111.Ac eta
z ol
amide

A)1only
B)111onl
y
C)1and11onl
y
D)11and111onl
y

i
76-Ana gentempl yedi nr
elie
vingsi
gnsa
nds
ympt
omsofs
pas
ti
cit
y
re
sul
ti
ngf r
ommul tiplescl
erosi
sis
A)Buspiron e(Buspa r)
B)Dantrolene(Da ntri
um)
C)Ursodiol( Act
igall)
D)Mexi l
e t
ine(Me xi t
il
)
E)Ami odarone(Cor da r
one)

i77-Whic
hoft hef ol
lowingis(a
re)MAOi
nhi
bit
ors
?
1.Par
gyli
ne( Eutonyl
)
11.Tra
nylcypromine(par
na t
e)
111.Cycl
obenz a
prine(Fl
e xer
il
)
A)1onl y
B)111onl y
C)1a nd11only
D)11a nd111only
E)1,11a nd111

i
78-Ar ugthatisi ndicat
edforthetr
eat
mentofbothdia
rrheaand
const
ipa ti
onis
A)Bis acodyl(Dul c
olax)
B)La ctulose(Ce phylac)
C)Ma gnesiums ul f
a t
e
D)Se nna( Senokot )
E)Polyc arbophil( Mitr
olan)
i
79-Whi choneoft hefol
lowingismic
ros
oma lenzymeindic
er?
A)Indome thaci
n
B)Rifa mpi n
C)Tol butamide
D)Tobr amycin
E)Ibypr ofen

i80-Thet hiazidederivat
ivediaz
oxide( Hyperst
at)
A)I sastronge rdi
ureticthanhydrochlorot
hiaz
ide
B)I snotadi ureti
c
C)Pr oducesa boutthes a
medi ure
ticresponseasanequa
ldos
eof
hydrochlorothiazi
de
D)Pr oducesdi ure
ticsinnormotensivesubject
sonly
E)Isapr essora gent

i81-Whichofthefol
lowi
ngi
s(a
re)br
oad-s
pec
truma
nti
funga
lage
nts
?
1.Gri
seoful
vin
11.Ket
aokonazole
111.Miconaz
ole

A)1only
B)111onl
y
C)1and11onl
y
D)11and111onl
y
E)1,11a
nd111

i
82-Whi choft hefoll
owingba
rbi
tur
ate
sisus
eda
sani
ntr
ave
nousa
nes
the
tic
?
A)Me phoba r
bita
l
B)Amoba r
bi t
al
C)Me t
hohe xit
alsodium
D)Pentobarbit
alsodium
E)Secobarbit
alsodium

i
83-Themos tus
e f
uldrugt het
rea
tme
ntofdi
abe
tesi
nsi
pidusi
s
A)Chlorpr
opamide(Diabinese
)
B)Glucagen
C)Ins
uli
n
D)Glyburi
de(Microna
s e)
E)Lypress
in(Di
apid)

i
84-Apha rmacistrecei
vesapre
scri
ri
pti
onor
derforindi
methaci
n(I
ndoci
n)
ca
psules.
He/s
hes houldc onsul
twithphys
ici
anift
hemedi
ationrec
ordindi
cat
est
hat
t
hepatient
A)Ha sgout
B)Hasa rt
hr i
ti
s
C)Hasape pti
cul c
e r
D)Ha sinsomni a
E)
Ishype rt
ensive

i85-Thesulfonylyrea
s( eg.Diabinese
,Glucot
rol
)arebel
ieve
dtoexe
rtt
hei
r
hypoglycemice ff
ectby
A)De c
rea
singt hedesir
ef orsugarconsumpti
on
B)I nhi
bit
ingbr ea
kdownofe ndogenousinsul
in
C)Enha nci
ngt heeffecti
ve ne
ssofthes mal
lamountsofi
nsul
int
hatt
he
diabeti
ccanproduc e
D)I ncr
easi
ngt heperipheraluti
li
zati
onofglucose
E)St i
mulati
ngt herel
e as
eofi nsuli
nfromthepancre
as
i
86-Whi choft hef oll
owinghypoglycemicdrugsha
slonge
sts
erumha
lfl
if
e?
A)Ac et
ohe xa
mi de( Dyme l
or)
(1.3hr)
B)Tolbutamide( Or i
nase
)(8hr
)
C)Glyburide(Di abines
e,Mi c
ronase)
(24hr)
D)Chlorpropami de( Di
abines
e)(36hr
)
E)Allofthea bovea boutthesames er
umha l
flif
e

i
87-Vidarabine
(Vir
a -A)isanant
ivi
rala
genti
ndi
cat
edf
ort
het
rea
tme
ntof
A)Rubella
B)Sma l
lpox
C)Inf
luenza
D)Pneumo cyst
isca
rinipneumoni
a(PCP)
E)Herpessimplexencephal
it
is

i88-Zidovudi
ne(Ret
rovir
)isi
ndic
atedforthet
rea
tme
ntofpa
tie
ntswi
th
1.Inf
luenzaAvirusi
nfect
ion
11.Herpessimpl
exinfec
ti
on
111.huma nimmunodefi
encyvi
rus(HIV)infec
ti
on

A)1onl y
B)111onl y
C)1a nd11only
D)11a nd111only
E)1,11a nd111

i
89-Whi c
honet hefoll
owingstat
ementi
str
ueofa
lte
pla
se(
Act
iva
se)
?
A)Iti
sderivedfrombovineti
ssue
B)Iti
sthrombolyti
cagent
C)Iti
sderivedfr
ompor ci
neti
s s
ue
D)Iti
sana nti
coagul
ant
E)I
tisadmi ni
st
eredint
ramuscula
rly

i
90-Cr
omyl
ins
odi
um(
Int
al,Na
sal
crom,Opt
icr
om)i
sadr
ugt
hati
s
A)Ef
fect
iveina cuteast
hmati
cat
ta
cks
B)Asynthet
iccor t
icos
ter
oid
C)Ahist
a mi
nea ntagonis
t
D)Atheophyll
inede ri
vat
ive
E)Ama stce
llstabil
izer

91-Whi c
honeoft hefoll
owi
ngcal
ciumc
hanne
lbl
ocke
rsma
ybee
mpl
oye
d
pare
ntera
1.Amlodipine(
Nor vas
c)
11.Is
radi
pine(Dyna Ci
rc)
111.Ve r
apa mi
l(I
sopti
n,Cal
an)

A)1only
B)111only
C)1and11only
D)11and111only
E)1,11and111

i
92-Whichoneoft hefol
lowi
ngi
sNOTapr
oge
sti
n?
A)Nore
thynodr el
B)Nore
thindrone
C)Et
hynodi oldi
acetat
e
D)Leve
nor gestr
el
E)Mest
ranol (
est
rogen)

i
93-Whi choneoft hefol
lowingbet
a-adr
ene
rgi
cbl
ocki
nga
gent
sha
s
i
ntr
insicsympathomime t
icact
ivi
ty(
ISA)?
A)Esmol ol(
Brevibl
oc)
B)Atenolo(Tenormin)
C)Pindolol(
Visken)
D)Me toprol
ol(Lopres
sor)
E)Propranol
olHCL( I
nderal
)

i
94-Tors
emide(De
madex)ismos
tsi
mil
ari
nac
tiont
o
A)Spi
ronol
act
one(
Alda
c t
one)
B)Ris
peri
done( Ri
spe
rdal
)(
CNS)
C)Bume t
anide(bumex)
D)Chl
ort
hal
idone(Hygrot
on)
E)Acet
azol
ami de(Di
amox)(
CAI
s)

i95-Potassi
ums upplementat
ioni
sLEASTl
ike
lyt
ober
equi
redi
napa
tie
nt
using
A)Et hacr
ynica cid(Ede c
rin)
B)Ch lort
halidone(Hygr ot
on)
C)Fur osemide(La six)
D)Ac et
azol
a mide( Diamox)
E)Triamt er
ene( Dyre ni
um)

i
96-Acycl
ovi
r( Zovira
x)i sindi
catedf
ort
hetr
eat
mentof
A)Shi
ngle
s(c
hicke npox)
B)Pse
udomembr anouse nt
e r
ocoli
ti
s
C)HIVinf
ect
ion
D)Measl
es
E)I
nfl
uenzacausedbyi nfluenz
aAvi r
usst
rai
ns

i
97-Adr ugt hatiseffectiveinthetr
eat
me ntofal
coholwi
thdr
awa
l
syndr
ome sa ndinthepr eve nt
ionofdel
ir
iumt r
emensis
A)Disulf
iram( Ant abuse)
B)Me t
hadone( Dol oph i
ne )
C)Phenytion(Dilantin)
D)Chlordiazepoxide( Librium)
E)Haloperidol(Haldol)

i98-Whi choneoft hefoll

owingsta
tementisTRUEofba
cit
rac
in?
1.Itiseff
ec t
iveint
reati
ngPseudomonasinfect
ion
11.Itisana minogl
yc osi
deanti
microbi
alagent
111.Ne phrotoxi
cit
ylimitsi
tspare
ntera
luse

A)1only
B)111onl
y
C)1and11only
D)11and111only
E)
1,11a nd111

i
99-Olzal
azines odium(Dipe
ntum)i
sempl
oye
dint
het
rea
tme
ntof
A)Diabet
esme llit
us
B)Duodenalulce r
s
C)Ulc
e r
ati
vec oliti
s
D)Uri
narytractinfect
ions
E)Di
abetesinsipidus

i
100-Betacarote
nei
scons
ide
redt
obeapr
ecur
sorf
or
A)Betas
eron
B)Bet
ainter
feron
C)Vit
aminD
D)Vit
aminA
E)Cart
eolol

Si
xth100

1-Thehighe
stc
onc
ent
rat
ionofbe
nzoylpe
roxi
def
ora
cnet
obes
olda
sOTC
intheUAEis
A)2.5%
B)5.0%
C)10%
D)15%

i
2-Theappr
opr
iat
ePHr
angef
ora
pht
hal
micpr
oduc
tsi
s
A)2.
0to3.0
B)4.
0to6.
0
C)6.
0to8.
0
D)8.
0to10.
0

i
3-Whi choft hefol
lowi
ngshoul
dNOTbea
dmi
nis
ter
edt
oapa
tie
ntbe
ing
t
reat
edforna r
row-angl
egl
aucoma
A)Dipivefrine
B)Pi
locar
pi ne
C)Carbachol
D)Homa tropine

i4-Allofthefoll
owi
ngdr
ugsa
reus
edt
otr
eatpa
tie
ntswi
thope
n-a
ngl
e
glauc
omaEXCEPT
A)Ca rbachole
B)At ropi
ne
C)Di pivef
rine
D)Be taxolol

i
5-Me t
hylcel
lul
os eandsi
mila
ragent
sarei
nopht
hal
mics
olut
ionst
o
A)Inc
reasedrops i
ze
B)Reducedropss i
ze
C)I
ncreas
eoc ul
a rcont
actt
ime
D)Reducetearformati
onduri
nginst
il
la
ti
onoft
hedr
ops

i
6-Whi c
hoft hefol
lowi
ngs
ulf
onyl
ure
asha
sthel
onge
stha
lf-l
if
e
A)Tol
but a
mide
B)Gli
benclamide
C)Tol
z a
mi de
D)Chlorpr
opamide

i
7-Thei ns
ul i
nprepar
ati
onwhic
hisnon-i
mmunoge
nic
A)Pr
otami nez i
ncins
uli
nsus
pensi
on
B)Huma ni ns
ulin
C)Bovineinsulin
D)Allofthea bove
i
8-Inc
ombi nedor alcontr
acept
ives
,oe s
troge
nsac
tto,
A)I
nhibitofleuteini
singHormone
B)I
nhibi
tr e
leaseofFol li
cl
es t
imul
atinghormone
C)I
nhibi
tovula t
ion
D)Causethic
ke ningofc er
vica
lmuc us

(
@)9-Whi c hofthefol
lowingsubs
tanc
eswhe
npr
ese
nti
nur
inei
sthemos
t
l
ike
lyposit
ivesi
gnofpr egnanc
y
A)Thyr
oids t
imulat
inghormone
B)Melat
onin
C)Humanc hri
onicgonadotr
opin
D)Cort
icot
ropin

i
10-Whichofthefoll
owingisNOTs
ecr
ete
dbyt
hepi
tui
tar
ygl
and
A)Somatot
ropin
B)Humanc hor
ioni
cgonadotr
opi
n
C)Fol
li
clesti
mulat
inghormone
D)Cort
ic
otropi
n

i
11-Sideeff
e ctsofi
sot
ret
inoi
n(Roa
ccut
ane
)inc
lude
A)Dermatologicalr
eac
ti
ons
B)Depresi
on
C)Terat
ogenicity
D)Allofthea bove

i
12-LidocainHclisNOTa dmi
nis
ter
edor
all
ybe
caus
eiti
s
A)ine
ffect
ivebythisrout
e
B)Tooa c
idic
C)Tooa c
idicbythisr
out
D)Ac aus
eofa r
rhythmias

i
13-Calc
itoni
nispr
oduc
edi
nthe
A)adr
enalcort
ex
B)Thyr
oidgla
nd
C)Panc
reas
D)Adrena
lmedul
la

i
14-Whi chofthef
oll
owi
ngi
sthes
hor
tes
tac
tingMydr
iat
ic
A)Atropine
B)Pil
oca r
pine
C)Tropicamide
D)a,ba ndc

i
15-Tineai
nfec
tionsar
ec a
use
dby
A)Virus
B)Fungus
C)Gram-posi
ti
veba c
ter
ium
D)Noneoftheabove

i
16-Prolac
tininhi
bit
ingf
act
ori
s
A)Dopa mine
B)Thyrotr
opin
C)Soma t
otropi
n
D)Corti
cotropi
n

i17-Whi choft hef ol

lowi
ngdr
ugsi
sNOTa
ssoc
iat
edwi
thi
ncr
eas
ed
prola
c t
insec r
etion
A)Chl orproma zine
B)Me t
ocloproami de
C)Br omoc rypt
in
D)Me t
hyldopa

(
@)18-Thea ct
ionofDi
goxi
nise
nha
nce
dbyahi
ghl
eve
lofwhi
choft
he
f
oll
owingi on
A)Sodium
B)Calc
ium
C)Magne ssi
um
D)Pota
s s
ium
i19-Whic hofthefoll
owingist
hef
ir
stdi
agnos
ti
csympt
omofdi
goxi
n
overdose
A)Anor exia
,na us
ea,vomit
ing
B)Co nst
ipati
on
C)Hi ghbodytempe r
atur
e
D)Br onchospa
s m

i
20-Whichofthefol
lowi
ngi
sabl
oodpl
ate
leta
dhe
sioni
nhi
bit
or
A)Dipyr
ida
mol e
B)Nit
raf
ura
toi
n
C)Dextr
opr
opoxyphene
D)Imipr
amine

i
21-Ni t
rogl
yceri
nhasarelat
ive
lyl
owbi
o-a
vai
labi
li
tybe
caus
e
A)Itschemica
ll
yuns t
abl
e
B)Itspoorl
yabsorbe
d
C)Ithasafir
stpassme t
abol
ism
D)a,bandc

i
22-Sucral
fat
eisuse
dtot
rea
t
A)Pept
iculcer
s
B)Carc
inoma
C)Calc
iumde pl
et
ion
D)Obesit
y

i
23-Methyldopaisuse
dasa/
an
A)Anti
pa r
kinsoni
sm
B)Seda
tive
C)Anti
hypertensi
ve
D)Pr
olacti
ni nhi
bit
or
i
24-Pe
ntoxi
fyl
li
nea
ctspr
ima
ril
yby
A)Di
ssol
vingc
hol
est
erol
B)De
cre
asi
ngvi
scos
it
yoft
hebl
ood
C)Oxi
dat
iveme
cha
nis
ms
D)Pr
eve
nti
ngf
orma
ti
onofc
hol
est
erol

i
25-Whi
choft
hef
oll
owi
ngi
smos
tus
efuli
ntr
eat
inghype
rte
nsi
vec
ris
is
A)Chl
ort
hia
zide
B)Spi
ronol
act
one
C)Sodi
umNi
tr
opr
uss
ide
D)Ade
nos
ine

i
26-At
ri
plet
her
apyf
ore
rapyf
ore
radi
cat
ionofH.pyl
oric
ont
ains
A)Amoxyc
il
li
n,Ome
pra
zol
e,Cl
ari
thr
omyc
in
B)Te
tra
cyc
li
ne,Amoxyc
il
li
n,Cl
ari
thr
omyc
in
C)Va
ncomyc
in,Amoxyc
il
li
n,Me
troni
daz
ole
D)Pe
nci
ll
in,Cl
ari
thr
omyc
in,Me
troni
daz
ole

i
27-Li
doc
ainei
sus
eda
s
A)Ge
ner
ala
nae
sthe
sia
B)Ant
ipr
uri
ti
c
C)Ant
ia
rryt
hmi
c
D)Pr
eana
est
het
ic

i
28-Thepr
inc
ipa
ltoxi
cef
fec
tof
A)Br
onc
hos
pas
m
B)Ch
ill
is
C)Ha
irl
oss
D)Ha
emor
rha
ge

i
29-Whi
choft
hef
oll
owi
ngi
sNOTt
ruea
boutMi
sopr
ost
ol
A)I
t'
sapr
ost
agl
andi
nana
logue
B)I
tisus
edt
opr
eve
ntNSAI
D'Si
nduc
edpe
pti
cul
cer
C)I
tma
ybeus
edi
npr
egna
ntwome
n
D)I
tca
use
sdi
arr
hea

i
30-Whi
choft
hef
oll
owi
ngi
sal
ipi
dlowe
ringdr
ug
A)Apr
oti
nin
B)Tr
ane
xami
cac
id
C)La
nsopr
azol
e

D)Ac
ipi
mox

31-Si
methi
conei
sa\
an
A)Antac
id
B)Anti
fl
atul
ent
C)Const
ipat
inga
gent
D)Laxat
ive

i
32-Whi chofthef
oll
owingsi
dee
ffe
ctswi
llbec
aus
edbya
nta
cids
cont
aini
ngsodiumbic
arbona
te
A)Belchi
ng
B)Consti
pati
on
C)Diarr
hoea
D)Blurre
dvisi
on

i
33-Whichoft hef
oll
owi
ngi
sadopa
minea
nta
goni
st
A)Granni
steron
B)Dompe r
idone
C)Cis
apri
de
D)Lopera
mi de

i
34-Whi c
hofthefoll
owi
ngdr
ugsi
sas
yst
emi
camoe
bic
ide
A)Dil
oxamidefuroa
te
B)Pyri
me t
hamine
C)Emetin
D)Sodiumsti
bogl
uconat
e

i
35-Whi chofthefol
lowi
ngdr
ugsma
yca
usedi
scol
our
ati
onofna
ilbe
dsa
nd
mucousme mbrane
s
A)Tetra
c ycl
ine
B)Chloroquine
C)Doxyc ycl
ine
D)Rifampicin

i36-Whichofthefol
lowi
ngdr
ugsi
sthec
hoi
cef
ort
het
rea
tme
ntofa
llf
orms
ofSchist
osomias
is
A)Praziquant
el
B)Me bendazol
e
C)Niclosamide
D)Thiabendazol
e
i
37-Whichofthefol
lowi
ngdr
ugsc
anbeus
edf
ort
het
rea
tme
ntofi
nfl
uenz
a
Ainf
ect
ion
A)Zi
dovudine(AZT)
B)Amantadine
C)Ri
bavir
in
D)Vida
rabine

i
38-Whi choft hefoll
owingdr
ugsi
sus
edi
nthet
rea
tme
ntofl
eis
hma
nia
sis
A)Pyrimethami ne
B)Diloxamidef ur
oate
C)sodiums t
ibogluconat
e
D)Eme ti
n

i
39-InWhichofthefol
lowinginfe
c t
ionsci
prof
loxa
cil
lini
slea
ste
ffe
cti
ve
A)UTIduetoabe t
a-la
ctamaseproducingst
rai
nofklebsi
el
la
B)Pneumoni
aduetotos t
rept
ococcuspneumonia
C)UTIinf
ect
ionduetoE.c ol
i
D)UTIduetopseudomonasaerugi
nos a

i
40-Whichoneofthefoll
owings t
ate
mentsaboutTet
rac
ycl
ine
sisnot
cor
rec
t
A)Iti
susef
ulfortr
eat
me ntofre
s i
st
ants
tra
ins
B)Iti
scont
rai
ndica
tedinpregnancy
C)Iti
seff
ect
iveinf
ect
ionc a
usedbyChlamyd i
a
D)Itca
nleadtodis
coloura
ti
onoft ee
thi
fgiventocgi
ldr
en
i41-Whichoneofthef ol
lowi
ngisbot
hpe
nci
ll
ina
ser
esi
st
anta
nde
ffe
cti
ve
byoraladminis
tra
tion
A)Penc i
ll
inV
B)Me thi
cil
li
n
C)Amoxi cil
li
n+Cl avu
lanica
cid
D)Ca r
bima z
ole

i
42-Whi c
hoft hefol
lowi
ngdr
ugsi
sus
edt
opi
cal
lyf
orbur
npa
tie
nts
A)Sulpha
cet
ami de
B)Sul
phadia
zine
C)Sul
phasal
zine
D)Sil
versul
pha di
azi
ne

i43-
Whi c
honea mongthefol
lowi
ngdrugsi
sef
fec
tivei
nthet
rea
tme
nti
f
pneumoniacausedbypneumocys
ti
sca
rini
i
A)Sulphacet
amide
B)Sulphasa
lzine
C)Sulphis
oxzole
D)Co-Tr i
moxa zol
e

i
44-Sulphonamidesar
eus
efuli
nthet
rea
tme
ntofwhi
choneoft
he
f
oll
owing
A)Inf
luenza
B)Gonorrhoe
a
C)Uri
na r
ytracti
nfec
ti
ons
D)Me i
ngococcal

i45-Inwhichoneofthefoll
owingcli
nic
a ls
it
uati
onsi
sthepr
ophyl
act
icus
e
ofantibi
oti
csNOTwa rr
ante
d
A)I ti
susefulfort
hetre
atmentofr
esi
stantst
rai
ns
B)I ti
scontrai
ndic
ate
dinpregnanc
y
C)I
tisef
fec
ti
veininf
ect
ioncausedbyChl
amydi
a
D)Pat
ie
ntwithahe
a r
tpr
osth
esishavi
ngatoo
thr
emova
l

i
46-Whichofthefol
lowi ngcli
nica
lindi
cat
ionswi
llNOTr
equi
rea
combi
nat
ionofanti
biot
ics
A)Tre
atmentofmixedinf e
cti
ons
B)Tre
atmentoft
uberculosis
C)Tre
atmentofcr
yptococ c
alme ni
ngit
is
D)Tre
atmentofgonnorhoea

(
@)47-Whi c
hoft
hef
oll
owi
ngdr
ugwi
lla
nta
goni
zeme
thot
rexa
te
A)Thiami
ne
B)Foli
cacid
C)Biot
in
D)Cyanocobal
ami
n

i
48-Allofthefoll
owingaret
herape
uti
cindi
cat
ionsofs
ali
cyl
ate
sEXCEPT
A)Rhematoidart
hrit
is
B)Feveri
nc hil
drenwit
hva r
ice
lla
C)Feveri
na dult
swithinf
luenz
a
D)Spasmodicdysmennorhoea

(
@)49-Famot i
dineiscl
assi
fi
eda
s
A)Ant
idepress
ant
B)H1rec
eptorantagon
ist
C)H2rec
eptorantagon
ist
D)Bet
a2a goni
st

i
50-Ma
tcht
hedr
ugc
har
act
eri
st
ics(
1-4)
.Ea
cha
nswe
rma
ybeus
edmor
e
t
hanonce
A)Auranof
in
B)Penc
ill
amine
C)As
pir
in
D)Cort
icos
ter
oids

1-Pl
at
el
e tf
unct
ioneffe
c t
2-Or
alformofgold
3-Gi
venona nemptystomach
4-Maybegivenint
ra-ari
cul
arl
y

i
51-Fore ac
hs i
deeffct(
1-4)
,li
stt
hemos
tli
kel
yca
use(
A-D).
Eac
hans
wer
maybeus edmoretha nonce
A)Sodiumbi c
arbonate
B)Al
umi ni
umhydr oxide
C)Ami t
rypti
li
ne
D)Ma gness
iumhydr oxi
de

i
1-Maycausediar
rhea
i
2-Sh
ouldnotbeus e
dbypati
ent
sofhea
rtfa
il
ure
i
3-Maycausedrymouth
i
4-Canbeincor
porat
edwit
hananta
cidmixt
uret
ocont
roldi
arhoe
a

i
52-Pyridoxinerequi
reme
ntsma
yinc
rea
sedur
inga
dmi
nis
tra
tionofa
llof
t
hefol
lowi ngEXCEPT
A)Is
oniazid
B)Cycloseri
ne
C)Oralcontrace
ptive
s
D)Levodopa
i
53-Thepr oc
essofr
ubbi
ngorgr
indi
ngas
ubs
tanc
einamor
tari
sca
lle
d
A)Tri
turat
ion
B)Spactul
ati
on
C)Levigat
ion
D)Coating

(
@)54-Whi choft
hef
oll
owi
ngi
sana
tur
ale
mul
si
fui
nga
gent
A)Acaci
a
B)Lac
tose
C)Pol
ysor
bate20
D)Pol
ysorba
te80

i
55-Allofthefoll
owingprepa
rat
ionsc
ont
aina
lcoholEXCEPT
A)SyrupsimplexB.P
B)Aroma t
icammoniaspir
itUSP
C)Aceti
ca ci
dN. F
D)Bella
donetinct
ureB.P

i
56-theRDA( Re
comme
nde
dda
ilya
llowa
nce
)ofe
leme
nta
lir
onf
ora
n
adul
tma nis
A)1-5mg
B)10-18mg
C)50-100mg
D)150-200mg

i
57-Ac ontr
aindi
cat
iont
othea
nti
migr
ainedr
ugs
uma
tri
pta
nis
A)Hypote
nsion
B)Hirs
uit
ism
C)Gingi
valhype
rpl
asi
a
D)a,bandc

i
59-Parac
e t
amol
A)Isnotr
e comme nde
dforpost
-immuniz
ationin2-3mont
hol
dinf
ant
s
B)Hasana nti
-infl
ammatorya
cti
vit
ysimil
artoaspir
in
C)Isaneffect
iveanal
ges
icinse
verere
nalcoli
c
D)Ma ycauses e
verel
ive
rtoxi
ci
tyift
akeninoverdose

i
60-Ani norga
nicmol e
cul
eus
edi
nthet
rea
tme
ntofma
niai
s
A)Aluminiumhydr oxi
de
B)Cr
omol ynsodium
C)Li
thiumbi c
arbonate

D)Ma
gne
siumoxi
de

i
61-Whi chofthefol
lowi
ngi
sthedr
ugofc
hoi
cef
ora
nac
utef
ebr
il
e
convul
s i
on
A)Ca r
ba ma z
epine
B)Clona zepam
C)Di a
z epam
D)Phe nyti
on

i
62-Whichoft hef oll
owingisatr
icyc
lica
nti
-de
pre
ssa
nt
A)Cl
omi pr
ami ne( Anafr
anil
)i
B)Fl
uoxeti
ne( Proz a
c)i
C)Maproti
ll
ine(Ludi omil)
i
D)Tr
anylcypromi ne(Par
na t
e)i

i
63-Whi choft
hefoll
owi
ngc
ompone
ntsofa
nal
ges
ict
abl
etsc
ommonl
y
ca
use
sc onst
ipa
tion
A)Aspir
in
B)Caff
eine
C)Code
ine
D)Pa
racet
amol

i
64-Whi chofthefol
lowingchemica
lgroupsdos
eNOTha
vea
nti
depr
ess
ant
ac
tivi
ty
A)Tricyc
lics
B)Select
iveserot
oni
nRe upta
keInhi
bit
ors
C)Monoa mineoxida
seinhibi
tor
s
D)Phenothia
zines

i
65-Whi chofthef
oll
owi
ngi
sche
mic
all
ysi
mil
art
oas
pir
in
A)Difluni
sal
B)Etodola
c
C)Suli
ndac
D)Indomethac
in

i
66-Whichoft hefol
lowi
ngdr
ugsha
sant
imus
car
ini
cac
tivi
ty
A)Benzhexol
B)Benz
tropine
C)Pr
ocyclidi
ne
D)Al
lofthea bove

(
@)67-Le vodopais
A)Thela
ti
nna mef ordopamine
B)Theaminoa c
idprecurs
orofdopamine
C)Themainme t
aboli
teofdopamine
D)Thenat
uraldopaminerecept
orant
agoni
st

i
68-Parkinson'
sdis
eas
eisc
aus
edbyade
fic
ienc
yofwhi
chne
urot
rans
mit
ter
i
nthesubs t
anti
alni
gra
A)Dopa mine
B)Noradrenali
ne
C)Acet
yl choli
ne
D)Adrena l
ine
i
69-Whi chofthefol
lowi
ngi
sthea
mino-a
cidpr
ecus
sorofdopa
mine
A)Levodopa
B)Br
omoc rypt
ine
C)Carbidopa
D)Pr
oc ycli
dine

i
70-fora4ye
arol
dchi
ld,t
hema
ximumda
ilydos
eofpa
rac
eta
moli
s
A)240mg
B)480mg
C)1g
D)2g

i
71-Whichofthef
oll
owi
ngi
sava
ila
blea
sani
nje
cti
on
A)Al
prazolam
B)Br
oma zepam
C)Cl
ora
z epat
e
D)Di
azepam

i
72-Whi choft hef
ollowingagent
sshoul
dnotbeus
edc
onc
urr
ent
lywi
th
l
evodopa
A)MonoAmi neOxidaseInhi
bit
ors
B)Diphenhydr ami
ne
C)Benzt
ropine
D)Ama ntadine

i
73-Ane xampleofa5-HT3r e
cept
ora
nta
goni
sti
s
A)Bromocrypti
ne(Parl
odel
)i
B)Ci
me ti
dine(Tagamet)
i
C)Ondanestr
on(Zofra
n)i
D)Fl
uoxe t
ine(Pr
ozac)
i

i
74-Whichofthef
olloe
ingCANNOTbegi
venwi
thaMAOIa
nti
depr
ess
ant
A)Bet
ablocki
ngdrugs
B)NSAID'S
C)Be
nzodi
aze
pines
D)Se
lec
ti
veSerot
oni
nRe
upt
akeI
nhi
bit
ors

i
75-Whi chofthefoll
owingcanl
owe
rthec
onvul
si
ont
hre
shol
d(a
t
t
hera
pe ut
icdoses)
i
A)Ca r
bamazepine(Tegret
ol)
i
B)Propanol
ol(Indera
l)i
C)Ami tr
ypt
ili
ne(Trypti
zol)
i
D)Phenytoi
n(Epa nut
in)i

i
76-Whi chanti
convul
santi
sas
soc
iat
edwi
ths
eda
tiona
ndt
ole
ranc
e
A)Va l
proi
ca ci
d
B)Phenobarbit
one
C)Clonazepam
D)Vigabatri
n

i
77-Benzodiazepi
nesmainl
yaff
ectwhi
chne
urot
rans
mit
ter
A)Gama -amino-butyr
ic-
aci
d
B)Noradre
naline
C)Ser
otonin
D)Dopamine

i78-
Whi chifthefoll
owi
nga
nti
epi
lept
icdr
ugsi
sal
sous
edi
nthepr
ophyl
axi
s
ofma nicdepressi
on
A)Phe nyto
in
B)Ca rbamazepine
C)La motri
gine
D)Phe nobarbi
tone

i
79-I
nt hee l
de r
ly,ana
nti
psyc
hot
icdr
ugs
ucha
sHa
lope
ridoli
sli
kel
yto
ca
use
A)Hyperther
mi a
B)Hypert
e ns
i on
C)Hypotension
D)Hypopr ol
ac t
inae
mia
i
80-Se lec
tthedrugofchoi
ceforpr
eve
nti
ngt
heDELAYEDe
met
ic
symptomsofc ancerche
mothe
rapy
A)5HT3a nta
gonist
B)Dexa methasone
C)Me tocl
opramide
D)Proc hl
orper
a z
ine

i81-Whichofthefoll
owingisef
fect
ivewhe
ngi
venonc
eda
ilyf
ort
he
preve
nti
onofe pil
epsy
A)Ca r
bamazepine(Tegr
etol)
B)Sodiumva l
proate(
Epili
m)
C)Phenytoi
n(Epa nut
in)
D)Ca r
bamazepine(Tegr
etolRet
ard)
i

i
82-Alloft hefoll
owi
ngc
anbeus
edt
otr
eatpe
sudome
mbr
ane
ousc
oli
ti
s
EXCEPT
A)Vancomyc i
n
B)Metronidazole
C)Cholest
yr a
mi ne
D)Cli
nda myc i
n

i
83-Theroteofc i
lasta
tininthec ombi
nati
onimipe
nem/c
ila
stat
inis
A)Toinhibi
tbe t
a-lacta
ma see nzymes
B)Toma keas ust
ainedreleaseformul
a
C)Toblocktherena lme t
aboltsmofimipene
m
D)Toinhibi
tthelivermi c
rosoma lenz
yme sf
romme t
aboli
zingimi
pene
m

i
84-Thepha
rma
cis
t'
sadvi
cet
oapa
tie
ntwhoi
sus
ingc
ipr
ofl
oxa
cins
houl
d
bet
hat
A)Donottakei
tdi
rec
tl
ya ft
eramealwhic
hcont
ainsmil
kanddair
y
pr
oduct
s
B)Donotitatt
hes
amet i
mewi t
haci
ds
C)Sepa
rat
eitfr
omcalc
iuma ndi
ronsuppl
ement
satle
astf
or2hour
s

D)Al
loft
hea
bove

i
85-Whi
choneoft
hef
oll
owi
ngs
tat
eme
ntsi
snut
ruea
bouta
ztr
eona
m

A)Itisact
iveagai
nstbothgr
ampos i
tiveandgramne
gat
ivemic
ro-
or
ganisms
B)Itisamonoba cta
m
C)Itsusualdos
eisonegrame very8hours
D)Ithaslowt e
ndancytocau
se hype
rsens
iti
vit
yinpe
nci
lli
nal
le
rgi
cpa
ti
ent
s

i
86-Biphosphonatesar
eusedc
lini
c a
llyt
otr
eat
A)Hypoc a
lceami a
B)Htponatrea
mi a
C)Hype r
calceamiarel
ate
dtoma l
ignanc
y
D)Hypoka le
ami acaus
edbydiure
tics

i
87-Wha ti
stheequivalentant
i-i
nfl
amma
tor
ydos
eto5mgofpr
edni
sol
one
A)50mgofc or
ti
soneac e
tate
B)50mgofhydrocort
isone
C)0.75mgofbeta
me t
ha s
one
D)10mgofpr e
dnisol
one

i
88-Thefoll
owingstat
ementsar
et r
uewhenwet al
kaboutoestr
ogense
xcept
A)Iti
sre
sponsibl
eforfemalese
condarysexua lchars
cter
ist
ic
s
B)Itc
aus
e smyome t
ria
latr
ophy
C)Itc
anbeus e
di npostmenopa
us a
lost
eopor osi
s
D)Longtermtrea
tmentwithoes
trogenmayi nc r
easetheri
skofendometr
ial
ca
ncer
i
89-Whic honeofthef
oll
owi
nghor
mone
siss
ecr
ete
dbyt
hehypot
hal
amus
A)Gonadore l
in
B)Cort
icotropin
C)Va
sopress i
n
D)Genotropin

i90-Whichoneofthefol
lowi
ngi
sthemos
tcommonl
yre
por
teds
idee
ffe
ct
ofant
ipsychot
icsi
ntheel
derl
y?
A)Agr a
nulocyt
osi
s
B)Arrhythmia
C)EPS
D)Exc e
ssiveur
inat
ion

i
91-Al lt
hefoll
owi
nga
rec
ons
ide
redt
obebe
ta–l
act
amt
ype
ant
ibi
otic
s,EXCEPT
A)Ceftri
axone
B)Pierac
il
lin
C)Ofloxacil
li
n
D)Imipenem

i92-Whichoneofthef
oll
owi
ngor
gansi
sinvol
vedi
nca
lci
um-ba
lanc
eand
homeost
asis
A)Pancreas
B)Hypothala
mus
C)Parot
idglands
D)Parat
hyroid

i
93-Themos tc
ommons
idee
ffe
ctofaNSAI
Dis
A)Hea
da che
B)Naproxen
C)Ski
nr ash
D)Diar
rhoea

i
94-Whi
choneoft
hef
oll
owi
ngi
sus
ual
lygi
venonc
eada
y
A)Piroxica
m
B)Na proxen
C)Diflunis
al
D)Ibuprofen

i
95-Whi c
honeoft hefollowingca
nbegi
vens
afe
lyt
oapa
tie
ntr
ece
ivi
nga
n
MAOI
A)Cromoglic
atena saldrops
B)Ephedri
nenas aldrops
C)Oxyme taz
olinena saldrops
D)Xylome t
azolinena saldrops

i
96-Whichoneoft henas
a lspra
ysisusua
llyus
edONCEda
ily
A)Becl
oma ta
sone(Becot
ide )
i
B)Dexame t
hasine(Dexar hi
naspr
ay)i
C)Fl
uti
casone(Fli
xonase
)i
D)Cr
omog lycat
e(Rynacrom) i

i
97-Whi c
hi sthemostpotentear\nos
edr
ops
A)Beta
me thasone(
Be t
nesol)i
B)Dexame t
hasone(Sofr
adex )
i
C)Hydrocorti
sone(
Ot o
sporin)i
D)Pr
ednisolone(Pr
edsol)
i

i
98-Whi choneofthef
oll
owi
ngs
houl
dbea
voi
deddur
ingt
rea
tme
ntwi
th
war
f a
rin
A)Amoxi ci
ll
in
B)Glibencl
amide
C)Indomethac
in
D)VitaminD

i
99-Whi choneoft
hef
oll
owi
ngc
anbeus
edt
otr
eata
cut
ego
A)Diclofe
nac
B)Ibuprof
en
C)Indometha
cin
D)Al
loft
hea
bove

i
100-Whi choneofthef
oll
owi
ngi
smos
tcl
ose
lyr
ela
tedt
oas
pir
in
A)Acetaminophhe
n
B)Dic
lofenac
C)Dif
lunisal
D)Sal
azopyrine

Se
vent
h100

(
@)1-Whi chofthefol
lowi
ngdr
ugsi
nhi
bit
sthef
orma
tionofur
ica
cid
A)Aspi
rin
B)Colc
hici
ne
C)All
opuri
nol
D)Sodi
ums al
ic
ylat
e

i
2-Whichofthefoll
owingisNOTa ni
ndic
ati
onofdi
goxi
n
A)Congest
ivehear
tfai
lure
B)Atr
ialf
ibri
ll
ati
onora t
ri
alf
lut
te
r
C)Vent
ric
ularta
chycar
dia
D)Si
nustachycar
diaca
us e
dbyconges
ti
vehear
tfa
il
ure

i
3-Thether
ape
uti
ce f
fectofwarfar
inisachie
ve dby
A)Dis
solvi
ngexi
st
ingthrombi
B)Pr
eventi
ngt
hethrombusf or
ma t
ionwhe nbloodst
asi
soc
cur
s
C)Pr
eventi
ngt
herenalsynthes
isofVitaminK
D)Pr
eventi
ngt
hethrombusf or
ma t
ioninvitr
o
i
4-Thea nti
hyper
tensi
vee
ffe
ctofGua
net
hidi
nei
sinhi
bit
edbywhi
choft
he
f
oll
owing
A)Diazepam
B)Amitrypti
ll
ine
C)Hydrochlor
thi
azide
D)Nit
rofurant
oin

i
5-Inint
eracti
onofAmil
ori
dewi
thCa
otopr
ilt
her
eisapos
sibi
li
tyof
A)Hypokaleamia
B)Hyperkal
eamia
C)Hypocalc
a mia
D)Hypophosphat
eami
a

i
6-Whichofthefoll
owingi snottr
ueaboutSimvast
ati
n
A)Iti
saHMGCoAr eductaseinhi
bit
or
B)It
sma i
nadvers
ee f
fectisGldist
urbances
C)Concomit
tanta
dministr
ationofSimva st
at
inwit
hcyclos
por
inei
s
as
soci
at
edwithincr
easedriskofmyopa thy
D)Thedoseshoul
dbea djustedinre
nalf a
il
urepa
ti
ents

i7-Thepos s
ibl
einte
ract
ionbetweenCisapride(
Pr e
puls
id)andHyosci
ne
butyl
A)Ci s
apridewil
lincre
asetheAnti
mus cari
nicsideeff
ectofBus
copan
B)The ycounte
ractt
hee f
fectofea
chot her
C)Bu scopanwil
lincre
asetheadvers
ee ff
ectsofcisa
pri
de
D)Ci s
apridewil
ldispl
aceBus c
opanfromt heplasmaprote
inbi
ndingsi
te
s

i
8-Whi c
hoft hefol
lowi
ngdos
enotl
owe
rpl
asmal
ipopr
ote
inc
onc
ent
rat
ions
A)Ni
c ot
inamide
B)Si
mva st
ati
n
C)Choles
tyra
mi ne
D)Gemfibroz
i l
I
9-Themos tcommonsi
dee
ffe
ctr
ela
tedt
otheus
eofAl
umi
niumc
ont
aini
ng
ant
aci
dsis
A)Nausea,Vomi t
ti
ng
B)Const
ipation
C)Diar
rhoea
D)Glbleeding

i
10-Adi s
a dvantageintheuseofcimet
idi
ne,i
sit
sabi
li
tyc
aus
e
A)Ha i
rgrowth
B)De c
rea
s edpr ol
acti
nsecre
tion
C)Inhi
bit
ionofhe pat
icmicr
os oma
lenzymes
D)Oe s
opha ge
a lrefl
ux

(
@)11-Re gularuseofsubl
ingua
ldos
esofGl
yce
rylt
ri
nit
rat
eisl
ike
lyt
o
r
esul
tinthedevelopmentof
A)Hepatot
oxici
ty
B)Nephrot
oxici
ty
C)Tol
e r
ance
D)Respir
ator
yimpa i
rment

I
12-Gast
ri
cint
ri
nsi
cfa
ctori
sagl
ycopr
ote
int
hati
sre
qui
redf
orGl
a
bsor
pti
on

A)Vita
mineB12
B)Foli
caci
d
C)Ir
on
D)Calci
um

I
13-Whi c
hofthef
oll
owi
ngACEi
nhi
bit
orsha
sthes
hor
tes
tdur
ati
onof
ac
tion
A)Enala
pril
B)Captopr
il
C)Li
sinopri
l
D)Pe
r i
ndopri
l

i
14-Whichofthefoll
owinga
nta
cidsi
smos
tli
kel
ytoi
nduc
ere
bound
ac
idi
ty
A)Alumini
umhydr oxi
de
B)Magnesi
umhydroxide
C)Si
me t
hicone
D)Calci
umc ar
bonate

i
15-Apati
entwhoha
sexc
ess
ivel
eve
lsofa
myl
asei
ndi
cat
eadi
sea
seoft
he
A)Li
ver
B)Hear
t
C)Pa
ncrea
s
D)Ki
dney

i
16-Sucral
fateisbestdes
cribeda
sa\
an
A)Art
ifici
alswe et
ner
B)Denaturi
nga gentfora
lcohol
C)Ulcerprot
ectant
D)Oralhypoglyceamic

i
17-Whichofthefoll
owingdr
ugsissui
tabl
etot
rea
tahype
rte
nsi
vepa
tie
nt
whoal
sohasAs t
hmaa ndHyperur
ice
amia
A)Amlodi
pine
B)Hydr
ochlor
thi
azide
C)Moduret
ic
D)Pr
opanolol
I
18-Cromolynisusedinthefol
lowingEXCEPT
A)Inpreve
nti
ngfooda l
ler
gy
B)Forl
oc a
lappl
icat
iontotheeye
C)Forl
oc a
lappl
icat
iontothenose
D)Forloca
lappli
cat
iontotheskin

I
19-Anove rdos
eofwhi
chdr
ugc
anc
aus
eins
omni
a,
arr
ythma
isa
nd
convul
sions
A)Ami nop hyll
ine
B)Prednisolone
C)Adrena l
ine
D)Be cl
ome t
hasone

i
20-Whichofthefoll
owingi
smos tli
kel
yt ohavelongt
erms
idee
ffe
cts
whenusedtot
reatas
thmaina10yrol dchil
d
A)Dail
ya dmi
nis
trat
ionofsa
lbut
amolbyi nhal
er
B)Dail
ya dmi
nis
trat
ionofpr
ednis
olonebymout h
C)Dail
ya dmi
nis
trat
ionofbe
clomethas
onebyi nha
ler
D)Dail
ya dmi
nis
trat
ionofcr
omolynbyi nhal
er

I
21-Whi chofthef
oll
owi
nga
nti
biot
icsi
sONLYus
edt
opi
cal
ly
A)PolymixinB
B)Pencil
li
nG
C)Carbenic
ill
in
D)Clindamycin
I
22-Chlorampheni
coli
sthedr
ugofchoi
cei
n:
A)Symptoma t
icsa
lmonel
lai
nfec
ti
ons
B)Tubercul
osi
s
C)Cholera
D)Str
eptococc
alphar
yngi
ti
s

I
23-Whi c
hofthef ol
lowingstat
ementsisNOTTRUEa boutc
linda
myc
in
A)Iti
seffe
cti
vea gai
nststa
phylococ
c usaure
us
B)Iti
seffe
cti
vea gai
nstanaer
obicorganis
ms
C)Thema j
orsideeff
e c
tisPseudomembr aneousc
oli
ti
s
D)Iti
sindic
ate
df orseri
ousboneinfecti
ons

I
24-Ne docromili scl
ass
ifi
eda
s
A)Abe ta-agonist
B)Me t
hylxanthine
C)Ma s
t-c e
ll-st
a bil
iz
er
D)Glucocortic
oid

i
25-Sa
lmeteroli
sa :
A)Abet
a-agonis
t
B)Met
hylxanthi
ne
C)Mast
-cell
-sta
bili
zer
D)Muscar
inicanta
gonis
t

i
26-Whi chofthefoll
owingstat
eme
ntsi
sNOTTRUEa
bout
Diphenhydr
amine
A)Ithasanexpectora
nteffe
ct
B)Ithasananti
hista
mi ni
ceff
ect
C)Ithasanatr
opinelikeeff
ect
D)I
tisc
ont
rai
ndi
cat
edi
npa
ti
ent
swi
thpr
ost
at
ehype
rtr
ophy

i
27-Whichofthef
oll
owi
ngdr
ugsDOESNOTc
aus
eins
omni
a
A)MAO'S
B)Caf
fei
ne
C)Bet
ablocker
s
D)Bar
bit
urate
s

i
28-Whi chofthefol
lowi
ngc
anr
educ
ethee
ffe
cti
vene
ssofs
ulphona
mide
s
ant
ibi
otic
s
A)Foli
ca ci
d
B)Pantot
henicaci
d
C)Vita
mi nB12
D)Me t
hotre
xa t
e

I
29-Whi choft hefol
lowi
ngi
sthemos
tef
fec
tivedr
ugf
ort
het
rea
tme
ntof
moti
ons i
ckne s
s
A)me toclopramide
B)onda nestron
C)Proc hl
orpe r
azine
D)cinna r
izine

I
30-Whi choneoft
hef
oll
owi
ngi
sabe
nzodi
aze
pinea
nxi
olyt
icdr
ug
A)Buspir
on e
B)Loraze
pam
C)Haloperi
dol
D)Pimozide
(
@)31-IfaCNSdr ugisexte
nsivel
yioniz
edatt
hePHofbl
ood,i
twi
ll
A)Pene
tra
tetheBl
oodbrainBarri
ersl
owly
B)Pe
netr
atet
heBloodbrainBarri
erra
pidly
C)Beeli
minate
dsl
owly
D)Notbedis
tri
but
edtoanytis
suesit
es

i
32-Whichofthefoll
owi ngisNOTa nindi
cati
onofTranexa
micaci
d
A)Tr
eatmentofhaemor r
hagea ssociat
edwithexces
sivefi
bri
nol
ysi
s
B)Ananti
doteforstr
eptokina
s eove r
dose
C)Pr
ophylaxi
sofhe r
editar
ya ngioedema
D)Pr
eventhaemorrhageduetohe par
inoverdose

I
33-Phe nobar
bit
alwillint
eractwit
hwa rf
ari
nthr
oughwhi
chme
cha
nis
m
A)Induc t
ionofmicrosomale nz
yme s
B)Induc t
ionofnon-mi cr
osoma lenz
yme s
C)Inhibit
ionofnon-mi cr
os omalenzymes
D)Inhibiti
onofmicrosoma lenzymes

i
34-Sulphonyur e
ase.g.
;Glibe nclamide(Daoni
l)a
ctby
A)Increasingt hesec
r e
ti
onofi nsuli
nfrombe t
acell
s
B)Inc
reasingt heuptakeofgl ucosebymus cle
C)Reducingt hehe pa
ticsynthe si
sofglucos
e
D)Allofthea bove

i
35-Whichofthef
oll
owi
ngi
sNOTat
hir
dge
ner
ati
onc
epha
los
por
in
A)Cef
uroxime
B)Cef
ri
axone
C)Cef
tazi
dime
D)Cef
otaxi
me

i
36-Whi c
hoft hefoll
owingdr
ugsha
slowt
her
ape
uti
cinde
x
A)Digoxin(Lanoxin)
B)Dil
iti
azem(Di l
zem)
C)Theophyll
ine(Theodur)
D)aandca bove
i
37-Whichoft hefoll
owings
alt
scommonl
yca
usedi
arr
hea
A)Al
umi numhydr oxide
B)Fe
rrouss ul
phat
e
C)Magnesiumhydr oxide
D)Al
loft heabove

i
38-Whichofthefoll
owingi
sagr
ampos
it
iveba
cte
ria
A)St
rept
ococcusfae
cali
s
B)Sal
monell
styphi
C)Haemophi
lusinfl
uenza
D)E.Col
i

i
39-Whi chofthefoll
owingc
anbeus
eds
afe
lyt
otr
eatdi
abe
tesi
npr
egna
ncy
A)Me t
formin(Glucopha
ge)
B)Gli
benc l
amide(Daoni
l)
C)Ins
ulin
D)Noneoft heabove

(
@)40-Ta moxif
en( Nolvadex)is
A)Pr
ogeste
ronerec
e pt
orantagonis
t
B)Pr
ogeste
ronerec
e pt
oragonist
C)Oes
trogenrec
eptoragonist
D)Oest
rogenrec
eptorantagonis
t

i
41-Whi c
hofthef
oll
owi
ngi
nsul
insha
sthel
onge
stdur
ati
onofa
cti
on
A)Actr
apid
B)Ins
ult
ard
C)Monotard
D)Ultr
ale
nte

i
42-Whi choft
hefoll
owingcani
ncr
eas
ethel
eve
lofHDL-c
hol
est
erol
A)Chole
styr
amine(Quest
ran)
B)Fluvas
tat
in(
Le s
col)
C)Gemf
ibr
osi
l(Lopid)
D)Si
mvast
at
in(Zocor)

i
43-Whi chofthefoll
owi
ngdr
ugsi
sSAFEi
nG6PDde
fic
ienc
y
A)Cephalexi
n
B)Dapsone
C)Pri
ma quin
D)Sulphamethoxa
z ol
e

i
44-Whi chofthef
oll
owi
ngi
sapr
ost
agl
andi
nana
logue
A)Cime t
idi
ne
B)Misoprost
ol
C)Ome praz
ole
D)Sucral
fat
e

i
45-Whichofthef
oll
owingisana
tur
ale
mul
si
fyi
nga
gent
A)Acaci
a
B)Lact
ose
C)Pol
ysorba
te20
D)Sor
bit
ta
nmonopalmit
ate

i
46-Coc oabutt
er(Theobromaoil)e
xhibi
tsal
loft
hef
oll
owi
ngpr
ope
rti
es
exc
eptthat
A)Itmeltsbet
we en33and35de gre
esc e
nti
gra
de
B)Iti
sami xtureofglyc
eride
s
C)Iti
sus ef
ulinformulat
ingsuppos
it
ories
D)Iti
ss ol
ubleinwa t
er

(
@)47-Whi
choft
hef
oll
owi
ngi
sanoc
cas
iona
lsi
dee
ffe
ctoft
heACE-
i
nhi
bitor
s
A)Alopecia
B)cough
C)Hypokaleamia
D)Alloftheabove

i
48-Ibuprofe
nisa
A)Fenama t
ederivat
ive
B)Propioni
caci
dde riva
tive
C)Pyra
zolli
nederiva
tive
D)Noneoft heabove

i
49-Thespeci
fi
cant
agoni
stf
orbe
nzodi
aze
pineove
rdos
eis
A)Fl
ucyt
osine
B)Fl
umazenil
C)Fl
unar
izi
ne
D)Fl
uraz
epam

i
50-Inast
hma ,Cromolyns odi
um(Int
al)a
ctsvi
a
A)Ant
agoni
smofH- 1re
ceptor
s
B)Rela
xati
onofbr onchia
ls moot
hmus cl
e
C)Sta
bil
iza
tionofe pit
hel
ialmastcel
ls
D)Noneofthea bove

51-Ac c
or dingtor
ecentevidence
,whichoft
hefol
lowi
ngi
sas
soc
iat
edwi
th
thel
owe str i
skofgas
tro-inte
sti
nals
ide–ef
fec
t
A)Dic l
ofe nac
B)Ibuprofe n
C)Na proxe n
D)Piroxica m
i
52-Whi chofthefol
lowi
ngc
anbeus
eds
afe
lyi
napa
tie
ntwhoi
sal
ler
gict
o
as
piri
n
A)Dicl
ofenac
B)Ibuprof
en
C)Me loxi
cam
D)Noneoft heabove

i
53-Whi c
honeofthef
oll
owi
ngmus
tbea
voi
deddur
ingt
rea
tme
ntwi
th
met
hotre
xa t
e
A)Aspir
in
B)Cimeti
dine
C)Foli
cac i
d
D)Me t
oclopra
mide

i
54-Wha tdai
lydos
eofa
spi
ri
nisc
ons
ide
redt
obea
nti
-inf
lamma
tor
y
A)500to1 g
B)1gto2g
C)morethan3g
D)75mgd a
il
y

i
55-Whichoneofthef
oll
owi
ngbl
ockst
hene
uromus
cul
arj
unc
tion
A)Bac
lofen
B)Chl
ordi
azepoxi
de
C)Di
azepam
D)Vec
uronium

i
56-Thee
xpi
ryda
teofadr
ugi
sus
ual
lyt
het
imewhe
npot
enc
yfa
llsbe
low
A)90%
B)85%
C)
80%
D)75%

i
57-Theterm" s
tor
einac
oolpl
ace"
mea
nst
hatt
het
empe
rat
uremus
tnot
exc
eed
A)4centi
grade
B)10cent
igrade
C)15cent
igrade
D)30centi
grade

i
58-Whi chofthefol
lowi
ngi
sthedr
ugofc
hoi
cef
ora
nac
utef
ebr
il
e
convul
s i
on
A)Ca r
ba ma z
epine
B)Clona zepam
C)Di a
z epam
D)Phe nytoin

i59-Peri
phe r
alneur
it
isduet
ois
oni
azi
dca
nbea
voi
dedbygi
vingwhi
ch
vita
mi n
A)As corbicaci
d
B)Pyr i
doxine
C)Ri bofl
avine
D)Thi amine

i
60-Tubercul
os i
si st
reatedwithacombinati
onofdrugsbe
caus
e
A)Thispr
eve ntstheeme rge
nceofresis
tantor
ganis
ms
B)Iti
mprovesdr ugpe net
rat
ionintothemyc oba
cter
ium
C)Itmini
mi z
e stheri
fa mpic
intoxi
cit
y
D)Itmini
mi z
e stheisoniazi
dtoxic
it
y
i61-Accordi
ngt oUSP,i
fame
dic
inee
xpi
res"
Janua
ry2001"i
tmus
tnotbe
usedaft
er
A)J a
nuary01,2001
B)J a
nuary15,
2001
C)J a
nuary31,2001
D)De ce
mbe r31,2001

i
62-Thea nti
ba c
ter
ialme c
hanis
mofpe
nic
ill
ini
smos
tsi
mil
art
o
A)Clindamyc i
n(Da laci
n
B)Tetrac
yc l
ine(Achromyc i
n)
C)Ciprofl
oxa c
in(Ciprobay)
D)Cefachlor(Cecl
or

i
63-Whi choft hefoll
owings t
ate
me nt
saboutDoxycyc
lineisNOTt
rue
A)Itisma i
nlye xcre
tedinthefaece
s
B)Itcommonl yc ausesgas
troi
ntes
ti
naldi
s t
res
s
C)Itsabsor
ptionisinhibi
tedbtanta
c i
dsandmilk
D)Itma yproduc ephotot
oxicrea
cti
onone xposur
etosunl
ight

i
64-Whichoft hefol
lowi
ngant
ibi
oit
icss
houldbea
dmi
nis
ter
edt
oapa
tie
nt
whosere
nalfuncti
onisse
ver
lycompromise
d
A)Eryt
hromycin
B)Tobra
myc i
n
C)Norf
loxaci
ll
i n
D)Pipe
raci
ll
in

i
65-Alloft
hefoll
owi
nga
gent
sca
uset
hei
rtoxi
cef
fec
tsbyi
nte
rfe
renc
esi
n
DNAtranscr
ipt
ion
A)Cis
plat
in
B)Tamoxi
fen
C)Doxor
ubic
in
D)Cycl
ophospha
mide

i
66-Hyperkal
eamiai
sac
ont
rai
ndi
cat
iont
otheus
eof
A)Chl
orthal
idone
B)Acet
azolamide
C)Spi
ronola
ctone
D)Chl
orthal
idone

i
67-Whi chofthef
oll
owi
ngi
snotabe
ta-
lac
tama
nti
biot
ic
A)Aztre
onam
B)Imipenem
C)Str
eptomycin
D)Ampi ci
ll
in

i
68-Whi choft hefol
lowingisnotr
ecomme
nde
dfort
hea
mana
geme
ntof
al
ler
gicrhinit
is
A)Sys t
emicna salde
congest
ants
B)Cor t
ic
os t
eroids
C)Cromogl ycate
D)Ne docr
omi l

i
69-Whi
chofthefoll
owi ngi
sar
iskf
act
orf
orhe
artdi
sea
se
A)LowHDLc holes
ter
ol
B)LowLDLchol e
ste
rol
C)Lowt
ri
glyc
e r
ides
D)LowVLDLc holest
erol
i
70-Whi choft hefol
lowingisTRUE
A)Procainamideisme taboli
zedmor eslowl
ythanpr
ocaine
B)Sulphon yur
easareoralanti
coagulant
C)Ani mme di
ateI
Vi nj
ec t
ionsal
butamolisusedtot
rea
ta c
utes
yst
emi
c
an
aphylaxis
D)Ke t
ami neisusedinthetrea
tme ntofmigr
aine

i
71-Whi chofthef
oll
owi
ngc
anbeus
edi
nthet
rea
tme
ntofdi
abe
tes
i
nsi
pidus
A)Me tformin
B)Gluc agon
C)Vas opres
sin
D)Insulin

i
72-Manni
tolmaybeus e
fulinallt
hefol
lowingtr
eat
mentsEXCEPT
A)Tr
eat
mentofpulmonaryoedemawi t
hc onge
sti
vehea
rtfa
il
ure
B)Di
agnos
ticeval
uati
onofa c
uteoli
gour
ea
C)Tr
eat
mentofe l
evat
edint
raoccul
apres
sure
D)Pr
ophyl
axisofacut
erenalfai
lur
e

i
73-Ome pr
azol
es houldonl
ybeusedonpre
scr
ipt
ionbe
caus
e
A)Itisexpensi
ve
B)Ithasma nydruginter
act
ions
C)Itcanma skthesymptomsofgas
tri
ccanc
er
D)Itcanc a
usehepa t
it
is

i
74-Hi
st
amineinduc
edbr
onc
ho-
cons
tri
cti
oni
sduet
othea
cti
vat
ionof
A)H1re
cept
ors
B)H2r
ecept
ors
C)H3r
ecept
ors
D)Al
loft
hea
bove

i
75-Whi chofthef ol
lowi
ngme di
cinei
sava
ila
blea
sanOTCme
dic
inei
n
t
hetr
eatme ntofna us
eaandvomit
ing
A)Dime nhydri
nate
B)Pr
oc hlorpe
razine
C)Mec l
oz i
ne
D)Chlorpromazine

i
76-I
nAddi son'
sdiseas
etheproperre
place
mentt
her
apys
houl
dbe
A)Gl
ucocorti
coidplusmineral
ocor
ti
coid
B)Mine
ralocort
icoi
dthera
pya l
one
C)Gl
ucocorti
coidther
apyalone
D)Te
tra
cos a
c t
ri
n(a nal
ogueofACTH)

i
77-Str
eptomyciniisananti
biot
icindi
cat
edf
ort
het
rea
tme
ntof
A)Gram-negat
iveba c
teri
alse
ptice
a mi
a
B)Tuber
culosi
s
C)Penci
ll
in-r
esi
stantgonococ
c a
linfec
ti
on
D)Syphi
lli
s

i
78-Inthetreat
me ntofc hronicobst
ructi
vepulmonarydi
sea
se(COPD)
,
i
nhal
e dcort
icost
eroids
A)Aremor ee f
fect
ivei nthet r
eat
mentofa s
thma
B)Aremor ebeneficialwhe nusedalone
C)Producemor esidee f
fectsthanwhe nuse
dintheoralf
orm
D)Shouldbeus edf oratleast2weeksbe f
oreeff
ica
cyisass
ess
ed
i
79-Thepr i
ma r
ygoa lsofasthmat her
a pyi
ncl
udea
llt
hef
oll
owi
ngEXCEPT
A)Tre
a t
me ntofsecondarycompl ica
tions
B)Mana gementofacutea t
ta
c ks
C)Chronicsymptomma nageme nt
D)Pre
ve nt
ionoflungt i
ssuede s
truct
ion

i
80-Inthee me r
genc
yroom,
thepr
efe
rre
dfi
rstl
inet
her
apyf
ora
sthmai
s
A)Theophyline
B)Beta
-a gonist
s
C)Cort
icosteroi
d

D)Ant
ihi
st
ami
ne

i
81-Ce f
tr
iaxonecanbeuse
din
A)Gonorrhoea
B)Typhoidfever
C)Me ni
ngococcalmeni
ngi
ti
s
D)Alloftheabove

i
82-Whic hstatementwoul dmosta
ccurat
elyde
scri
betheanti
bact
eri
alof
t
etr
acycl
inea nti
biot
ics
A)Theya r
eba cteri
ost
atic
B)Theyinhibitprote
ins ynt
hesi
sbybindi
ngtothe30sri
bosomaluni
t
C)Theyinhibitbacter
ialcellwa
lls
ynthes
is
D)Allofthea bove

i
83)Whi c hoft hefol
lowingc
ort
icos
ter
oidsha
sthehi
ghe
st
mine
r a
loc orti
coidact
ivit
y
A)Cortisonea ceta
te
B)Hydroc or t
is
one
C)Fludroc ort
isone
D)Be t
ame tha
sone
i
84-Ther
ecomme ndedma
int
ena
ncedos
eofRa
nit
idi
nef
orpe
pti
cul
ceri
s
A)150mgatnight
B)300mgatni
ght
C)150mgtwic
eda il
y
D)300mgtwic
eda il
y

i
85-Whi c
hoft hef ol
lowingisNOTa
nindi
cat
ionf
orde
smopr
ess
in
A)Di
a bet
eesinsipidus
B)Pr
ima r
ynoc turnaleneur
esis
C)Renalfunc
tiont est
ing
D)Pr
os t
at
ea t
rophy

i
86-Ahype rtens
ivepati
entshouldbee ncour
age
dto
A)Reduc et
hea mountofsal
tint heirdi
et
B)Inc
r e
asetheamountofs a
ltint hei
rdie
t
C)Drinkmor ewa t
eri
ftheye atas a
ltymeal
D)Reduc et
heirfl
uidint
ake

i
87-Whi chofthefoll
owingisNOTt r
ueofme
tha
done
A)Ca nbegivenoral
lyorparent
era
ll
y
B)Iti
sana rcoti
canta
gonis
t
C)Iti
sa naddict
ivedrug
D)Ithassignif
ica
ntanal
gesi
ca c
ti
vit
y

i
88-Se lec
tthedrugofchoi
cef
oet
het
rea
tme
ntofa
not
it
ise
xte
rnac
aus
edby
st
aphylococcus
A)Alumi niuma c
eta
te
B)Ne omyc in
C)Ch lor
amphe ni
col
D)Fluc l
oxacil
li
n

i
89-Caff
einet
oxi
cit
yma
yinc
ludea
lloft
hef
oll
owi
ngs
ympt
omsEXCEPT
A)Cough
B)Anxie
ty
C)Re
sle
ssnes
s
D)Musc
letwit
chi
ng

i
90-Aba ct
eri
ostat
icagentha
swhic
hofthef
oll
owi
nge
ffe
ctsonba
cte
ria
A)Itkill
sbacter
iaonc ont
act
B)Itdehydrat
esbac t
eri
a
C)Itinhi
bit
smul ti
pli
cati
onofba
cte
ria
D)Allofthea bove

i
91-Apa t
ientindiabet
iccoma
A)Ma yhavetheadourofa ce
toneont
hei
rbr
eat
h
B)Usual
lyre c
overswithoutt
reat
ment
C)Maytremore xcess
ively
D)Noneoft heabove

i
92-Alloft hefol
lowi
ngdr
ugsma
ybeus
edf
ort
het
her
apyofhype
rte
nsi
ve
emer
ge ncyc ri
si
sEXCEPT
A)Furosemi de
B)Diazoxide
C)Nifedi
pine
D)propanolol

i
93-ACEi nhi
bit
orsa
reass
oci
ate
dwi
thahi
ghi
nci
denc
eofwhi
choft
he
f
oll
owingadver
serea
cti
ons
A)Hepati
ti
s
B)Hypokale
amia
C)Agranul
ocyt
osi
s
D)Cough

i
94-Ba r
bit
urate
sc ont
aini
ngas
ulphura
toma
reus
ual
ly
A)Shortact
ing
B)Ultr
ashortact
ing
C)Iongacti
ng
D)Me di
uma c
ti
ng
i
95-Adec
reas
einHDL/ LDLr a
tioi
ndi
cat
es
A)Inc
reas
edtri
acylglycer
ol
B)Inc
rea
sedmobiliza
tionoffat
C)Lowriskf
orarther
os c
ler
osi
s
D)Inc
reas
edeste
rifi
cati
onofchole
ste
rol

i
95-Diverti
cul
osi
sisa
ssoc
iat
edwi
th
A)Stomach
B)Sma l
lint
est
ine
C)l
iver
D)Colon

i
96-Dys pnoeameans
A)Painf
ulmus cl
espasm
B)Pai
ni nthehear
t
C)di
ffic
ultyinbre
athi
ng
D)noneoft hea
bove

i
97-Es
ter
saref
ormedbyther
eac
tionbe
twe
en
A)Aci
dsandbas
es
B)Aci
dsandal
cohols
C)Aci
dsandal
dehydes
D)Aci
dsandket
ones

i98-Forhowlongs
houldt
hepat
ientwai
taf
ters
toppi
ngMAOi
nhi
bit
or'
s
befor
ehes t
art
sonTri
cycl
ica
nti
depre
ssa
nts
A)1mont hs
B)2mont hs
C)2we eks
D)3da ys

i
99-Glipi
zidei
sus
edt
otr
ue
A)Pepti
culcer
B)Diabet
es
C)Colit
is
D)I
nfe
cti
ons

i
100-Inrunningpers
onWhichoft
hef
oll
owi
ngoc
cur
s
A)Hyperventi
lat
ion
B)Tachycardi
a
C)Incr
easedBP
D)Incr
easedstr
okevolume
E)Alloftheabove

Ei
ght
h100

i
1-Dr ugsgi vensyste
mica
llymayc
aus
eal
lthef
oll
owi
ngEXCEPT
A)Ha irloss
B)Ch ronicurti
cari
a
C)Erythe mamul ti
form
D)Funga linfe
cti
onsoftheski
n

i2-Gr a
pef r
uitjui
ceshoul
dbea voi
dedwi
thma
nydr
ugsbe
caus
e
A)Itspoilst
heta s
te
B)Itincr
e as
esthedrugmetabol
ism
C)Itdecrease
sthedrugme t
abol
ism
D)Itdelaysgastri
cemptyi
ng

i3-Gra
ve '
sdise a
semaybec
har
act
eri
zedby
A)Hypothyroidism
B)Hepat
icc ir
rhosis
C)Cort
isolinsuffi
ci
enc
y
D)Hyperthyroidi
sm
i4-Hyper
cal
ceami adosenotoccuri
nnor
mali
ndi
vidua
lsbe
caus
e
A)Calci
umisrapidlyexcr
eted
B)Calc
iumisrapidlybiot
rans
formed
C)Calc
iumisinsolubl
e
D)Excces
scal
c i
umi snotabsorbed

i5-Hype r-responsivenessofthetr
acheaa ndbronchitost
imuliwit
h
bronchiola
rcons tr
icti
ona ndsymptomsofwhe e
z i
nga nddyspnoeades
cri
bes
A)Chr onicobs t
ructi
on
B)As thma
C)Pne umonia
D)Chr ocicobstructi
vepul monarydis
ea s
e
i6-IfaCNSdr ugise xt
ensivel
yionize
da tthePHofbl ood,itwil
l
A)Pe netra
tetheBl oodBr ainBarri
ersl
owl y
B)Pe netr
atetheBl oodBr ainBarri
errapi
dly
C)Bee li
minatedslowl y
D)Notbedi s
tributedtoanyt i
ssuesti
es

i7-I
nahype rt
ensi
vepati
entt
akingins
uli
nwhichoft
hef
oll
owi
ngdr
ugst
o
beus
e dwithe xt
racaut
ionandadvic
etothepa
tie
nt
A)Hydr al
azine
B)Prazosi
n
C)Propanolol
D)Me thyl
dopa

i8-I
nmi grainema na
gement
,whi
choneoft
hef
oll
owi
ngi
scont
rai
ndi
cat
ed
ini
schea
mi che ar
tdis
eas
e
A)Pizot
ife
n
B)Sumatriptan
C)Propanolol
D)Flunari
zine

i9-I
ronisrequir
edbythebodyt
oma
int
ainnor
mal
A)Diges
tion
B)Bonegrowth
C)Vit
amina bsor
pti
on
D)Oxyge
ntr
ans
por
t

i10-Le
voc abast
inenas
aldr
opsa
rec
las
sif
ieda
s
A)Cort
icost
e r
oid
B)Sympathomi meti
c
C)Anti
hist
ami ne
D)Astr
ingent

11-Li
doc
aineHCLisnotusua
llya
dmi
nis
ter
edor
all
ybe
caus
eiti
s
A)Hasnosyst
emi
cacti
vit
y

B)Tooaci
dic
C)Toobasi
c
D)acaus
eofarr
hyt
hmi
a

i12-Megalobla
sti
caneami
ama yber
espons
ivet
oadmi
nis
tra
tionofa
llof
thef
oll
owingEXCEPT
A)Cyanocobalamin
B)Int
ri
nsi
cf act
orconc
entr
ate
C)Ferr
ouss ul
phat
e
D)Foli
cacid

13-Nasa
lc a
rri
ageofMethici
ll
inResi
st
a ntSt
aphyl
ococ
cusAur
eus(
MRSA)
canbetr
eatedwit
hoint
me ntt
hatcont
ains
A)Mupiroci
n
B)Gentamycin
C)Nysta
tin
D)Chlor
a mpheni
col

i14-Oest
rogenst
endtoinc
rea
set
her
iskof
A)Endome t
ri
alcar
cinoma
B)Hirs
uit
ism
C)Heari
ngloss
D)Vi
sua
lpr
obl
ems

i15-Penci
ll
a mi
mei st
hea
nti
dot
efor
A)Copperandlead
B)Iron
C)Co ba
lt
D)Noneoft heabove

i16-
Prost
aglandi
nsa
rec
hemi
cal
lys
imi
lart
o
A)Prote
ins
B)Carbohydr
a t
es
C)Lipi
ds
D)Enzyme s

i17-Ra dioact
ivei
sot
ope
sofwhi
chs
ubs
tanc
ear
eus
edwi
del
yindi
agnos
is
andt
he rapy
A)Ca rbon
B)Iodine
C)Ra dium
D)Noneoft heabove

i18-Ser
trali
neiscla
ssifi
edas
A)Selec
tiveMonoa mi neoxi
daseinhi
bit
or
B)Selec
ti
ves er
otoninreupt
akeinhi
bit
or
C)Tric
yclicant
idepres
sant
D)Dopami nere
c ept
orblocker

i19-ThenormalrangeofFASTI NGbloodgl
ucos
eis
A)3.0-
4.0mmol/L(55-75mg/dL)
B)4.0-
8.0mmol/
L( 75-150mg/dL)
C)8.0-
10.0mmol/L(150-180mg/dL)
D)5.0-
6.0mmol/L(90-110mg/dL)

i20-Thea
ntidi
ure
tichor
monei
sse
cre
tedf
rom
A)Therenalcor
tex
B)Therenalmedul
la
C)Theadrenalc
ort
ex
D)thepost
eri
orpit
uit
ary

21-Thea ntiobesi
tydrugOr l
ist
atact
sma inl
yby
A)I nhi
bit
ionofglucosea bs
orpti
onfromGI T
B)I nhi
bit
ionoffatdigest
ionbyinhibit
ingpancr
eati
cli
pas
e
C)I nhi
bit
ionofbilesalts
e c
ret
ion
D)Che lat
ewi thaminoa c
idsandpreventthe
irupta
kethr
ought
heGITwa l
l
i22-Thea pproxi
ma t
e*****a l
entdoseofLorazepamto5mgofDi
azepa
mi s
A)0. 5mg
B)4mg
C)5mg
D)0. 1mg

i
23-Thebrea
kdownofgl
ycoge
nisi
nit
iat
edby
A)Tryps
in
B)gl
ucagons
C)Pepsi
n
D)Renin

i24-Thedos
eofadrugis0.
5mg/ kgWhatdos
eshoul
dbegi
vent
oa6yr
.
oldchil
dwhoweighs44lbs
.2.
2lbs=1kgappr
oxi
ma t
ely
A)0.003g
B)0.010g
C)0.033g
D)0.05g

i
25-Thedrugofchoi
cefort
rea
tinga
nac
utea
tta
ckofr
e-e
ntr
ant
supr
avent
ri
cul
art
achyca
rdia
A)Ve r
apamil
B)Digit
al
is
C)Propano
lol
D)Phenyle
pher
ine

i
26-Thee nzymesinvol
vedine
tha
nolmeta
boli
smarepe
ima
ril
y
A)Lipas
e s
B)Ketas
e s
C)Dehydrogenases
D)Noneoft heabove
(
@)27-Thel ea
ststa
bleofwat
ers
olubl
evi
taminsi
s
A)Ascorbicaci
d
B)Thia
mi ne
C)Niaci
n
D)Foli
ca ci
d

i
28-Thema i
nfuncti
onoft
hega
llbl
adde
rist
o
A)Concent
rat
ebil
e
B)Sec
retebi
le
C)El
iminat
ebile
D)Noneoftheabove

i
29-Thema jorme
cha
nis
mfde
gra
dat
ionofdr
ugsi
ntheGlt
rac
tis
A)Oxidati
on
B)Hydrolys
is
C)Reducti
on
D)Conjugat
ion

i
30-Thema ni
fes
tat
ionsofMyastheni
aGr
avi
sar
eduet
o
A)hyper
toni
cit
yofsmoothmus cl
es
B)Hypert
onic
it
yofs t
ri
atedmuscle
s
C)We a
knessofst
ri
atedmuscle
s
D)Scle
rosi
sosstr
iat
edmus c
les
i
31-Themos tpr
eva
lentt
ypeofwhi
tebl
oodc
ell
sar
ethe
A)Monoc yt
es
B)Lymphocytes
C)Neutr
ophil
s
D)Basophil
s

32-Thepara
thyroi
dglandisr
esponsi
blefor
A)Pulmonaryfunct
ion
B)Ma i
nta
ini
ngt hepar
asympat
heti
cnervoussys
tem
C)Cardi
acoutput
D)Calci
umme t
aboli
sm

33-Thepri
ma ryf unct
ionofga
s t
roi
ntes
ti
nalvil
liis
A)Facil
it
ati
ngt hepa s
sageofchi
met hr
oughtheGI T
B)Incr
easi
ngt hes ur
facear
eaoftheGIT
C)Tobreakdowna minoaci
dsi
ntosma l
lermole
c ul
es
D)Noneoft hea bove

34-Thes ympatheti
cgangliaar
eloca
ted
A)Nearthehe a
rt
B)Nearthespina lcor
d
C)Nearthea drenalgl
ands
D)Ne a
rt het
issuestheyinner
vate

35-Tocophe
rol
sar
eafor
mof
A)Vita
mi nA
B)Vita
mi nE
C)Vita
mi nD
D)Vita
mi nBcompl
ex

36-Tr
icycl
icant
ide
pres
sant
sshoul
dbea
voi
dedi
nwhi
choft
hef
oll
owi
ng
condi
tions
A)De pres
sedpat
ie
ntswit
hinsomni
a
B)Cl
osedangl
egla
ucoma
C)Di
abeti
cperi
phe
ralne
uropa
thy
D)Noct
urnale
neur
esi
s

37-Whatisthewe i
ghtus
edt
oma
ke1500uni
ts
,ea
chofwhi
chc
ont
ains250
micr
ogra
mofadr ug
A)37.5mill
igram
B)37500mic rogr
a m
C)375milli
gr am
D)3750mi l
ligram

38-Wha twil
lresul
tifthedistr
ibut
ionofdr ugdr
ugsi
ssl
owe
rtha
nthe
proc
essofbiot
r a
naformati
ona ndelimina
tion
A)Incr
ea s
ebloodlevelofdrug
B)De c
reasebloodlevelofdrug
C)Synergis
m
D)Fail
uretoattai
ndi f
fusi
one quil
ibr
ium

39-Whichisr e
c ommende
dfora
cut
ecya
nidepoi
soni
ng
A)Desfer
rioxami ne
B)Dime r
caprol(BAL)
C)Dicobal
te dentat
e
D)Pencil
lamine

40-Whichofthefol
lowi
ngdr
ugsi
ncr
eas
est
her
iskofdi
goxi
ntoxi
cit
y
A)Neomyc in
B)Hydrochlor
thi
azi
de
C)Phenobarbi
tal
D)Oestr
adiol

41-Whichofthef
oll
owi
ngdr
ugsi
scl
ass
ifi
eda
sanHMGCO-
Are
duc
tas
e
inhi
bit
or
A)Probucol
B)Clof
ibra
te
C)Gemfibr
ozil
D)Lovast
ati
n

42-Whichofthef
oll
owi
ngdr
ugsunde
rgoe
sma
redhydr
olys
isi
ntheGlt
rac
t
A)Aspir
in
B)Penci
ll
inG
C)Para
ceta
mol
D)Hydrocor
ti
sone

43-Whi c
hoft hefoll
owingisacont
rai
ndi
cat
ionoff
orTr
icyc
lic
ant
ide
pressant
A)Insomnia
B)Rec e
ntmyoc ardi
alinf
arc
tion
C)Essenti
alhyperte
nsion
D)Noc t
urnaleneures
is

44-Whichofthefol
lowi
ngi
same
tabol
icpr
oduc
tofa
lcohol
A)Acet
aldehyde
B)For
mica ci
d
C)4-methylpyr
azol
e
D)Pyr
idoxine

45-Whic hoft hefoll

owi
ngi
sani
ndi
cat
ionf
orpa
ncr
eat
ice
nzyme
suppl
eme nts
A)Cysti
cf i
brosis
B)Postpa ncreate
ctomy
C)Posttotalga st
rect
omy
D)Alloft hea bove
(@)46-Whi choft hefol
lowi
ngisf
oundi
nvit
aminB12
A)Ma gne ssi
um
B)Ni ckel
C)Co ba l
t
D)Iron
47-Whi chofthefoll
owingisas
soc
iat
edwi
thl
essga
str
ics
idee
ffe
cts
A)Difflunis
al(Dolobid)
B)Ibupr ofe
n( br
ufen)
C)Ke toprofen(Oruvail
)
D)Piroxi ca
m( Feldene)

48-Whichoft hefol
lowi ngisnoti
ndi
cat
edf
orus
einc
hil
dre
nle
sst
han12
year
sold
A)Domperidone(Mot i
lium)
B)Doxycyc l
ine(Vibramyc i
n)
C)Ch l
ora
mphe ni
col(Chl or
omycet
in)
D)As t
emizole(Hismana l)

49-Whi chofthefoll
owi
ngi
sNOTna
tur
all
yoc
cur
ri
ng
A)Oe s
tradi
ol
B)Diethyls
ti
lbest
erol
C)Oestrone
D)Ethinyloest
radiol

50-Whichofthef
oll
owi
ngi
snotus
eda
save
hic
lef
ori
nje
cti
ons
A)Pea
nutoil
B)Cot
tons e
edoil
C)Cor
noi l
D)Theobromaoil
i
51-Whic hoft hef ol
lowingisTRUEa boutORSinsever
ediar
hoea
A)Sugaranda mi noa ci
dsinhibit
ssodiuma ndwat
err
eabsor
pti
on
B)ORSi ncludess odiuma ce
tateandca l
cium
C)ORSi sthet re
a t
me ntofchoiceinchildre
nwit
hdia
rhoea
D)Allofthea bove

52-Whic hofthefol
lowi
ngi
sus
eda
sapl
asmae
xpa
nde
r
A)Sodiums al
ts
B)Sta
rche s
C)Dextrans
D)Calciums a
lts

53-Whi choft hefol

lowi
ngi
sus
edt
otr
eathype
rthyr
oidi
sm
A)L-thyr oxine
B)Thyr oglobuli
n
C)Liothyronine
D)Ca r
bi ma z
ole

54-Whichoft hef oll

owingi
sus
edt
otr
eatpa
rac
eta
molove
rdos
e
A)Acetyl
cysteine
B)Methylenebl ue
C)Pyr
idoxine
D)Methylprednisolone

55-Whi choft hefol

lowi
ngpr
oki
net
icdr
ugi
sadopa
miner
ece
ptor
ant
agonis t
A)Me toc l
opramide
B)Betha nechol
C)Cisapr i
de
D)Busc opan
56-Whi choft hef ol
lowingstat
ementsiscorre
c taboutchlor
hexi
dine
al
coholi
cs olution
A)Chlorhe xi
dinewi l
ldisi
nfec
tthehandsifallowe dtodry
B)Iti
smos tsui t
ablefordis
inf
ecti
onofme di
ca lappl
iances
C)Iti
se ssenti
a ltouseitontheskinbeforevene punctur
e
D)Itprovidest hebe s
ttrea
tmentfori
mpe rti
go
57-Whi choft hef ol
lowingsti
mulate
she pati
cmi crosomalenzymes
A)Phenoba rbi
t one
B)Ma nnitol
C)Urea
D)Noneoft hea bove

58-Whi chofthefol
lowi
ngCANNOTbeus
eda
sapr
ophyl
act
icf
or
migr
aine
A)Pizotif
e n
B)Propano l
ol
C)Me thylser
gide
D)Dihydr oer
gotami
ne

59-Whic
hofthefol
lowingdrugsi
sindi
cat
edf
ort
het
rea
tme
ntofAt
tent
ion
ofDef
ici
tdi
sorde
rsi
nc hil
dre
n

A)Ps
eudoe
phe
dri
ne

B)Dexamphet
ami
ne
C)Venlaf
axi
ne
D)Phenyt
oin

(
@)60-Whichonet
hef
oll
owi
ngi
snota
nes
sent
iala
minoa
cid
A)Thre
oni
ne
B)Glut
ami
ne
C)Tr
yptophan
D)Methi
onine

61-Whichofthef ol
lowingOvertheCount
er(
OTC)medic
ati
onsha
sa
dange
rousdruginter
a c
tionswit
hMonoamineOxi
das
eInhi
bit
ors
A)Chlorpheni
raminema l
eat
e
B)Paracet
amol
C)Pseudoephedr
ine
D)VitaminC

62-Whichs ta
tementi str
ueaboutOt i
tisme di
at r
eatment
A)Localtr
e at
me ntismor ee
ffect
ivetha nsyste
mi cone
B)Eardropsc onta
iningloca
lanasetheticareofgreatvaluei
nthe
managementofpa in
C)Syst
emi cantibi
oticisnee
dedwhe nba c
teria
linvolvementi
sproved
D)Oralantibi
oticusea sapr
ophylacticme asureisnotindi
cat
edfor
rec
urr
entotiti
sme dia

63-Whichsubs t
anc
ecommonl
yfoundi
nfe
rme
nte
dfood,c
anbet
oxi
cwhe
n
MAO,Ia r
eus ed
A)Phenyl
a l
anine
B)Tyr
a mine
C)His
tidi
ne
D)Noneoft heabove

64-Oft hef oll

owinganxi
olyt
ica
gent
s,t
heonet
hatpos
ses
est
hel
eas
t
seda
tinga ctionis
A)Dia zepam( Val
ium)
B)Bu spirone( Bus
par)
C)Meprobamate(
Equani
l)
D)Chl
ordiaze
poxi
de(Libi
rium)
E)Oxaz
e pa
m( Ser
ax)

65-Penici
llinsarebeli
evedtoexer
ttheira
ntiba
cte
ria
lef
fec
tbywhi
choft
he
fol
lowingme chani
sms
A)De t
e r
gente ff
e c
tonthebact
eri
alcellmembrane
B)Inhibit
ionofba cte
ria
lcel
lwa l
lsynthes
is
C)Inhibit
ionofpr ote
insynt
hesi
s
D)Sterichindranceofme mbra
neami noacids

(
@)66-Whi chofthef
oll
owinga
nta
goni
zest
hea
cti
onsofs
ulphona
mide
s
A)St
rept
omyc in
B)Pe
nicil
linG
C)Morphine
D)Pa
ra-ami nobenzoi
caci
d

67-Whi choft hefollowingdr

ugsi
sindi
cat
edf
ort
het
rea
tme
ntofpr
ima
ry
noct
urnale neures
is
A)Ritordine( Yutopar)
B)Des mop ressi
na ceta
te(DDAVP)
C)Me tr
ola zone(Za r
oxolyn)
D)ami l
oride( Midamor )

(
@)68-t hethi
azi
dedi
ure
tic
sde
cre
aset
hee
xcr
eti
onof
A)sodium
B)Urea
C)Urica c
id
D)Bicarbona
te
69-Whichofthefoll
owingor alhypogl
yce
ami
cdr
ugha
sthel
onge
sts
erum
hal
fli
fe
A)Acetohexa
mide( Dymel or
)
B)Chlorpr
opamide(Diabinese)
C)Glyburi
de(Di a
be t
a)
D)Tolbuta
mide(Orinase)

70-Di
clofe
nacsodium( Volt
are
n)i
smos
tsi
mil
ari
nac
tiont
o
A)Buspir
one(Buspar)
B)Dic
yc l
omine(Be nt
yl)
C)Ret
oprofen(Orudis
)
D)Mecamylamine(Invers
ine)

71-Whichofthefol
lowingi
snotpr
oge
sti
n
A)Me st
ranol
B)Nor-et
hindr
one
C)Ethynordi
oldi
ace
tate
D)Levonerges
tre
l

i
72-Agent
susef
uli
nthetreatmentofbronchia
la s
thmaus
ual
ly
A)Bloc
kbothal
phaandbe t
aa dr
energi
cre c
eptors
B)St
imula
teal
pharec
eptorsbutblockbetarec
e pt
or
C)St
imula
tebet
are
ceptorsbutblockal
phar ec
e pt
ors
D)St
imula
teal
phaand/orbetarecept
ors

i
73-Allofthef
oll
owi
nga
reba
cte
ria
linf
ect
ionsExc
ept
A)Choler
a
B)Pl
ague
C)Rabie
s
D)Pert
ussi
s
(
@)74-Whi chofthefollowingst
ate
me ntsconser
ningBis
acodyli
sNOT
t
rue
A)Laxat
iveactionoccurswi t
h6hoursa f
terora
ladminis
tra
ti
on
B)Tabl
etsshouldbea dmi ni
st
ere
dwi thmilktoavoidgas
tri
cir
rit
at
ion
C)Acti
onofs upposi
tori
esoc cur
swithin1houra f
teri
nser
ti
on
D)Tabl
etsshouldbes wallowedwhole

i
75-Thel ocala
naest
het
icmos
tcommonl
yus
edi
nOTCbur
nre
medi
esi
s
A)Be nzocai
ne
B)butambe npi
cra
te
C)Lidoc a
ine
D)Phe nol
E)Tetracai
ne

i
76-Me t
hylcel
lul
oseandsi
mi l
aragent
sar
eus
edi
nopht
hal
mics
olut
ionst
o
A)Inc
reasedropsiz
e
B)Inc
reas
eoc ula
rconta
ctti
me
C)Reduceinf
lamma t
ionoftheeye
D)Reducedropsize

i
77-Themos tpot
entH2r
ece
ptora
nta
goni
st
A)Ome prazole
B)Sucr
a l
fat
e
C)Famotidi
ne
D)Metoclopramide

i78-Whi chse c
ondge
ner
ati
onc
epha
los
por
ini
sava
ila
blea
sapa
rent
era
land
oralme di
cation
A)Ce furoxime
B)Ce phalexin
C)Ce
clor
D)Ce
foni
cid

i
79-Ha loper
idoliscl
ass
ifi
eds
truc
tur
all
yasa
A)Benz odi
azepine
B)Butyrophenone
C)Phenothiazi
ne
D)Tri
c ycli
c
E)Malonylurea

i
80-Chr onictrea
tme ntofrheumatoi
darthr
it
iswi
thi
ndome
tha
cinr
equi
res
ca
rebe causeindome tha
c i
n
A)Isa nanti
-infl
amma t
oryster
oid
B)Ca useheadachesins omepa t
ie
ts
C)Inhibit
sthea ct
ionofpr os
tagl
andins
D)Ca usestac
hyc ardi
a

i
81-Thea minoglycos
idemostl
ike
lytor
ema
inaus
efult
her
ape
uti
cage
nti
n
t
heeventofr e
sis
tancetoGent
amici
n
A)St
reptomycin
B)Neomyc in
C)Ami kaci
n
D)Cepha l
ospori
n

i
82-Zoll
inger
-El
li
sons
yndr
omei
sther
esul
tofa
denoma
sint
he
A)Gall
bladde
r
B)Li
ver
C)St
oma ch
D)Pancr
eas
E)A,
B&D
i83-InExaminingthepati
ent
,thephys
ici
annot
est
hatt
hepa
tie
ntc
ompl
ains
polydeps
iaref
e r
s
A)Exc es
siveUr i
nati
on
B)Exc es
siveappetit
e
C)Exc es
siveWe ightga
in
D)Exc es
sivethir
st
E)B&C

i
84-Whi c
hoft hefol
lowingshouldNOTbea
dmi
nis
ter
edt
oapa
tie
ntbe
ing
t
rea
tedwithna r
rowanglegla
uc oma
A)Dipive
rine
B)Pil
ocar
pine
C)Carbac
hol
D)Homa t
ropine

i85-Al loft hef

oll
owi
ngdr
ugsa
reus
edt
otr
eatpa
tie
ntswi
thope
nangl
e
glauc
omaEXCEPT
A)Ca rba chol
B)At ropine
C)Di pive r
ine
D)Be ta xolol

i
86-Whi chofthef
oll
owi
nga
nti
funga
lage
ntsi
sNOTe
ffe
cti
vea
gai
nst
Candi
da
A)Nys ta
ti
n
B)Clotri
mazole
C)Tolnaft
ate
D)Mi conaz
ole

i
87-Whichofthef
oll
owi
ngs
ulphonyl
ure
asha
sthel
onge
stha
lfl
if
e
A)Tol
butamide
B)Gli
bencl
amide
C)Tol
azamide
D)Chl
orpr
opa
mide

i
88-Side-effe
c t
sofIsot
reti
noi
n(Roa
ccut
ane
)inc
lude
A)Derma t
ologicalr
eact
ions
B)Depressi
on
C)Terat
ogenicit
y
D)Allofthea bove

i
89-Whi chofthef
oll
owi
ngi
sthes
hor
tes
tac
tingMydr
iat
ic
A)At
r opi
ne
B)Pi
locarpine
C)Tr
opi c
a mide
D)A,
B&C

i
90-Tineainfect
ionsa
recaus
edby
A)Virus
B)Fungus
C)Gram-posit
ivebact
eri
a
D)Noneoft heabove

i
91-Prolact
ininhi
bit
ingf
act
ori
s
A)Dopa mine
B)Thyrotr
opin
C)Soma t
ropin
D)Corti
cotropi
n

i92-Whi chofthefoll
owi
ngdr
ugsi
sNOTa
ssoc
iat
edwi
thi
ncr
eas
ed
prola
c t
insecret
ion:
A)Chl orpromazine
B)Me t
oclopra
mi de
C)Br omc r
ipti
ne
D)Me
thyl
dopa

i
93-Thea ct
ionofDi
goxi
nise
nha
nce
dbyal
eve
lofwhi
choft
hef
oll
owi
ng
i
on:
A)Sodium
B)Calc
ium
C)Magne ss
ium
D)Pota
s s
ium

i94-Whic hofthefol
lowi
ngisthef
ir
stdi
agnos
ti
csympt
omofDi
goxi
n
overdose
A)Anor exia
,Na usea
,Vomit
ting
B)Co nst
ipati
on
C)Hi ghbodyte mpera
tur
e
D)Br onchospa
s m

i
95-Whic hofthefol
lowi
ngi
sabl
oodpl
ate
leta
dhe
sioni
nhi
bit
or
A)Dipyr
idamol e
B)Nit
rofura
ntoin
C)Dextr
opropoxyphene
D)Imipr
a mi
ne

i
96-Lidocaineisusedasa
A)Gene r
alanesthe
sia
B)Antipyret
ic
C)Antiarr
ythmic
D)Pre
-a naest
hetic

i
97-Thepr i
nci
palt
oxi
cef
fec
tofHe
par
ini
s
A)Bronchospa
sm
B)Chil
ls
C)Hairl
oss
D)Ha
emor
rha
ge

i
98-Thetwoma j
orproperti
esofdrugst
hata
reus
ual
lymodi
fi
edby
compl
exati
ona re
A)Odorandtast
B)Tasta
nds ol
ubilit
y
C)Chemicalst
ructur
ea ndsolubi
lit
y
D)Chemicals
truct
ureands t
abili
ty
E)Sta
bil
ityandsolubil
ity

(@)99-PHi s
A)Nottemperat
uredepende
nt
B)Ame a
sur
eofa ci
dit
y
C)Thes a
mea sPOH
D)ighforac
ids
E)Noneoftheabove

i
100-Sucral
fat
eisuse
dtot
rea
t
A)Pept
iculcer
s
B)Carc
inoma
C)Calc
iumde pl
eti
on
D)Obesit
y